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QUALITATIVE REPORTS OF MICHIGAN MEDICAL MARIJUANA  
PATIENTS AND CAREGIVERS INCLUDING 
 REDUCED OPIATE USE, DISPENSARY OPERATIONS,  
LEGAL CONCERNS, AND MARIJUANA STRAINS 
Chapter 1:  BACKGROUND
Introduction:  
The use of marijuana has been a particularly contentious issue in the United 
States for many decades.  This is unexpected since, until the 1937 Marijuana Stamp Act 
(P.A. 238, 75th Congress, 50 Stat. 551, Aug. 2, 1937) marijuana was common and 
grown throughout the country as a commodity that provided oil, fiber, food, and 
medicine.  Marijuana use in world history is also extensive, predating the written 
historical record by many thousands of years.  This substance, once commonly used by 
physicians for a variety of medical treatments, has gone from a commodity used across 
the globe for a number of purposes, including for medicinal purposes as a medicine, to 
totally banned in almost every country.  A resurgence in the use of marijuana in the 
1960’s was met by the counter-force of U.S. federal law and a variety of international 
treaties instigated by the United States government which legislated in 1970 that 
marijuana was a “schedule I drug” with “no legitimate medical use and a high propensity 
for abuse” (P.A. 91513, 91st Congress, 84 Stat. 1242, Oct. 27, 1970). 
Despite marijuana prohibition, recently there has been an increase in claims 
about potential medical uses for marijuana.  By 2013, the perceived efficacy of medical 
marijuana as a palliative for a number of diseases and conditions and even as an actual 
treatment prompted 17 States and the District of Columbia to legalize the medical use of 
marijuana in opposition to federal law while two States, Washington and Colorado, have 
legalized marijuana for all purposes.  These diverse views on marijuana have caused 
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numerous conflicts on the political scene, as well as confrontations between extremists 
on both sides. 
Although much has been written about marijuana use in contemporary popular 
media, these have tended to focus, until very recently, on validating the governments 
unambiguous anti-marijuana position.  A calmer, more reasoned and balanced analysis 
of the different perspectives of individuals who have specific concerns regarding the use 
of marijuana is needed. The major problem is that until very recently the perspective of 
marijuana users has not been the focus of the media, academia, medicine, and 
scientific research.  Meanwhile, the courts, law enforcement, and other government 
agencies have used harsh tactics to subject marijuana users to penalties and thereby 
marginalize them and made research on the population of users, and on the banned 
substance itself, extremely difficult.  As a result, there has been no almost no 
dispassionate analysis, almost no research, no funded clinical studies, and little 
research whatsoever since the 1950s on the people who have committed themselves to 
the use, provision, and supply of marijuana or the people claiming a medical need to 
use medical marijuana.  
The researcher of this study is medical marijuana patient in Michigan his 
physician approved certification card was issued by the State in 2008, the same year 
the Michigan Medical Marijuana Act was enacted into law by public referendum. For this 
dissertation, the initial idea was to explore one central question: is medical marijuana a 
legitimate medicine or a ruse to legalize marijuana?  This question encapsulates the 
societal dialectic on the issue of marijuana use with a clear split between users and 
supporters of Marijuana and non-users and detractors.   
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However, it quickly became apparent, the data being collected from medical 
marijuana patients was decidedly one sided and was going to strongly affirm the 
efficacy of marijuana as medicine. Thus the research question developed into a 
advocacy oriented approach with the search for finding the “ruses” in medical marijuana 
use changing to the more grounded, exploratory task of presenting the less researched 
side of the marijuana question; the perspective and views of marijuana users.  Thus, 
there is no representation that this data is unbiased. In fact, this data collected for this 
dissertation were all collected from patients and providers and is decidedly one-side of 
this complicated issue that should be read in that context.  In presenting the views of 
medical marijuana patients and caregivers, the aim of this paper became, and is, at 
least in part, a vehicle for the purpose of claims making and legal reform in favor of the 
pro-medical marijuana position and against the anti-marijuana position. 
The methodology of the data collection employed in this study arose primarily 
from an assumption that two distinct and polarized groups are represented by pro- and 
anti-marijuana social forces and that this societal split has been exacerbated by the 
increasing number of states that have legalized or allow the use of medical marijuana.  
The historical and social literature research led to this assumption even before the 
earliest collection of data which is that the pro-marijuana forces have not been given an 
equal voice in the ongoing social debate about marijuana.  Literature research very 
quickly and unambiguously revealed that little is known about the medical marijuana 
using population of the United States and less about the medical marijuana population 
in the state of Michigan.  Then, from the very earliest collection of data, it became very 
obvious that the answer to the initial question:  Is medical marijuana a “ruse” to legalize 
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marijuana or is marijuana actually being used as a medicine by some patients was 
going to be very clear:  Despite the claims of federal law, the popular media, political 
figures, and law enforcement, marijuana was and is being used as medicine, by at least 
some individuals, at least some of the time.  However, since the pro-marijuana forces 
have not been given an equal voice in the ongoing social debate about marijuana, there 
has been insufficient research on the topic of medical marijuana use and on the medical 
marijuana population.  
Therefore, the primary purpose of this study was to identify the unique 
perspectives of the marijuana using population, including the producers.  Despite 
considerable research on the negative effects of marijuana in the journals and 
presented in the media, there is, by comparison, almost no research on medical 
marijuana and even less research on the opinions and feelings of the population of 
marijuana users who feel that it is medically necessary.  Therefore, uncovering the 
perceptions, concerns, thoughts, ideas, and words of an understudied segment of 
society, the medical marijuana population in Michigan was the main objective of this 
study. 
In addition, the imbalance in the available research between pro and anti-
marijuana views within the government, law enforcement, popular culture and media 
became a primary driving force for this research.  The observation that the pro-
marijuana forces have not been given an equal voice in the ongoing social debate left a 
great deal of room for research of this topic.  Very little effort has been expended to 
discover the positive aspects of marijuana or the perspective of medical marijuana 
users and producers whose unique perspective about legal enforcement, organizational 
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structures, and the use of marijuana as medicine is relevant to the debate.  While there 
is certainly considerable research on the negative effects of marijuana in the journals, 
presented in the media, and funded by various federal agencies, there is almost no 
research on medical marijuana, and even less research on the opinions and feelings of 
the population of marijuana users who feel that it is medically necessary.  This creates 
an unbalanced split in society between the “pro” and “anti” marijuana groups. 
The Cannabis Dialectic:   
The dialectical form of argument is an attempt to resolve a highly polarized 
dispute by reasoned debate of the two sides and the formation of a generally agreed 
upon, logical conclusion. Hegel (1831, The Science of Logic), as later popularized by 
Kant and Marx, termed one side the “Thesis” and the other, the “Antithesis,” with an 
ultimate “Synthesis” usually resulting from a reasoned Socratic debate. A Hegelian 
Dialectic requires an intractable dispute not readily resolved, either because the 
premises are not predicated on logic, or there is not a single, logical conclusion. This 
true polarization of perspectives results because each side is convinced of the 
righteousness of their position this certainly describes the longstanding arguments 
about medical marijuana. The characteristics and views of patients and caregivers on 
the legalization and medical marijuana debate are important to a better understanding 
this “cannabis dialectic.”   
The two sides in the social debate about marijuana have predictably had very 
different responses to the legalization of medical marijuana in California. It was ratified 
by ballot initiative (Proposition 215, Nov. 5. 1996). It was passed by the electorate with 
approval from 56% of California voters. Rolling Stone magazine argued in response to 
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the proposition that the war on marijuana exists for “political purposes” and was 
“completely outside of medical considerations” (Akhavan 1997).  On the other hand, 
The New Republic argued that Proposition 215 serves as a front for drug legalization 
advocates and that medical cannabis clubs are populated by a "sorry lot of smokers 
who are not sick" (Akhavan 1997).  
Because of this dialectical social split, public perception about the actual 
characteristics of patients is extremely polarized with each side crafting an image of the 
marijuana population.  On one side, pro-medical marijuana activists characterize the 
issue using broad, largely unsubstantiated claims about the medical efficacy of 
marijuana and heart breaking stories of desperately sick patients who just want access 
to their “medicine.”  They claim to see a group of desperately ill patients who want to be 
left alone, so they can die in peace. The other side claims to see a group of 
malingerers, criminals, and drug addicts, who need to be regulated and controlled. They 
highlight the demonstrated dangers of marijuana, deny the efficacy of marijuana as 
medicine, and respond with loud cries of fraud alleging that the entire movement is a 
covert strategy to legalize all drugs for recreational purposes.  Despite the starkly 
contrasting images each side portrays, there is no academic research describing the 
Michigan medical marijuana population from the perspective of patients and providers, 
and almost no research attempting to describe the patient population in other States. 
The perspective of actual medical marijuana patients in this ongoing and widely 
commented upon public debate about marijuana has been almost completely 
overlooked despite the vitally important, albeit biased, views of this selected population. 
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Meanings Attached to Marijuana Use:   
The social group of medical marijuana users and suppliers, and the meanings 
they assign to the role of being a medical marijuana user have therefore gone through a 
dramatic transformation in the last few years. The search for meaning in this group has 
not been completely overlooked and has been a topic in sociology since Becker’s 
“Becoming a Marijuana User” in the 1950’s (Becker 1953).  Becker used a 
dramaturgical approach derivative of Ervin Goffman’s methodology to describe how 
participants adopt the role of marijuana users. The goal of this dissertation was similarly 
to present an interpretive structure that describes the meaningful social actions and 
interactions of legal medical marijuana use and reveals the meanings that users attach 
to the use of different types of medical marijuana. Though it would be fascinating to 
study the country as a whole and look at the regional differences associated with the 
meanings of medical marijuana, the focus of this study was limited to Michigan.  
Clearly, in the minds of the medical marijuana community, there is a strong belief 
that marijuana is a valid, safe medication that helps a number of conditions. While, 
those who believe in continued universal prohibition perceive marijuana as a dangerous 
drug with significant adverse health consequences and its potential use leads to the 
abuse of even more dangerous drugs. Thus the ultimate question for “medical 
marijuana” is whether marijuana is actually being used as a medicine or being abused 
as an intoxicant. The validity, safety and efficacy of marijuana as medicine is the pivotal 
issues for medical marijuana. If marijuana is a safe and legal drug that treats a number 
of medical conditions then the arguments of the anti-marijuana groups becomes 
substantially compromised. On the other hand, if marijuana is a dangerous drug with 
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significant side effects that do not actually treat or ameliorate the symptoms of several 
medical conditions then the arguments of the pro-marijuana groups becomes 
substantially compromised.  
The topics of the data collection were greatly influenced by the narrow time frame 
and the unique social and legal climate in which they took place.  Data collection was 
done during the time when the medical marijuana dispensary distribution network in 
Michigan was active and concluded one month before the Michigan Supreme court 
decision in People vs. McQueen outlawed dispensaries in Michigan.  Therefore, much 
of this study sheds light on a period of time prior to the current interpretation of the law.  
This data is still valuable insofar as it provides a social and legislative model for legal 
marijuana distribution in Michigan after McQueen.  
The marginalization of marijuana users is a relatively modern development.  In 
many social/political circles, marijuana is considered criminal and distasteful for any 
reason medical or otherwise. However, the use of marijuana is as pervasive and as 
persistently stubborn as the discrimination against marijuana users. The war on drugs 
continues even as many of the leaders of our society defend their experiences with 
marijuana. While there is a clear trend towards marijuana use being less and less of a 
scandal for political figures, it still creates a media frenzy when people who must have 
transparent social backgrounds and ideologies are discovered to have used marijuana 
purely for recreational purposes: 
-Current President Barrack Obama Who stated at a debate in 2007:  “Of course I 
inhaled, that was the point” (Venkataraman, 2007); 
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-Former President Bill Clinton who admitted in 1991:  “I did smoke marijuana, but 
I never inhaled” (Kurtzman, 2000);  
-Former Vice-President Al Gore who stated in 1987:  “When I was young, I did 
things young people do. When I grew up I put away childish things” (Gore, 1990);  
-Former Speaker of the House and former Republican candidate for President 
Newt Gingrich who stated in a column:  “[smoking marijuana]." was a sign we were alive 
and in graduate school in that era” (Gingrich, 2010).  He was joined by countless 
doctors, lawyers, professors, and engineers, among others. 
The history of Marijuana as a plant with Medicinal properties reaches back 
through thousands of years of history, moves up through the very foundations of our 
nation, and has played a surprisingly important part in U.S. history. The current state of 
marijuana use as a federal crime, when there is evidence it has a possible legitimate 
medical usage, is an interesting and unique social phenomenon. The modern social 
stigma on users, including those who use it for relief of suffering, has developed over 
time. Its development in history itself frames the current dichotomy in opinion about this 
controversial plant.  One side of this social debate has dominated popular culture, 
media, and government efforts for many years.  This paper is one answer to these 
many years of efforts to demonize marijuana users and is committed to presenting the 
perceptions and views of users and suppliers of medical marijuana in Michigan. 
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Chapter 2:  LITERATURE REVIEW 
Introduction:   
The history of hemp began thousands of years ago, long before the start of 
recorded history.  Before it was a target in the War on Drugs, hemp was an important 
cash crop, with many uses and many products were derived from the plant. The 
cultivation and use of marijuana in both World and American history is startling when 
the contemporary stigma of marijuana is dissected. Today’s legal issues, in particular 
the entire history of the War on Drugs and the more recent issue of medical marijuana, 
when viewed in historical context, provide some unexpected insight. One of the keys to 
better understanding the population of medical marijuana users, including obtaining a 
preliminary understanding of the demographics, the social and economic correlates and 
the meanings that patients attach to the use of marijuana, requires an exploration the 
meanings attached to marijuana and hemp use, both by the users and by those who 
stigmatize the users.  
There is little modern research on the medical marijuana population and that 
which exists has employed qualitative interview designs (Chapkis 2008). There has only 
been one study (published in a non-peer reviewed journal) detailing the demographics 
of the marijuana population in California (O’Connell  2007) and no such study has been 
published on the Michigan medicinal marijuana population. This lack of research is a 
consequence of a long and complicated history of hemp and cannabis in the United 
States. Therefore, to understand the status of research and how the current legal 
climate affects the type of data that can be collected in support or refutation of “medical” 
marijuana. It is important to review the status of this substance in our history. 
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The History of Hemp:   
Marijuana has been used in many ways for thousands of years and may even 
have been the first plant cultivated by hunter-gatherer groups (Herer 2000, Sagan 
1986).  “Primitive” hunter-gatherer bands did not wander aimlessly through the 
wilderness, but often completed a yearly circuit of their ranged habitat, returning to 
various areas during the times wild crops were ready for harvesting. Primitive humans, 
therefore, picked berries in one area. Then, when the supplies were depleted, they 
would pick wild rice in another, and it is likely they did the same thing when the 
marijuana plants were in bloom (Diamond 1998). Hunter-gatherer groups eventually 
settled in areas such as the Nile River Valley and the Fertile Crescent region of modern 
day Iraq located in the valley between the Tigris and Euphrates rivers. Each of these 
river valleys which are often called the ‘cradles of civilization’ overlap with the natural 
range of cannabis. This fact, considered in light of the ease of marijuana cultivation, the 
multiple uses of the plant, and the substantial increase in yields that can be achieved 
with minimal cultivation intervention, gives considerable weight to the notion that 
marijuana may have even been the first crop ever cultivated.  
Marijuana is a dioecious plant which means it has clear and obvious male and 
female genders that are quite unlike any other cultivated or wild-type crops. In 
particular, the mature (female) flowers of the marijuana plant are eagerly consumed by 
practically every mammal and even some birds (Begg 2005). There is no doubt the 
attraction of these flowers would have made the plants useful for lure as “baiting” which  
is still practiced today. 
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The strongest evidence that marijuana was actively cultivated in this way by early 
humans is indirect but persuasive.  As with any plant, active cultivation, regular 
weeding, fertilizing, protection against predation and so on will dramatically increase 
yields, but marijuana is unique in this regard.  Only a small amount of attention and 
cultivation work results in an increase in crop yield, especially yield that is not lost to 
predation that is remarkable (Rosenthol 2010).  In addition to this fact, anthropological 
evidence suggest that hemp was the first plant to be domesticated for human use, and 
these claims certainly abound at a number of activist web sites.  This contention is 
supported by one of the earliest pieces of agricultural evidence ever discovered. A 
hemp cord imprint on a shard of pottery was discovered in Central Asia dating back to 
25,000 B.C. (Herer 2000).  This suggests the cultivation and use of hemp in central Asia 
has been pursued for at least 27,000 years. 
The earliest evidence for the use of marijuana as a medicine was found in 
ancient Egyptian excavations dating from as early as 1600 B.C. One recovered 
document claimed that marijuana was used for pain relief, Asthma, and Gout. Ancient 
Hebrew excavations confirm this text and provide other texts, recommending the use of 
marijuana in childbirth around this same time (Herer 2000).  
The idea for using marijuana in a recreational manner does not appear in the 
historical record until the Greek historian Herodotus described the Scythians communal 
use in 440 B.C.  Herodotus noted that the nomadic culture sat around the fire, “creeping 
under the felt booths.”  They threw collected cannabis tops into a dish placed atop red 
hot stones:  “Immediately it smokes, and gives out such a vapor as no Grecian vapor 
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bath can exceed.”  This activity “delighted” the Scythians causing them to “shout for joy” 
(Id). 
By 1492, each of Columbus’ three ships carried some 80,000 pounds of hemp, 
primarily in the sailings, ropes and riggings (Booth 2005).  In the United States, hemp 
was an important cash crop for the Colonies. The first law on agriculture ever 
promulgated in the New World was in America’s Jamestown Colony, Virginia in 1619 
ordering all farmers to grow Indian hempseed. There were several other “must grow” 
laws over the next 200 years (farmers could be jailed for not growing hemp during times 
of shortage in Virginia between 1763 and 1767), and during most of that time, hemp 
was legal tender.  Citizens could even pay their taxes with bales of hemp (Id). 
Throughout history, Hemp has been a constant part of the growing and 
expanding global society and was used for clothing, rope, medicinal purposes and 
paper. The Magna Carta and the U.S. Constitution were written on hemp paper, 
although this has been recently disputed. In 2006, the tour guides who present the 
Declaration of Independence and the U.S. Constitution at the National Archives claimed 
the original documents were written on hemp paper.  However, the National Archives 
web site now claims that hemp paper was not used and that copies of the documents 
were transcribed onto parchment rather than hemp paper (National Archives 2013). 
This recent change of the historical record by the National Archives in Washington D.C. 
scrubbing cannabis from U.S. history is interesting in light of the marginalization of 
marijuana that affects medical marijuana users and which is particularly interesting in 
light of the fact that historically marijuana was not merely considered useful but 
essential. This idea, strange to contemporary perception of marijuana, is exemplified by 
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two of the men that our society holds up as examples of what a citizen of the United 
States should emulate. 
Thomas Jefferson, the drafter of the Declaration of Independence and 3rd 
President of the United States was a strong advocate of hemp growing.  In one speech 
Jefferson said, “Hemp is of first necessity to the wealth & protection of the country.”  In 
his Garden Book Jefferson writes, “An acre of the best ground for hemp, is to be 
selected and sewn for a permanent hemp patch" (Jefferson 1849). According to 
presidential historians another quote has been misattributed to Jefferson,  “Some of my 
finest hours have been spent on my back veranda, smoking hemp and observing as far 
as my eye can see" (Monticello 2011). The authoritative cite for these Jefferson quotes 
was provided in an earlier draft of this paper at:  
www.wiki.monticello.org/mediawiki/index. php with a copy of the full speech given by 
Jefferson and a complete scanned copy of his “Garden Book.”  However,, the 
information was apparently altered after 2011 by the webmasters at Monticello. The 
above link is now broken, and all references to “hemp” use have been removed from the 
site except a link that redirects the above link (which was last available in 2011) 
containing a paragraph denying that Jefferson ever said anything about smoking hemp. 
Despite the (apparent) rewriting of the historical record, there is even better 
evidence that President George Washington, the first President, grew (and smoked) 
marijuana for its psychoactive properties. A scanned copy of Washington’s handwritten 
diary from the library of Congress states:  (the slaves working his farm) “began to 
separate the male from the female hemp plants rather too late” (Washington 1765).  
This strongly suggests Washington was growing hemp to use in smoking preparations 
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since keeping the female hemp plants from being seeded is only important if the 
intention is to smoke the female flowers. A grower would want seeds if he were 
extracting various food products or oils and the grower would not care whether there 
were seeds if the intent was to grind the seeds and stalks into rope or textiles 
(Rosenthal 2010).  The use of marijuana was not remotely marginalized during the 
youth of the United States but was considered useful and productive. 
Similarly, the medical use of hemp products was commonplace in Colonial and 
early America. Over 100 articles recommending hemp for medicinal purposes were 
published between 1840 and 1900 alone (Herer 2000). Hemp was an important part of 
the pharmacopoeia from 1870 up until 1937, when the Marijuana Tax Act effectively 
banned the plant from public consumption regardless of its intended use (Chapkis 
2008). Hemp extracts were used by physicians as a painkiller during childbirth, as a 
palliative for gonorrhea symptoms and to effectively treat asthma and anxiety patients. 
The medical uses of hemp were very well-documented in standard pharmacological 
texts. The question then remains why there is such a social stigma and strong legal 
prohibition on users of marijuana in the United States today. How did this plant go from 
being used as legal tender and a common medical treatment to a criminal and tightly 
regulated product? 
Racist Origins of the “War On Drugs?”   
After the early 1900’s, the story of marijuana in World History took a turn, making 
it even more accessible to analysis using the sociological lens and, in particular, the 
conflict paradigm. As in contemporary America, the South-Western states developed 
increasing problems with the huge influx of “undocumented” Mexicans following the 
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Mexican revolution of 1910. With the Depression, which hit the United States about 20 
years later, the problems became more severe as jobs and welfare resources became 
scarce. The people began to elect representatives who promised to solve the problem 
and marijuana use among Mexican immigrants was a useful foil. 
As early as 1905, newspapers began a campaign to negatively portray marijuana 
as a drug used by the lower classes. One column claimed marijuana was linked to 
“super-human, soul-bursting feats of valor by Latin American revolutionaries” (Gieringer: 
28, 1999 quoting:  “Terrors of Marihuana,” in the Washington Post, Mar 21, 1905 p. 6). 
The desire to clear the country of illegal Mexican immigrants became more important 
than the desire to continue using a plant that was claimed to be commonly used by 
those immigrants. California passed the first State marijuana law, outlawing 
“preparations of hemp, or loco weed.”  Other states quickly followed with marijuana 
prohibition laws in Wyoming (1915), Texas (1919), Iowa (1923), Nevada (1923), Oregon 
(1923), Washington (1923), Arkansas (1923), and Nebraska (1927) (Herer, 2000).  
Commentaries about the dangers of marijuana became increasingly common in 
years leading up the 1937 Marijuana Stamp Act as the anti-marijuana claims makers 
built their case.  Many popular newspaper articles at the time described the violence 
caused by marijuana. One columnist wrote: 
Hasheesh will turn the mildest man in the world into a blood-thirsty murderer. 
The man who takes hasheesh ‘runs amuck’ with his bloody knife in one hand 
and his strangling cloth in the other, and he kills, kills, kills, until the hasheesh 
has burnt out its deadly flame (Gieringer 29, 1999). 
 
In the Eastern States, the “issue” of marijuana use was attributed to “negro” jazz 
musicians from New Orleans, to Detroit, Chicago and Harlem. One 1935 newspaper 
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editorialized: “Marihuana influences Negroes to look at white people in the eye, step on 
white men’s shadows and look at a white woman twice” (Abel, 1980). 
 This sentiment of degradation and marginalization toward the Mexican classes 
was often promoted in the media at the time. 
Marihuana is a weed used only by people of the lower class and 
sometimes by soldiers, but those who make larger use of it are prisoners 
sentenced in long terms…[we are seeing]…the increasing use of marihuano 
[sic] or loco weed as an intoxicant among a large class of Mexican laborers, 
(Gieringer: 20, 1999). 
 
And while there is no doubt that Mexican immigration increased greatly after the 1910 
Mexican revolution, it was not until the late 1920s and 1930s with the Great Depression 
that this became classified as a ‘social problem.’  Significant anti-Mexican sentiment 
quickly developed as competition for scarce jobs became fierce.  
However, other research has refuted the ‘racism’ meme.  The argument that 
marijuana was used as foil against Mexicans is undercut by the fact that none of the 
major anti-Mexican groups concerned with Mexican labor and crime problems 
mentioned their use of marihuana at the time (Meier and Ribera1993). 
The Campaign Against Marijuana: 
 The claims of anti-marijuana crusaders at the time, like the contemporary claims 
that marijuana is “medical” were not substantiated by any scientific research or medical 
testing.  This allowed the propagation of patently ridiculous claims such as:  “People 
who smoke marihuana finally lose their mind and never recover it, but their brains dry 
up and they die, most of the time suddenly” (Gieringer, 1999). The papers of the time 
also claimed that the marijuana was more potent than morphine and that “the habitual 
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user of mariahuana [sic] finally loses his mind and becomes a raving maniac” 
(Gierenger 1999). 
The campaign against marijuana was accelerated by the campaign of Harry 
Anslinger, head of the federal Bureau of Narcotics from the 1930’s to the 1960’s. 
Anslinger claimed that police officials in cities of those states where it [marihuana] is 
most widely used estimate that “fifty per cent of the violent crimes committed in districts 
occupied by Mexicans, Spaniards, Latin-Americans, Greeks or Negroes may be traced 
to this evil” (Chapkis 2008).  While this may well have been the case, there was no 
research supporting the claims.  Separating the forces that marginalize groups such as 
poverty, unemployment, and maladaptive social influences from the propensity to turn 
towards mind-altering substances can be very difficult.  Rather than asking whether 
illegal marijuana use was co-incident with other crimes and if those tending to be violent 
criminals might also be more prone to violate the law and use marijuana, Anslinger and 
the media claimed that marijuana was the “cause” of violent crime:  “[H]abitual users of 
the drug are said eventually to develop a delirious rage after its administration during 
which they are temporarily, at least, irresponsible and prone to commit violent crimes 
(Id). 
Anslinger’s 1961 Book:  The Murderers: The Story of the Narcotics Gangs 
describes the alleged physical effects of marijuana creating misconceptions about the 
effects of the drug that are pervasive even today and which include “vivid kaleidoscopic 
visions… and an increased feeling of physical strength and power.” (Anslinger 1961) 
Hollywood also entered the battle at this time with iconic films like “Reefer 
Madness,” in 1936, which was originally a serious attempt at propaganda against 
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marijuana (Sloman 1998). This film was used as a scare tactic and includes scenes 
where the use of marijuana use causes a hit-and-run accident, murder, suicide and 
insanity. The climax of the movie features a young woman “high on marijuana” 
inexplicably leaping to her death through the window of a high rise while her boyfriend, 
a wild eyed, twitching man in a courtroom is sentenced to an asylum for the “criminally 
insane for the rest of [his] natural life.”  The movie ends with the camera zooming in on 
the announcer who sternly warns while pointing his finger at the audience: 
If their stark reality will make you think, will make you aware that something 
must be done to wipe out this ghastly menace, then the picture will not have 
failed in its purpose....Because the dread Marihuana may be reaching forth 
next for your son or daughter....or yours....or YOURS! 
 
With these powerful images, it is not surprising that the drug was soon considered the 
“Assassin of Youth” (another 1930’s era anti-marijuana film), and that it had to be 
stopped. The anti-marijuana campaign and the claims making by government, law 
enforcement, and other interests worked. The 1937 Marijuana Tax Act passed 
Congress and instituted an elaborate set of rules that effectively made hemp cultivation 
illegal in the United States (Marihuana Tax Act, Public Law 238, 75th Congress, 50 Stat. 
551 (Enacted: Aug. 2, 1937). 
Meanwhile, the medical use of marijuana was suddenly claimed to be non-
existent. Anslinger himself stated:  “The medical profession after many such 
experiments was forced to drop the narcotic as a possible analgesic because of this 
unpredictable quality” (Id: 27-28). This claim contradicted the physicians who testified 
before federal committees in defense of medical marijuana and the position of The 
American Medical Association (AMA) which came down strongly against the removal of 
marijuana from the physician’s tool chest in the 1930’s (Chapkis 2008).  However, the 
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medical uses of cannabis could not withstand the concerted onslaught of negative 
associations with marijuana and political motivations overshadowed medical concerns. 
The sudden and severe public reaction to this "new" drug in the 1930’s was 
intense considering that no one in America had even heard the word "marijuana" until 
the late 1920s. The very word “marihuana (later spelled "marijuana") was invented in 
the early 1930s to “confuse Americans who had positive associations with hemp, a 
major cash crop, and cannabis, a well-known medicine and mild intoxicant” (Chapkis 
2008). The federal strategy was to assign various social problems to the “new” drug 
“marijuana” which permitted legislation banning an otherwise commonly known and 
accepted substance (Herer, 2000). 
Nixon and the Modern War on Drugs:   
In the 1969 case of Leary vs. United States, a critical part of the 1937 Act was 
ruled unconstitutional. The government quickly responded with the Controlled 
Substances Act of 1970 which declared marijuana a schedule 1 drug with “no legitimate 
medical purpose” (21 USC 81 et seq) and instituted severe penalties for the use and 
possession of marijuana. 
Despite the federal position, the 1960’s saw a time of greatly increased use of 
marijuana, primarily by those in the anti-war movement as a counterculture response. 
With this increasing influence of the “Hippy Culture” and the “Peacenicks” use of 
marijuana, President Nixon ordered the Shaffer Commission on Marijuana and Drug 
Policy to issue a report. The Commission studied the issue and concluded:   
Marijuana users are essentially indistinguishable from their non-marijuana 
using peers by any fundamental criterion other than their marijuana 
use….Neither the marijuana user nor the drug itself can be said to 
constitute a danger to public safety (Nixon1972). 
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President Nixon ignored his commission and instead began America’s longest and most 
costly war, the War on Drugs. 
In contrast to the caricatures about violent marijuana users, the War on Drugs 
has led to real violence involving marijuana. Unlike the faux stories in the papers during 
the 1930s, today people really are dying on an almost daily basis over a drug that has 
few side effects, has never caused a substance related death, and may even have 
medicinal properties. The War began as most wars do with relatively minor skirmishes 
in the earliest part of the 20th century with State actions in response to Mexican 
migration. The War grew and today it does not respect territory or nationality. In August 
of 2010, Mexican National Security Director Guillermo Valdes Castellanos claimed that 
28,000 people have been killed since 2006 when President Felipe Calderon began 
cracking down on the drug cartels (Brice 2010). Daily shootouts at the Mexican border, 
mass graves (Reuters 2011), and the increasing violence of the drug gangs are adding 
to nativist fears which are hardly unfounded. The killings regularly spread across the 
border. 
The cost in lives taken by law enforcement and rival gangs delivering a product 
that is both illegal and popular is not the only cost of the war on drugs. A 2010 study by 
Harvard economist Jeffrey Miron estimated that legalizing marijuana would inject nearly 
$7 billion a year into the U.S. economy through tax revenues and decreased 
incarceration costs (Miron, 2010). However, an argument could be made that as an 
economist, rather than a sociologist, Miron underestimates the savings and the ultimate 
societal costs of prohibition. In 2008 alone, there were over 800,000 arrests for 
marijuana. With costs of $27,000.00 per year per inmate the total cost potentially related 
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to those arrests amounts to more than $22 billion (Bureau of Justice Statistics, 2010). It 
is easy to see how the massive amount of money spent on hunting down marijuana and 
incarcerating marijuana users influences the perception that marijuana, and its users, 
are criminal and a menace to society.  
The unintended consequences of the anti-marijuana law and policies also include 
more than mere financial costs. As a trial lawyer for several years, this researcher has 
witnessed some of the adverse consequences of marijuana prohibition, particularly 
among minority populations. In my observations, even before beginning this research, it 
is beyond doubt the persecution of those who use marijuana diminishes that 
population’s confidence in the police and governmental institutions and causes 
increased racial, ethnic, and socioeconomic polarization with the widely held perception 
that disadvantaged groups are disproportionately targeted.  By allocating societal 
resources towards military, police and prison operations and away from medical, mental 
health, and private/public charitable endeavors, this problem has become greatly 
compounded with an ever increasing prison population (Peters 2010).  These problems 
reflect the current societal and legal stigmas on the use of marijuana and any medical 
use of marijuana is tainted by the war on drugs. The perception created by the media 
and the government may be relatively new and contrary to the earliest history of the 
United States, but it is now pervasive and causes considerable legal and emotional 
problems for medical marijuana users. 
The anti-marijuana view has been promoted by the fact that scientific research 
on marijuana is strictly limited by the government. The research acquisition process is 
so cumbersome that few scientists have been able to successfully navigate it. The 
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Marijuana Stamp Act of 1937 outlawed the growing of hemp unless the grower 
possessed a stamp, but then the government never issued the stamp. Similarly today, 
the government today claims that scientists are free to conduct research on marijuana 
while at the same time denying legal research marijuana. 
The appropriately dated written statement of Robert Meyer, Director of FDA 
Office of Drug Evaluation before the House Subcommittee on Criminal Justice and Drug 
Policy on April 1, 2004 is illustrative of the government position on marijuana research: 
Researchers who wish to conduct clinical studies of marijuana must first 
contact NIDA to make an inquiry to NIDA to determine the availability and 
costs of marijuana. If NIDA determines that marijuana is available to support 
the study…If the researcher is proposing a study in humans, after obtaining 
the right of reference to the DMF, the researcher must proceed through the 
FDA process for filing an IND application under 21 CFR part 312…In 
addition, all researchers must obtain from DEA registration to conduct 
research using a Schedule I controlled substance (Meyer 2004). 
 
In order to better understand the gravity of complying with this overlapping web of 
regulations and hurdles, a very brief overview of the process put in place by the DEA 
just to obtain the licensing that is required is germane.  Issuance of a controlled 
substances license, the last requirement listed in the above quote, enables a researcher 
to submit an application to obtain marijuana from the National Institute of Drug Abuse 
(NIDA). However, just the Table of Contents from this section in the Code of Federal 
Regulations on what is needed to “obtain from DEA registration to conduct research 
using a Schedule I controlled substance” comprises 35 statutory sections and runs for 
more than six pages of single spaced type. Nor are bureaucratic hurdles the only 
obstacle.  The main barrier to marijuana research is the NIDA policy which openly 
admits they will only grant a controlled substances license and the legal marijuana on 
which to conduct research, to individuals who are studying the harmful effects of 
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marijuana. Studies using research marijuana on the potential beneficial effects are  
stymied in the United States 
The War Against Marijuana Research:   
There are several instructive case studies that illustrate the anti-marijuana bias in 
research approval and funding. In 1994, Dr. Abrams of the University of California 
received the first marijuana from NIDA for medical research in more than 10 years. 
However, to get funding for his study which had been approved by the FDA more than 2 
years before, he was forced to reframe the research questions. The FDA approved 
study called for an investigation into the safety and efficacy of marijuana for AIDS 
related wasting syndrome. However, NIDA is only interested in studying the harmful 
aspects of drugs (NIDA 2011). In order to get the marijuana from NIDA, Abrams had to 
reframe his research questions to investigate whether marijuana interfered with the 
protease inhibitors used to treat HIV (Chapkis: 2006 at page 66 citing Abrams, 2004). 
Despite the manipulation of his research, Abrams was able to “sneak a peek” and show 
a significant weight and BMI gain for AIDS patients using medical cannabis (and no 
effect on protease inhibitors). At the same time, drug Czar Barry McCaffrey publically 
stated that “Drug policy must be based on science, not ideology” (Chapkis). 
In another example of federal drama that began in 2001 and recently ended in 
total victory for the government, Dr. Craker of the University of Massachusetts applied 
for a license to produce alternative cannabis for medical research (Chapkis 2006). This 
is a critically important issue in medical cannabis research because all research in the 
U.S. is limited to the few strains grown at the University of Mississippi by NIDA (NIDA, 
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2011). Craker hoped to establish a second production facility where actual medical 
grade cannabis could be cultivated for scientific research. 
The DEA first claimed to have lost his petition. One year later as the professor 
was assembling all the documents to resubmit the proposal (they would not accept a 
photocopy of the documents they had lost and demanded originals) he received a copy 
of his original application sans any cover letter but time stamped with the original 
application date a year before. He resubmitted the application and more than 20 months 
later received a response requiring “credible evidence” that researchers were 
insufficiently served by NIDA marijuana. In other words, the federal government was 
now demanding proof of a negative which is almost like demanding proof of non-divinity. 
How could Craker possibly prove the researchers were not served by NIDA marijuana 
when the absence of available marijuana limited the number of researchers in the field?  
Nevertheless, the evidence was submitted and once again DEA held his application for 
more than a year. Finally, three full years after the initial application, Dr. Craker sued the 
agency in federal court alleging in 2004:   
They always say we need more research, but at the same time, they block it. 
The government is placing ideology above the health and safety of patients” 
(Abrams 2004). 
   
On December 6, 2009 in the waning days of the Bush administration, a DEA 
administrative law judge issued a ruling GRANTING Craker’s application. However, this 
decision was overruled by the DEA Administrator in an Order which became final on 
January 14, 2009, just six days before President Obama was inaugurated. A Motion For 
Reconsideration was timely filed and (leaving no opportunity to extend the time for this 
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litigation) the DEA granted permission to file a Brief In Support of Reconsideration by 
March 11, 2011 (Craker 2010).  At this point, the 70 year old Craker finally gave up. 
 For the reader not schooled in the Federal Rules of Evidence, it is important to 
understand precisely what the DEA and NIDA did in this case.  First, the agencies 
delayed responding to a request for more than 3 years. Then when the applicant filed a 
case in federal court alleging undue delay, the agency claimed a “final disposition” had 
not been granted at the administrative level (Federal Rules of Appellate Procedure, 
Number 15). This means the applicant’s court case must be dismissed because only a 
final order and action of an administrative agency can be appealed to the federal district 
court. Then, once the federal case is safely dismissed they delay again, and again, 
extending the litigation for more than 11 years (Craker 2011). On March 3, 2011 Dr. 
Craker announced he was finally giving up his quest to grow medical grade cannabis for 
research (Miga 2011). 
 This calculated lack of ability to study medical grade marijuana has hampered 
both the understanding of the substance and its acceptance. The legal permutations 
that Dr. Craker endured are ubiquitous when dealing with medical marijuana and 
attempting to conduct research on medical marijuana. The lack of research on medical 
marijuana has caused many people searching for relief to turn to a synthetic, and legal 
form of THC, Marinol.  
Synthetic THC (tetrahydrocannibinol), Marinol:   
Not only did NIDA seal off access to marijuana for clinical trials in the 1970’s, in 
1986, the government diverted 90% of the funding for marijuana research to the 
development of synthetic THC (Chapkis 2006).  Marinol is a synthetic THC drug 
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approved by the FDA for use as a palliative for nausea and vomiting associated with 
cancer chemotherapy. The synthetic THC in Marinol is purified and does not contain 
any other cannabinoids.  In contrast, cannabis contains dozens of separate chemicals, 
many of them psychoactive. Users claim this combination of chemicals creates a 
different reaction in patients than synthetic, purified THC. 
This observation launches the authors of Dying to Get High into a detailed 
description and a general demurer to the federal agency preference for “purified” 
compounds delivered by a pill to “botanical” compounds delivered by a plant. “[Drug] 
warriors are left with little more than an appeal to the superiority of the man-made over 
the natural and of the pharmaceutical over the botanical” (Chapkis, 2006). The authors 
observe there is an almost “preternatural” belief in the superiority of purified 
pharmaceuticals over naturally occurring botanicals which: 
…is not a scientific fact, but rather part of an ideological apparatus used to 
create an imaginary line separating safe and effective pharmaceuticals from 
crude and dangerous botanicals (Chapkis, 2006 at page 71). 
 
The federal government has spent billions of dollars to purify THC by funding the drug 
Marinol.  In favoring a patented pill over a naturally occurring botanical, the government 
ignores the physical and psychological buffering characteristics of various cannabinoids, 
rejects the synergistic effects of isomerically and stereo chemically related naturally 
occurring compounds, dismisses potential benefits of ingesting other compounds and 
chemicals resulting in better regulation of bioavailability. All of this is done in order to 
favor a synthetic compound and a valuable patent with only a few years of research 
over a natural compound to which humans have had thousands of years of experience.  
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Purified, concentrated, synthetic THC does not occur in nature and the majority 
of patients who have experience with both Marinol and medical marijuana favor the 
naturally occurring compound as easier to regulate and for producing far fewer side 
effects (Armentano, 2005). For example, Grinspoon (2001) stated: 
I have yet to examine a patient who has used both smoked marijuana and 
Marinol who finds the latter more useful; the most common reason for using 
Marinol is the illegality of marijuana. If patients were legally allowed to use 
marijuana relatively few would choose Marinol. 
 
The odd result of Marinol containing concentrated, synthetic THC being approved 
by the FDA as a “safe and effective” Schedule III drug while diluted natural, organically 
grown cannabis is unsafe and has no known medicinal use as a Schedule I drug is an 
interesting comment on how our society views “drugs” versus “pharmaceuticals.”  
Corporate interests and large drug manufacturers with profitable patents are greatly 
preferred over smaller operations even when the corporate product is more dangerous.   
         When Marinol was finally synthesized, the side effects of the concentrated product 
that contained only THC, and none of the other modulating chemicals in natural 
cannabis, were found to be dramatic. The package insert of Marinol states that the drug 
“may be habit forming…may cause side effects such as:   
“feeling high" (i.e. easy laughing, elation, and heightened awareness), 
abdominal pain, dizziness, confusion, depression, nightmares, speech 
difficulties, chills, sweating, psychological and physiological dependence.”  In 
case of accidental overdose, a potentially serious oral ingestion, if recent, 
should be managed with gut decontamination. In unconscious patients with a 
secure airway, instill activated charcoal via a nasogastric tube. A saline 
cathartic or sorbitol may be added to the first dose of activated charcoal. 
Patients experiencing depressive, hallucinatory or psychotic reactions should 
be placed in a quiet area and offered reassurance (Marinol  2011).  
 
While more dangerous and less tolerated, Marinol is not even as effective as medical 
marijuana:  “In practice it has been found that extracts of cannabis provide greater relief 
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of pain than the equivalent amount of cannabinoid given as a single chemical entity 
[such as Marinol]” (Whitle 2001).  
 Since almost all marijuana research in humans has used this form of synthetic 
THC delivered orally, in pill form, there are very few reported studies on the use of 
smoked marijuana.  For example there is only one reported study using smoked 
marijuana in Multiple Sclerosis (M.S.) which is a condition which considerable anecdotal 
reports suggest may be improved by the use of marijuana.  In fact, 97% of M.S. patients 
reported that smoked marijuana improved their condition (Consrue 1997).  Despite the 
growing evidence, no blinded, randomized clinical study using smoked marijuana has 
ever been approved in the United States for problems associated with M.S. Grant, 
Atkinson, & Gouaux (2012) provide a recent review on the accumulating anecdotal 
reports on the potential medical benefits of marijuana. However, the lack of proof for the 
medical benefits of marijuana remains a hurdle for those who feel they could benefit 
from using cannabis for treatment. 
Due to NIDA’s Policies The Medical Claims about Marijuana Remain Unproven:   
 As new medical uses for marijuana have been discovered, people suffering from 
illnesses have illegally medicated themselves. By the early 1970’s, treatment of 
glaucoma, chemotherapy induced nausea, spastic disorders, AIDS wasting syndrome 
and other less severe illnesses were being illegally treated by the therapeutic use of 
marijuana (Chapkis 2008). There have also been claims that marijuana relieves pain, 
nausea, swelling, inflammation, and seizures, decreases ocular pressure in glaucoma 
(c.f. MCLA 333.26421 et seq), helps regulate blood sugar (Izzo 2009) and can even 
treat cancer by shrinking metastatic brain and breast cancer tumors (Angelo 2009). 
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Authorities responded partially to growing demand for medical marijuana in 1969 by 
supplying a few selected patients and researchers with government-grown marijuana 
originally slated for use in scientific experimentation. The University of Mississippi in 
Oxford raised thousands of cannabis plants behind a twelve foot tall barbed wire fence 
for the National Institute of Drug Abuse (NIDA).  
      Evaluating medical marijuana research is almost impossible because only this 
particular marijuana grown by NIDA at this facility can be used for research involving the 
actual use of marijuana in the United States.  NIDA openly admits that their task is to 
study only the harmful effects of drugs, and they will not provide funding- or research 
marijuana- for any study that does not support this proposition (Craker 2005, testimony 
of NIDA Administrator day 2). 
While maintaining these strict barriers to research, the regulatory agencies claim 
that marijuana research is not actually being blocked.  On February 16, 2011, Drug 
Czar Gil Kerlikowske was interviewed by The Daily Caller’s Mike Riggs. Kerlikowske 
claimed “there are over 100 groups doing marijuana research.”  In fact, according to 
clinicaltrials.gov as of February, 2011 there are presently only six FDA-approved trials 
taking place anywhere in the world involving subjects’ use of actual cannabis. Of these, 
two are completed, one is assessing the plant’s pharmacokinetics, and one is assessing 
pot’s alleged harms (Armentano 2011).  Limitations on marijuana research means that 
little current usable data on the effectiveness of medical marijuana can ever be 
collected in the United States. 
Immunosuppression:   
31 
 
Research on medical marijuana is important for several reasons including safety.  
There have been claims of reduced immune function with heavy marijuana use which, if 
true, are important to explore before recommending marijuana to patients who are 
already ill and immune compromised. The “fact” that “marijuana weakens the immune 
system” has become a much touted quote by the anti-marijuana groups and the 
government. For example, theologian and Pastor James Dobson (head of the 
conservative Christian organization “Focus on the Family”) in a Washington Times op-
ed piece stated his medical opinion categorically that “marijuana weakens the immune 
system” (Adams 2006). While there is certainly evidence for this interesting line of 
study, selectively suppressing immune function is also an important medical protocol for 
many types of disease (Earlywine 2002) because an overactive immune system may 
cause diseases as harmful as a weakened immune system.  
This creates a striking nexus between medical marijuana and the claims of 
immune suppression insofar as auto-immune diseases and many long term debilitating 
diseases appear to align with the diseases and conditions that advocates claim is 
treated by medical marijuana. Autoimmune diseases that advocates claim are treated 
by marijuana include:  Type 1 diabetes (in which the immune system attacks and 
destroys the insulin producing Islets of Langerhorn cells in the pancreas); Rheumatoid 
Arthritis (in which the immune system attacks the connective tissue in the joints); 
Multiple Sclerosis (in which the immune system attacks the myelin sheaths lining the 
nerves that innervate skeletal muscles) and many others. A more complete list of 
diseases caused by the immune system misidentifying various parts of the body 
includes more than 50 conditions (List 2011).   Immune function is a double-edged 
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sword that is critically important to human life, but the immune function can also be 
harmful and suppression of immune function can be beneficial.  
Thus, the question framed in this way becomes whether the immunosuppressive 
effects of cannabis are beneficial or harmful. In contrast to human studies, there is a fair 
amount of experimental data from experiments on cell lines. However, these results 
have been inconsistent on whether the immunosuppressive effects of marijuana are 
beneficial or harmful.  Some studies suggest that cannabis decreases immune function 
by decreasing T-lymphocyte, and Natural Killer T-Cells (NTK’s), in healthy subjects 
(Pacifici 2003). T-Lymphocytes and NTK’s are important immune system cells 
responsible for developing immunity and resistance to viral infections, and a decrease 
suggests the impairment of normal immune function. However, the authors note that 
they were only allowed to experiment on various cell lines so “the clinical relevance of 
these findings in humans has not been established” (Id). Other studies contradict the 
findings in cell assays and also suggest the reduction of these important immune 
system cells is associated with a dramatic reduction in IL-2 and an increase in IL-10 
levels (Croxford 2005). Interleukin-2 cells are associated with cell mediated 
inflammation and apoptosis (programmed cell death) which is strongly implicated in 
diseases of the immune system such as Alzheimer’s disease, Multiple Sclerosis and 
Diabetes (Croxford Id). Il-2 cells (decreased by marijuana) promote inflammation and 
death of deficient cells while IL-10 cells (increased by marijuana) are anti-inflammatory 
cells. In other words, although there is good evidence immune function is impaired by 
marijuana there is also good evidence that what is impaired are primarily the 
inflammatory modulators responsible for auto-immune diseases caused by an 
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overactive immune system. With little current research, it is difficult to pinpoint what 
components of medical marijuana create precisely what effects. 
Chemical Components and Effectiveness of Marijuana:  
Of the more than 100 components of marijuana, only two have ever been studied 
in any significant way:  Cannibidol (CBD) and Tetrahydrocannibinol  (THC). The most 
widely noted Cannabis effects include both euphoria and sedation and both occur 
simultaneously in the user.  However, these effects appear in different proportions 
depending on the strain and cultivation techniques. (c.f. Rosenthol, 2002).  Some of 
these effects are what users claim makes marijuana an effective treatment of certain 
conditions by easing the suffering that is caused by certain diseases and by providing 
palliative comfort. These effects also depend on the social context in which the 
marijuana is consumed, the experience of the user, and the psychoactive and 
physiological effects of various components in the marijuana (Id). 
When considering the effectiveness of medical marijuana, the specific effects of 
the individual chemical components are important. According to experienced users and 
a variety of non-systematic reports, high THC content is associated with euphoria while 
higher CBD (Cannabidiol) is associated with sedation (Rosenthal 2010). Delta 9-THC is 
a moderately psychoactive cannabinoid receptor with a relatively low affinity for 
endogenous cannabinoid receptors (CB1 in the central nervous system and CB2 
distributed in the gut and throughout the body). The CB1 Cannabinoid receptor is found 
widely distributed throughout the brain and is activated by exogenous (from outside the 
body) THC and endogenously (from inside the body) by the neurochemical anandomide 
(Vincenzo 1994). In contrast, to THC, CBD is not very psychoactive at all but appears to 
34 
 
modulate various physiological processes (Santos 2010) including the effectiveness of 
THC. When the CB1 receptor is activated, this decreases GABA availability in the brain 
(Pagott 2006). GABA is an inhibitory neurotransmitter, so the net effect of consuming 
THC is a decrease in inhibition. In short, the effect of THC in decreasing the inhibitor is 
thought to be responsible for the increased euphoria and the selective enhancement of 
attention, concept formation and sensory awareness reported by users while CBD 
modulates this interaction and may also have other effects. 
Although CBD does not bind, inhibit, or activate CB1 receptors, it may increase 
receptor permeability with a net effect of enhancing the effect of THC. Perhaps even 
more important for medical marijuana, CBD does weakly activate the 5-HT receptor 
which is the target of the widely prescribed anti-depressant selective serotonin reuptake 
inhibitors and may activate other cannabinoid receptors that have not yet been identified 
(Ryberg 2007). Therefore, CBD works as a long-term anti-depressant and also has anti-
cholinergic (blocks acetylcholine), anti-pyretic (reduces fever) and anti-inflammatory 
effects (Id).  
The key point is that the two primary components: THC and CBD are found in 
widely varying quantities depending on the particular strain of marijuana and the harvest 
techniques (Gonzoles 2007). Medical marijuana growers, seed banks, and many 
experienced users claim that the ratio of THC to CBD determines the effect of the 
medical marijuana, and that the early harvest of a particular strain results in lower CBD 
to THC content while a later harvest results in higher CBD to THC content. The 
Michigan Medical Marijuana Association (the MMMA site is located at 
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www.michiganmedicalmarijuana.org)1 and contains detailed forums for “Collective 
Growing” (with 120 topics, 1200+ Replies), “The Grow Room” (924 topic, 1800+ 
Replies), “General Growing Information” (454 Topics, 1600+ Replies) and “Seeds, 
Strain Clones” (700 Topics, 1800+ Replies) (MMMA, 2011). This information helps 
growers create the “best” and most potent combinations of chemical compounds in the 
plants. 
A product with higher THC content is reported to have a more uplifting effect and 
is thought to impart some other effects such as:  increased imagination enhanced 
selective sensory and cognitive awareness, increased laughter and even euphoria 
(Gonzales 2007). Because there is no regulation in the growth of medical marijuana in 
Michigan with the current system, the level and potency of cannabinoids in marijuana 
varies considerably, not only in ratio, but also in potency. Very detailed information 
about growing marijuana and the claimed effects of different strains are available on 
many internet discussion boards and seed banks, but there is almost no clinical 
research supporting or refuting these claims (c.f. Rosenthal 2002). 
This lack of research is one of the central problems with marijuana research in 
the United States and is irredeemably compounded by the fact that the very limited 
supplies of marijuana available for clinical research is much less potent than the 
marijuana available to the typical medical marijuana patient.  As we have seen, NIDA 
has the sole right to supply marijuana for research purposes in the United States and 
operates the only federally authorized marijuana grow operation at the University of 
Mississippi (21 USC. 801 et seq).  NIDA research marijuana has a THC content 
                                                 
1
 The Michigan Medical Association (MMMA) is not to be confused with the other MMMA (Michigan 
Medical Marijuana Act). 
36 
 
between 1.5% and 8.37% with 99% of that supply falling in the 1.5% range (FOIA 2005) 
compared to the 25-30% THC levels commonly available at dispensaries. These figures 
on the quality of research marijuana available in the United States have remained 
unchanged up to the present time, even while strains available on the street have 
become considerably more potency, because NIDA has not grown any additional 
research marijuana since at least 1998 (Pro-Con 2008).  
The fact that research on different strains is so limited was confirmed by a 2009 
NIDA Request for Proposal (RFP (No. N01DA-10-7773) seeking competitive bids on a 
production facility to produce research marijuana). The proposal states that NIDA 
wanted to produce “125,000 marijuana cigarettes in four potencies from "placebo" (0% 
THC) to "high" (3.5-5% THC), plus 500-1,000 cigarettes at greater than 5% THC.  In 
other words, NIDA is, or at least was, planning that less than 1% of marijuana available 
for research in the United States will be greater than 5% THC2 even though the 
marijuana commonly used in the United States is at least 5 times as potent.   Therefore, 
research on the perceived effects of potent medical marijuana currently being used by 
medical marijuana patient population is clearly warranted.  
In addition to the potency levels of THC and CBD in marijuana, there is another 
complication in studying the effectiveness of medical marijuana. There are 100 plus 
components in marijuana, but only a few have been studied beyond characterizing them 
                                                 
2 This RFP was located on a private job site and the author investigated further. Government officials 
referred me to the NIDA Request For Proposal (RFP) page which does not contain any information 
whatsoever about this RFP. Another advised me that this RFP was currently under review. There was no 
reply to my follow up query on whether the proposal was public information subject to FOIA . The 
private job search site was located at: https://www.fbo.gov/index?s=opportunity&mode= 
form&id=13b43512c37e45befa6e8f9556d276b0&tab =core&_cview=1 but the RFP has now been 
apparently scrubbed from government sites. 
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in chemical essays or introducing them to various cell cultures. Further, NIDA does not 
measure or report the level of CBD or other cannabinoids in its research marijuana   
Thus CBD and other THC’s beyond delta-9 (delta-8, delta-7, etc.) have had almost no 
research at all and none in humans even though they are also psychoactive, albeit with 
considerably less affinity for the cannabinoid receptor than delta-9. Other Cannabinoids 
such as Cannabinol (CBN) are also psychoactive but have not been investigated in 
humans in even a single study. CBN is a degradation byproduct of THC (McParland 
2001). Since the widely varying compounds in cannabis are found in  different quantities 
depending on the particular strain of marijuana and the harvest techniques (Gonzoles 
2007) this makes any research on marijuana as a medical compound extremely difficult. 
Research with NIDA marijuana is akin to studying a drug using sub-clinical doses and a 
product more likely to cause a headache than to produce any medicinal or therapeutic 
effects (Armentono, 2010). 
Neuroimaging studies provide further evidence for the suggestion that marijuana 
is highly heterogeneous with findings of activation patterns throughout the brain 
apparently depending on what type of marijuana is ingested. However this hypothesis 
has never been tested since there is such heterogeneity of compounds in marijuana, it 
is not surprising that both the perceived effects and the neuroimaging results would also 
be heterogeneous. The most common findings from brain activation studies includes 
increased resting prefrontal, insular (responsible for emotion regulation and homeostatic 
mechanisms) and anterior cingulate (responsible for emotion, attention, motivation and 
error detection) (Santos 2010). These findings are very inconsistent which, 
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paradoxically, makes them consistent with the theory that a diversity chemicals in 
marijuana is responsible for different reported subjective effects of marijuana. 
If marijuana is a legitimate therapeutic agent, then a widely divergent set of 
claims about the type and quality of the efficacy of medical marijuana would suggest 
that some varieties of marijuana may be more therapeutic for some conditions and less 
therapeutic for other conditions. For example, there may be marijuana strains best 
suited for treating muscle spasms, and other strains best suited for treating pain.  
In addition to the effects of euphoria and sedation, there are other effects to 
marijuana. In particular the Cognitive and Clinical Psychology Genre primarily funded by 
the National Institute of Drug Abuse (NIDA) has outlined many negative effects from 
using marijuana. This line of research focuses on “a motivational syndrome,” the 
problems of addiction, how marijuana suppresses the immune system, potential long-
term cognitive deficits, and the Gateway Hypothesis. These potentially negative effects 
have been repeated in well-funded study after well-funded study and are important 
because they are the primary reason why marijuana, medical or otherwise, has such a 
negative social image. 
Marijuana and Diminished Social Function: 
Demographic studies of marijuana users have long shown a fairly strong 
correlation between cannabis use, particularly early cannabis use, and diminished 
social activities, lower educational attainment and decreased monetary success. The 
hypothesis is that poor social skills, smaller academic potential and/or membership in a 
relatively lower social class is connected to greater cannabis consumption. The 
interpretation favored by anti-marijuana groups is that cannabis use causes lower social 
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performance (Kandel 1986). This perspective has been supported by longitudinal 
studies which attempt to adjust for variables such as family income and other 
confounding covariates (Fergusson 1997; Elickson 1998). These studies on a 
motivational syndrome were primarily approved and funded in the 1980’s and used 
large national databases purporting to show a negative correlation between marijuana 
use and educational attainment (Lynsky 2000). Although these studies attempt to adjust 
for covariates, suggesting the problem is consequential rather than contributory, they 
cannot rule out the possibility of an underlying common factor. In other words, despite 
decades of well-funded research attempting to pathologize cannabis use, it still is 
possible that youth who use an illegal substance carrying extraordinary social and legal 
penalties may have a lower regard for educational attainment and other measures of 
success used by our society. This contributes to the stigma of marijuana usage, 
including the self-selected group of medical marijuana users even though they are 
usually older and suffering from specific diseases which are not necessarily predicted 
by socio-economic class or social attainment. 
Cognitive Functioning:   
The literature is also muddled in the area of cannabis induced cognitive decline. 
Some studies claim a “small but apparently permanent effect on memory, information 
processing, and executive function” (Kalaunt 2004). Others claim TCH causes “minimal 
cognitive deficits” and is a “minimal confounder in experienced marijuana users” (Chait 
1990). One author found a “significant difference in cognitive function between long-
term users and short-term/nonusers of marijuana” (Solowji 2002), but this study had 
several methodological problems. First, it did not control for age-related differences in 
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memory and cognitive function, suggesting that the “difference” between long-term and 
short-term users was due to the older population of long-term users. Second, it only 
included patients who were “seeking treatment for long-term cannabis addiction.”  Third, 
the short term duration (overnight) between administration and testing could have been 
confounded by the lingering presence of cannabinoids in the subject’s system (Nyquist 
2002). The conclusion of Pope on the alleged cognitive deficits of long-term cannabis 
use is particularly illuminating:   
Cognitive deficits may be caused or exacerbated by withdrawal effects from 
the abrupt discontinuation of cannabis; these effects typically peak after 30-
7 days of abstinence. It is less clear, however, whether heavy cannabis use 
can cause neurotoxicity that persists long-term after discontinuation (Pope 
2001). 
 
The fact the academic debate continues decades after the government and news media 
has reported the long-term cognitive effects of cannabis as fact supports Pope’s summary 
conclusion:  “long-term effects, if they exist, are subtle and not clinically disabling” (2001). 
This leads to another fact that the media and government have continually promoted, the 
addictive quality of marijuana. 
Addiction:   
Another widely claimed effect that greatly contributes to the negative image of 
marijuana in our current society is the claim about addiction. Though an addiction risk in 
humans has never been conclusively shown with marijuana use, there are varying 
claims including that cannabis dependence is the most common type of drug 
dependence after alcohol and tobacco (Anthony 1991). One study claims that 2% of the 
entire adult population is currently “addicted” to marijuana while 4% of the adult 
population is now or was in the past “addicted” to marijuana (Swift 2001). The risk of 
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such dependence is claimed to be 6% for any persons who have ever tried marijuana 
and 9% for those who tried marijuana for the first time in adolescence and rising to one 
in three for daily users (Anthony 2006).  With more than 40% of the U.S. population 
admitting to having smoked marijuana at least once, 5% of the population admitting to 
daily use, and a national population of 300,000,000, this equates to some 15,000,000 
patient beds. 
However, one of the most important criteria in establishing that a substance is 
“addictive” is evidence for the presence of physical withdrawal symptoms. “Dependent” 
cannabis users who have been abruptly withdrawn from high daily doses of THC report 
decreased mood, increased irritability, anxiety, appetite disturbance and depression 
(Budney 2004). Some writers have characterized these effects as similar to caffeine 
withdrawal (Grinspoon 1997).  Anyone who has suffered a “caffeine headache” must 
agree that caffeine is addictive, yet on the scale of addiction it is quite low.  Similarly, 
the withdrawal effects of marijuana are low enough that most medicinal marijuana users 
experience few withdrawal symptoms and what is experienced is usually much less 
than with many pharmaceutical compounds and even less than with caffeine. Yet, the 
purported addictive properties of marijuana have fueled government law enforcement, 
the drug treatment industry, and movie producers of government sanctioned 
propaganda (c.f. Budney, 1999- funded by NIDA grant R29DA08655; Hughes, 2002- 
funded by NIDA grant DA00490 inter alia).  
Here again is the difference in our society between criminalized marijuana and 
the accepted pharmaceutical. The medical studies suggest that marijuana activates the 
same dopamine reward system as heroin (Wichelgren 1997), but that since the 
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metabolites of marijuana leave the body slowly there are very mild withdrawal issues 
comparable to denying an “addict” his daily cup of caffeine and primarily manifesting in 
restlessness, irritability, and some insomnia which invariably disappears after a few 
days (Grinspoon 1997). Most patients do not refuse a medicine that can help with 
suffering because of a side effect (withdrawal). Indeed a huge portion of pharmaceutical 
drugs have much more addictive properties than marijuana. Alcohol is well known to be 
highly addictive as are stimulant drugs frequently forced on young children (almost 
exclusively young boys) and opiate narcotics which are widely accepted in 
contemporary society. The negative is perhaps not that medicinal marijuana might be 
addictive, but instead that it is marijuana. 
The Gateway Hypothesis:    
There are numerous studies on the “Gateway Hypothesis” that the use of 
marijuana leads to use of “hard” drugs like heroin and cocaine (DiSimone, 1998, Mills & 
Noyes, 1984 et al).  The “Gateway Hypothesis” could even be viewed as the 
centerpiece of the government campaign against cannabis and whether marijuana use 
leads to the use of “hard” drugs or whether there might be a different, precisely opposite 
claim, was a central topic of the data collection in this paper. The DEA claims:  
 Marijuana is a frequent precursor to the use of more dangerous drugs and 
signals a significantly enhanced likelihood of drug problems in adult life... 
Marijuana use in early adolescence is particularly ominous. Adults who were 
early marijuana users were found to be five times more likely to become 
dependent on any drug, eight times more likely to use cocaine in the future, 
and fifteen times more likely to use heroin later in life (DEA, 2011). 
 
Some studies have found that regular or heavy cannabis use is associated with an 
increased risk of using other illicit drugs, abusing or becoming dependent upon other 
illicit drugs and using a wider variety of other illicit drugs. Again, almost all of these 
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studies are funded by NIDA. Even though such risks decline with increasing age, a 
number of studies conclude the findings support a general causal model on the 
cannabis gateway hypothesis (Fergusson 2006) while others dispute the methodology 
and interpretation of these findings (Kandel 2006). Most reviews acknowledge the 
interesting correlation but reach an inconclusive result. 
The state of the current data on the issue of the Gateway Hypothesis in cannabis 
use is highlighted in a 2009 review article (Hall). Hall and his colleagues attempted to 
reconcile the well-known fact that cannabis use usually precedes the use of other illicit 
drugs, and that earlier and heavier cannabis use is more predictive of future illicit drug 
use. They examined three theories that explain these findings:   
1) that the relationship is due to the fact that there is a shared illicit 
market for cannabis and other drugs which makes it more likely that 
other illicit drugs will be used if cannabis is used;  
2) that they are explained by the characteristics of those who use 
cannabis; and  
3) that they reflect a causal relationship in which the pharmacological 
effects of cannabis on brain function increase the likelihood of using 
other illicit drugs (Hall). 
 
Hall concluded that the evidence from longitudinal epidemiological studies, simulation 
studies, discordant twin studies and animal studies indicates pre-existing traits along 
with social and peer influences caused by early and/or heavy entry into the drug culture 
are the primary influences in later abuse of other illicit drugs. Although this article does 
not dismiss the evidence from animal studies suggesting regular cannabis use may 
have pharmacological effects on brain function that increase the likelihood of using 
other drugs, the authors conclude that this “minor” effect is a secondary concern in 
human subjects.  
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 These findings are supported by other studies, including a 2007 paper about 
using marijuana to decrease alcohol intake suggesting that chronic alcoholics may use 
marijuana to substitute for alcohol (Lenza 2007). Another very early study used 
synthetic THC with a group of psychiatric patients that happened to include some 
alcoholics in the acute phase of recovery and found improvement in alcohol withdrawal 
symptoms in 85% of the cases (Thompson and Proctor 1953). One writer to the 
American Journal of Psychiatry claimed he had clinical experience suggesting 
marijuana is a viable treatment for alcoholism (Scher 1971). He also claimed that 
marijuana and alcohol are “mutually exclusive agents.”  In other words, he argued that 
greater use of marijuana is associated with less use alcohol. 
In contrast to the “Gateway Hypothesis”, there have also been claims to the 
opposite effect, in particular the claim by patients that marijuana reduced opiate use 
which is contrary to many previous studies on marijuana use and abuse (Golub & 
Johnson 1994). As an increasing number of states allow the use of medical marijuana, 
the conflict between advocates and detractors of marijuana has only intensified.  
State Medical Marijuana Laws:   
As the first state to outlaw marijuana, California was also the first state to pass a 
medical marijuana law. The California medical marijuana resolution, Proposition 215 
was known as the Compassionate Use Act and was passed by the voters in November, 
1996. Since then, a cottage industry has grown up to service the marijuana industry and 
well over a billion dollars in taxes have already been collected by the State of California 
(Stateman 2009). California could have been the first state to completely decriminalize 
marijuana in November, 2010, but the referendum narrowly failed. Instead Colorado and 
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Washington State first legalized marijuana in 2012. However, federal prohibition 
continues and the States have come increasingly into conflict with the central 
government. 
Michigan Medical Marijuana:   
On November 4, 2008, the people of the State of Michigan passed a referendum 
that enacted a medical marijuana law. Until this law, users of marijuana in Michigan 
were unanimously labeled as criminals. The medical marijuana population was officially 
created when the State of Michigan joined a growing number of states, 15 (17 by 2013), 
and the District of Columbia, that have that openly defied United States federal law by 
permitting the use of marijuana for medically certified patients. The Proposal 1 ballot 
initiative in Michigan passed with the approval of 63% of the electorate and effectively 
became part of the State constitution that can only be overturned by a two-thirds 
majority vote in both houses of the State legislature (Michigan Constitution Article 2, 
Section 9). 
After passage by the people, Proposal 1 became the Michigan Medical Marijuana 
Law creating two new categories of people:  “Patients” are certified by a medical doctor 
to use marijuana and “caregivers” may register up to five patients and supply them with 
marijuana. These are not arbitrary statistics, but are carefully defined by the state. 
A medical marijuana patient must be certified by a doctor to have a: 
Serious and debilitating medical condition…[such as]… Cancer, Glaucoma, 
positive status for Human Immunodeficiency Virus, Acquired Immune 
Deficiency Syndrome, Hepatitis C,Amyotrophic Lateral sclerosis, Crohn's 
disease, agitation of Alzheimer's disease, nail patella, (MCLA 333.26421 et 
seq). 
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Not only must the patient be suffering from one of these conditions, but the state of the 
illness must serious enough that they are currently in treatment and that the condition is 
causing: 
cachexia or wasting syndrome; severe and chronic pain; severe nausea; 
seizures…epilepsy; or severe and persistent muscle spasms, including but 
not limited to those characteristic of multiple sclerosis (MCLA 333.26421 et 
seq). 
 
These medical conditions create a difficult living environment and the groups of people 
suffering from these conditions are often already marginalized by society due to their 
illness and poor health even before attaining the status of medical marijuana user. 
Under the Michigan Medical Marijuana Act (MMMA), a medical doctor with a 
physician-patient relationship may provide the patient with a signed statement that in 
the physician’s professional judgment, the patient has a debilitating medical condition 
and that the medical use of marijuana is likely to provide palliative or therapeutic 
benefits for the symptoms or effects of the applicant’s condition (MCLA 333.26424(f)). 
Michigan initially regulated this process through the Michigan Department of Community 
Health, but the responsibility was passed to the Michigan Regulations Bureau in 2011 
by the new Republican Governor Rick Snyder (Cleary 2013, Ramsdel 2012). 
The status of caregiver is also regulated and carefully defined by the Michigan 
Medical Marijuana Act.  A caregiver is a person who grows or supplies marijuana to a 
patient he or she has registered with the Regulations Bureau.  A caregiver may register 
up to 5 patients with the bureau and may grow up to 12 plants and possess up to 2 ½ 
ounces of marijuana for each patient registered.  This means a caregiver who is also a 
patient may grow up to 72 plants (6 X 12) and possess up to 15 ounces (6 X 2 ½) of 
marijuana. 
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Presidents Clinton and Bush (H.W.) actively tried to subvert state laws through 
raids on state approved marijuana dispensaries and grow operations. The Supreme 
Court decision in Gonzales v. Raich affirmed the right of the federal government to 
conduct operations based on federal law alone even when there was a conflict with 
state laws. In response, medical marijuana states began withdrawing support from 
federal police agencies and setting the stage for increasing conflict between state and 
federal government not seen since the 1950’s desegregation battles. The standoff 
continued for several years with state law enforcement withdrawing support and 
cooperation from federal law enforcement and growing public support for medical 
marijuana with each DEA raid (Pew 2013, Gallup 2012). 
Finally acting in response to the majority, the federal government backed off. 
With national polling data showing support for medical marijuana as a favorable 
percentage in the mid 80’s (Langer 2010), the only surprise was that it took over a year 
for President Obama to fulfill one of his campaign promises to end raids on state 
sanctioned medical marijuana patients. President Obama made at least five statements 
on medical marijuana during the 2008 campaign (Laugesen 2011). Taken together, they 
promise tightly regulated medical marijuana at the federal level and state that 
prosecution of state sanctioned patients is “not a good use of federal resources” 
(Venkataraman 2007). In February of 2009, the Obama administration, through Deputy 
Attorney General David Ogden, sent letters to all U.S. District Attorneys directing:  
As a general matter, pursuit of [drug enforcement] priorities should not focus 
federal resources in your States on individuals whose actions are in clear and 
unambiguous compliance with existing state laws providing for the medical 
use of marijuana (Ogden 2009). 
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Marijuana operations not in clear compliance with state laws continue to be subjected to 
federal law enforcement raids. 
Despite the apparent release of many legal prohibitions, there is still no published 
literature on the Michigan Medical Marijuana patient population except the following 
very basic statistics published on the Michigan Licensing and Registrations Bureau web 
site as of May 31, 2013 (LARA 2013):  
• 402,688 original and renewal applications received since April 6, 2009. 
• 128,441 active registered qualified patients. 
• 26,875 active registered primary caregivers. 
• 25,788 applications denied -- most due to incomplete application or 
missing documentation. 
Michigan is one of the few States to even keep official records. The statistics from most  
 
States are not available from official sources. Nor are statistics describing the 
population of users of medical marijuana  
Distribution of Marijuana Under The Michigan Medical Marijuana Act:   
As the interpretation of the Act continues to unfold in Michigan, a variety of 
medical marijuana distribution methods appeared almost organically and spontaneously 
to fill the new demand. They appeared even though regulations concerning medical 
marijuana centers were left conspicuously out of the referendum because 
“dispensaries” were not polling well (MPP 2013). The story of medical marijuana centers 
in Michigan is interesting but a story with consequences for the people impacted by the 
deliberate ambiguities left in the law to insure passage and by how the case law 
developed in Michigan. 
Therefore, before proceeding further, the context in which the data was collected 
needs further elucidation. This study did not take place in a laboratory with carefully 
isolated and controlled variables that were carefully separated from the natural 
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environment. The data was collected from real people, with real life problems and real, 
legitimate concerns.  During the time of the interviews, the patient and caregiver 
participants were confronted with a constantly changing legal environment, a State 
Attorney General who was and is anti-marijuana, and an erratic, often unclear and 
conflicting series of appellate court decisions. A myriad of legal, legislative and policy 
decisions affected the participants and determined the topics covered in the interviews. 
In particular, several of the major themes and issues in the interviews depended on the 
dynamic interaction between the topics being discussed and the developing case law. 
The issues pertaining to the access and use of marijuana were particularly sensitive to 
the changing legal interpretations. Therefore, it is necessary to conduct a thorough 
review of the Michigan Medical Marijuana Act and the case law as it developed during 
the course of the interviews. 
The theme of interactive responses to changes in the law was actively sought 
from the beginning of data collection in order to explain and describe how patients and 
caregivers adapted to the changing interpretations of the Michigan Medical Marijuana 
Act. Particular attention was given to the structures and functioning of the alternate 
medical marijuana distribution centers that arose in Michigan following passage of the 
Act. The principles of reciprocal change have rarely been as obvious as in the 
responses from patients and caregivers and from law enforcement and prosecutors to 
the Michigan Medical Marijuana Act. Therefore in order to set the stage for the interview 
data, a review of the law and legal environment created by the Michigan Medical 
Marijuana Act along with the case law that developed around the Act is provided. As 
well as, a discussion of alternate interpretations of the Act, and an investigation as a 
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purely legal issue into the rise, variable fortunes, and ultimate fall of alternative medical 
care provider distribution networks in Michigan following enactment of the Michigan 
Medical Marijuana Act. 
People vs. McQueen:  The Supreme Court outlaws dispensaries in Michigan:   
By the fifth year of enactment of the Michigan Medical Marijuana Act, the 
Supreme Court of Michigan had given minimal guidance until deciding People vs. 
McQueen in February of 2013. In McQueen, the Supreme Court voted 4-1 against 
allowing medical marijuana dispensaries to operate in Michigan. The court quoted 
section 4e in full twice during the opinion without providing any legal analysis of the 
section. Then, in a very unusual move, the court put the ruling on dispensaries in an 
Appendix at the end of the opinion after the judge’s signature. This avoided any need 
for the court to provide an analysis of Section 4e. In general, courts organize the rulings 
or decisions in a “Holdings” section or at least in a conclusion section prior to the 
judge’s signature on the opinion. However, in this opinion, in the Appendix, after the 
judge’s signature the court stated:     
Section 4 does not offer immunity to a registered qualifying patient who 
transfers marijuana to another registered qualifying patient, nor does it offer 
immunity to a registered primary caregiver who transfers marijuana to anyone 
other than a registered qualifying patient to whom the caregiver is connected 
through the MDCH registration process. 
 
This statement is unsupported by any legal reasoning or analysis and was apparently 
placed in an “Appendix” for the sole purpose of avoiding the provision of any legal 
analysis to support the court’s position. Use of an Appendix to issue a “Ruling” is an 
extraordinary move not supported by any known precedent.  In fact, an analogy may be 
drawn to the Marijuana Stamp Act, where marijuana cultivation was allowed, but only 
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with a stamp that the government then refused to issue. The Supreme Court of 
Michigan in McQueen effectively issued a Judicial Stamp Act by ruling that the Michigan 
Medical Marijuana Act permits patients to legally purchase marijuana, but anyone 
selling or even providing the patients with that marijuana except the narrowly defined 
“caregiver” to whom they are registered with through the State, commits a felony. 
In the legal analysis that the court avoided Section 4e clearly states:   
“A Caregiver may assist a patient in the medical use of marijuana.”  (MCLA 
333.26424 section 4e, emphasis added).  
  
In other words, the plain meaning of the statute that was relied upon by each of the 
“Caregiver” interviews and most of the “Patient” interviews is that “A” Caregiver may 
assist “A” patient in the medical use of marijuana. The word “A” does not precisely 
mean “any” but obviously refers to a larger and broader classification than “THE 
(emphasis added) caregiver” connected through the caregiver registry system. The 
preceding sections 4a- 4d state that:  “The caregiver (shall not be criminally liable) for 
assisting a qualifying patient to whom he or she is connected through the department's 
registration process (MCLA 333.2624 section 4a-4d, emphasis added). Unless the 
legislature clarified this term, then the plain meaning of the statute is that “A” or “Any” 
Caregiver can assist “A” or “Any” patient in the medical use of marijuana. In case there 
was any doubt what this passage means and precisely what is covered in the meaning 
of “medical use,” the law explains in the next sentence: 
“Such assistance shall not be considered the sale of a controlled substance.”  
(MCLA 333.2624 section 4e). 
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In other words, the plain meaning of the law clearly states that a caregiver, may sell 
marijuana to a patient and such assistance “shall not be considered the sale of a 
controlled substance.” 
The decision of the Michigan Supreme Court was viewed with universal outrage 
by the participants in this study, several of whom complained that the decision does not 
enhance the Court’s stature among the several States with one referring this researcher 
to the below cited University of Chicago study.  The Michigan Court has long had a 
reputation nationally as a political entity with few legal scholars on the bench, low 
standards and a marked lack of judicial independence.  According to a University of 
Chicago study, the Michigan Supreme Court ranks at the very bottom, number 52 out of 
52 in the survey:  “Which States have the best (and worst) Supreme Courts?”  
(University of Chicago 2008).  
In People vs. McQueen, the court ruled that the plain meaning of Section 4 
provides for immunity from arrest or prosecution for the use of marijuana by patients 
registered with the State of Michigan though the caregiver registry system. 
Notwithstanding the language in section 4e, the court further “ruled” (in an Appendix) 
that caregivers are only protected if they are providing marijuana to the patient to which 
they are registered under the caregiver system. 
Section 4 also provides specific guidelines to patients and caregivers on 
allowable plant counts and usable marijuana weight limits. 
Section 8 provides different and less comprehensive protections for transactions 
and patients which occur outside of the section 4 caregiver registry system. The 
Supreme Court in People vs. Kolanek held previous to McQueen:  
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The stricter requirements of section 4 are intended to encourage patients to 
register with the state and comply with the act…if patients choose not to 
abide by the stricter requirements of section 4 they will not be able to claim 
this broad immunity but will be forced to assert the affirmative defense under 
section 8 (at page 2). 
   
The affirmative defenses are asserted after arrest, before a court, and provide 
protections for the use or possession of marijuana in a quantity that was not more than 
“reasonably necessary to ensure the uninterrupted availability of marijuana” (Kolanek, 
id) but which is not otherwise protected under Section 4. In other words, if a caregiver 
has too many plants under Section 4, engages in any transaction outside the caregiver 
registry network protected by Section 4, or a patient possesses to much usable 
marijuana under Section 4, the caregiver or patient may still assert the medical 
necessity defense under Section 8 before a court and have the case dismissed if the 
amount was “reasonably necessary to ensure the uninterrupted availability of 
marijuana” for the patient. 
The Supreme Court cases of McQueen and Kolanek are, in one sense, the “end” 
of the story.  Given the status of marijuana under federal law, any appeal to the United 
States court system would be ridiculous. Although there are legislative efforts underway 
in Michigan to change the law to allow dispensaries, the interpretation of the current 
iteration of the Michigan Medical Marijuana Act has finally been clarified. Dispensaries 
and all transfers of marijuana, except in a few very narrowly prescribed circumstances, 
are now illegal in Michigan. This was not the case during the data collection in this 
paper, and the progression of legal cases that led us to McQueen is a necessary 
predicate to understand the context of the interviews. 
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Michigan Medical Marijuana Act Case Law and History 2008 – 2013:   
While the Michigan Medical Marijuana Act was enacted in November 2008 by 
public referendum with the support of 63% of Michigan voters, very few Michigan 
Supreme Court cases have clarified the law in the last five years even while 
contradictory appellate court decisions continue to be issued. In short, the case law in 
Michigan on the question of medical marijuana has not developed in a straight line of 
logical or legal reasoning.  
Thus the legal realities for Michigan medical marijuana was constantly changing 
during the course of the interviews, providing an opportunity to employ two related fields 
of study.  “Sociology of the Law” and “Law and Society” are related interdisciplinary 
programs that incorporate theoretical paradigms from sociology, law, science, and the 
humanities. “Sociology of the Law” is the use of sociological techniques and theory to 
study the legal system or portions of the legal system as an integrated, but discretely 
defined, social institution while “Law and Society” explores the reciprocal relationship 
between the effect of the law on the overall social system, or a segment of that social 
system, and the impact of the social system on the development of the law (Sutton 
2004).  Changes in society cause changes in the law and this causes further changes in 
society. Similarly, changes in law cause changes in society which causes further 
changes in the law. The changing laws affected the patients and caregivers and heavily 
influenced the open ended interviews as participants adapted to the constantly 
changing interpretations of the Michigan Medical Marijuana Act. 
Therefore, an understanding of the changing legal analyses of the Michigan 
Medical Marijuana Act is necessary to fully understand the personal and professional 
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views of Michigan medical marijuana patients and caregivers as they developed over the 
course of the interviews used in this study. Further, a full legal review requires a detailed 
history of the case law that developed around the Act, a discussion of alternate 
interpretations of the Act, and the investigation of the rise, variable fortunes and ultimate 
fall of medical marijuana dispensaries and alternative medical care provider distribution 
networks in Michigan following enactment of the medical marijuana act in 2008 and the 
2013 decision in People vs. McQueen outlawing dispensaries and any transfers of 
marijuana outside the limited number of patients connected to a caregiver through the 
state registry system. 
People vs. Feezel No 138031, June 8, 2010 (Michigan Supreme Court) 
effectively reversed the 0-tolerance provisions of People vs. Derror 475 Mich 316 (2006). 
The issue was whether a metabolite of THC (11-Carboxy-THC), which is often measured 
in blood tests, was a “controlled substance” and thus subject to Michigan’s 0-tolerance 
policy barring any Michigan driver from operating a vehicle ‘in the presence of’ a 
controlled substance.’ The court overruled Derror thereby providing considerable 
protections for Michigan medical marijuana patients from the 0-tolerance policy. 
Many of the rulings from this time forward, until 2012, were in the appellate court. 
As with many statutes, the first set of questions dealt with by the court was the issue of 
retroactivity. In People vs. Campbell (Case no. 291345, decided:  July 13, 2010, 
approved for publication August 26, 2010, Michigan Court of Appeals), the court held 
that the Michigan Medical Marijuana Act is not retroactive and that any physician’s 
recommendations used in a Section 8 defense must have come before any arrest or 
prosecution for possession or cultivation of marijuana. See also People v. Reed, Case 
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No. 296686, August 30, 2011 (Michigan Court of Appeals). This is a common ruling on 
statutes that do not specify they are retroactive. 
Next, the Michigan Appellate court attempted to interpret the section 8 defense:  
In People v. Redden, Case No. 295809, September 14, 2010, the Michigan Court of 
Appeals held that an assertion of the Section 8 affirmative defense requires a bona-fide 
doctor-patient relationship and that the Defendants have to see the physician for good 
faith medical treatment and not merely to obtain marijuana under false pretenses. This 
case included a controversial concurring opinion by Judge O’Connell and was 
remanded to the trial court where an order of dismissal is pending Supreme Court 
decisions on the Section 8 and Section 4 defenses. 
In People vs. King Case No. 294862, February 3, 2011, the Michigan Court of 
Appeals held (in obvious contradiction of the plain meaning and wording of the statute) 
that Section 4 and Section 8 required the same plant counts and weight limits and that 
only those complying with the Section 4 limits could assert the Section 8 defense. This 
was overturned by the Michigan Supreme Court (King, supra). 
In People vs. Anderson Case No. 3000641, June 7, 2011, the Michigan Court of 
Appeals upheld the longstanding rule that courts have discretion to impose summary 
disposition on any case where there is no genuine issue of material fact (MCR 2.116 
C(5)). In other words, although patients and caregivers may assert the Section 8 
defense for a jury, a judge may still deny the use of the defense where no reasonable 
juror could find on behalf of the party asserting the defense. This has been long-
standing law in Michigan as reiterated in King. 
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In the first direct case impacting the issues of access to marijuana and the 
delivery of that access in the context of alternate provider organizations, the Michigan 
Court of Appeals in State of Michigan vs. McQueen (Case No. 301951 Decided: August 
23, 2011) held the “medical use of marijuana” does not include patient-to-patient sales 
of marijuana under the Michigan Medical Marijuana Act.”  This was the same case that 
became the definitive Supreme Court case of People vs. McQueen.  
In People vs. Koon (Case No. 301443, Decided:  April 17, 2012) the Michigan 
Court of Appeals distinguished Feezel which had held 11-Carboxy-THC in a driver’s 
body (this is different from the metabolite that was judged by the Michigan Supreme 
Court) was not evidence of a violation of the 0-tolerance of drivers using controlled 
substances policy in Michigan. Medical marijuana patient Koon had active THC in his 
blood and the court held that the 0-tolerance for controlled substance use in a driver 
was applicable. In effect, this decision means that medical marijuana patients may not 
legally drive in Michigan since almost all patients regularly and chronically have 
measurable levels of THC in the blood. The case is also being appealed to the Michigan 
Supreme Court. 
In People vs. Bylsma (Case No. 302762), Decided: September 27, 2011, the 
Michigan Court of Appeals held that the defendant could not assert a Section 8 defense 
because he had violated an Attorney General opinion that each set of twelve plants 
permitted under the Act must be kept in an enclosed, locked facility that can only be 
accessed by one individual. This was overruled by the Supreme Court on December 19, 
2012, Supra. However two months later in People vs. Danto, November 8, 2011, the 
Michigan Court of Appeals held that “marijuana” and “plants” were identical in the 
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medical marijuana statute which states:  “for each registered qualifying patient who has 
specified that the primary caregiver will be allowed under state law to cultivate 
marijuana for the qualifying patient, twelve marijuana plants kept in an enclosed, locked 
facility.”  The court held this requires that both dried marijuana and plants must be kept 
in a “locked enclosed facility” and denied the defendant the right to assert the medical 
marijuana affirmative defenses at trial. This case is also on appeal to the Michigan 
Supreme Court.  
The second medical marijuana case decided by the Michigan Supreme Court 
was People vs. Kolanek and King Case No. 142695, (Michigan Supreme Court, May 31, 
2012). These two cases were decided on the narrow grounds of whether the assertion 
of the Section 8 affirmative defenses in the Michigan Medical Marijuana Act also 
required a defendant to comply with the requirements of Section 4. Despite an appellate 
court opinion to the contrary (c.f. People vs. King Michigan Court of Appeals), the 
Supreme Court held that the plain meaning of the statute established two different 
sections and two different sets of requirements and protections to assert a medical 
defense to the use of marijuana. This was viewed as extremely positive in the medical 
marijuana community and several interviews conducted in the May, 2012 time frame 
included discussions about this case. 
The Michigan Supreme Court ruled in Kolanek and King that there are two 
separate sections of the Act, and that the caregivers who fall outside the weight or plant 
count limits may still assert the section 8 affirmative defenses at trial. Both King and 
Kolanek were remanded for further action consistent with the opinion but only Kolanek 
was permitted to assert the Section 8 affirmative defense because King was held to 
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have lost the argument of whether a material fact for the jury existed since the lower 
court ruled as a matter of law that no reasonable jury could have found in his favor. 
Kolanek is currently at the trial court again while King filed for another appeal and the 
case is again working its way through the legal system. 
On December 19, 2012, the Michigan Supreme Court unanimously overruled 
People vs. Bylsma in part stating, that although Bylsma had more plants than permitted 
to him under the Section 4 immunity defense, he was still entitled to assert the Section 8 
affirmative defenses. Bylsma will have to show he possessed the marijuana in a 
quantity that was not more than “reasonably necessary to ensure the uninterrupted 
availability of marijuana.”  The court remanded the case for the trial court to conduct an 
evidentiary hearing on that issue. This case was also extensively discussed during the 
interviews, particularly in the caregiver interviews involving growers and medical 
marijuana facility operators who were very concerned about allowable plant and weight 
counts. 
These laws on medical marijuana have confused many patients, including the 
participants in this study. During the time before the Supreme Court rule in McQueen, 
there were several unanswered questions about the appropriate interpretation of this 
referendum. The Michigan attorney general has been critical of the Act while various 
circuit court jurisdictions have exercised their discretion in vastly different ways. Several 
Oakland County Circuit Court judges have added their own interpretations to the 
Michigan Medical Marijuana Act and the court is known to be very anti- medical 
marijuana. Therefore it is not surprising that not a single volunteer came forward to be 
interviewed who lived in Oakland County. One court ruled against patient-to-patient 
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transfers (People v. Nater, Case No. 10-234179-FH, January 12, 2011 (Oakland 
County).  Another ruled directly against dispensaries and other alternative medical 
provider delivery services People v. Vlasenko 11-236616-FH, August 17, 2011 
(Oakland County) stating that:  “There is no language in the Michigan Medical Marijuana 
Act that provides protections for dispensaries.”  In People v. Hicks, Case No. 2010-
232705-FH, March 15, 2011 (Oakland County), the court held that the defendant did not 
have a sufficient medical history to justify his use and possession of marijuana, and that 
his medical marijuana card was thus invalid. Therefore, he had no right to present a 
section 8 defense. In People v. Prell, Case No. 2010-233008-FH, March 4, 2011, the 
court refused to accept the testimony of the defendant’s certifying physician in support 
of his Section 8 defense. 
Gaps in The Literature and Rationale:   
As we have seen, in a very real sense, the bulk of the literature on medical 
marijuana research is a giant gap.  There is little research about the medical marijuana 
population nationwide and no published research about the Michigan population. There 
has been no clinical research approved in the United States using medical grade 
marijuana and very few randomized controlled studies in the entire world on the effects 
of marijuana. In fact, more than 95% of the studies purporting to investigate marijuana 
are not studies of natural smoked marijuana but of synthetic, oral pharmaceuticals such 
as Nabilone, Dronabinol, or Levonantradol (Armentono  2011, Earleywine 2002). There 
is no published research on the impact of marijuana use on prescription medications or 
the hypothesis that marijuana might reduce prescription opiate intake except a single 
publication derived from this dissertation (Peters, 2013).  There is no research on the 
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operation of medical marijuana dispensaries in Michigan and almost no research on the 
topic in other States.  There is no research on the opinions of the Michigan medical 
marijuana population and almost no research in other States. The Michigan Medical 
Marijuana Act (MCLA 333.26421 et seq) was passed in November 2008 and, to date, 
there are no published studies on the medical marijuana population in Michigan.  The 
state of California was the first to pass a medical marijuana statute in 1996, and there 
are still only a handful of peer reviewed studies on this population and no controlled 
clinical studies. 
There are dramatic claims from seed manufacturers, trade publications, and 
growers about the different types and strains of marijuana, but there is no controlled 
scientific research on them.  More research is warranted on the population of medical 
marijuana patients and on the perceived positive and negative effects of medical 
marijuana. 
Delta-9 tetrahydrocannabinol (THC) which binds to endogenous cannabinoid 
receptors (CB1 and CB2) and cannabidiol (CBD) which modulate various neurochemical 
and physiological processes (Santos 2010) have been studied to some extent, but the 
ratio of THC to CBD and the subjective effects of each is a potentially important piece of 
the medical marijuana research puzzle; the investigation of which has been grossly 
deficient. As we have seen, NIDA will only supply research marijuana which averages in 
the 1.5% THC range while medical marijuana dispensaries often provide products with up 
to 25% THC.  There are some studies using CBD in human subjects (Mechoulam 2002, 
Kowel 2013) and quite a few using synthetic THC (Lile, 2013) but almost no studies on 
the combined effects of THC and CBD.   
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Most of the studies on the dozens of psychotropic agents in marijuana beyond 
CBD and THC have been limited to characterizing them in chemical assays or introducing 
them to various cell cultures.  Research into the other psychoactive THC’s (delta-8, delta-
7 etc.) along with cannabidiol (CBD) and cannabinol (CBN) is currently lacking in the 
cannon of work on medical marijuana (McParland 2001).  There is even less work on the 
potential effects of other cannabinoids, terpines, and flavinoids of the cannabis sativa 
plant as it is found in nature. 
Despite the relatively large size of the population, medical marijuana patients 
have not been extensively studied by any measure. The dramatic lack of research on 
the topic is highlighted by comparing it to other sociological topics that have been a 
focus of research. For example, a search of the sociological abstracts for the term 
“transgender” reveals over 1,000 hits while a similar search for “medical marijuana” 
reveals 25 hits, most addressing policy issues like drug legalization or the neurobiology 
of marijuana use. Only 6 studies directed at the population of medical marijuana 
patients could be found in the sociological abstracts (Boudrias 2004, Chapkis 2007, 
Chapkis & Webb 2005, Goode1970, Hathaway & Rossiter 2007, and Lenza 2007). In 
contrast to medical marijuana, the population of transgendered individuals in the entire 
United States is estimated to be only between 3,000 and 10,000 (Paisley 2006). In other 
words, with 17 States now participating in some form of legalized medical marijuana, 
and a medical marijuana population that is at least 100 times larger than the 
transgender population, there has been at least 100 times less research on the group 
that is the topic of this paper.  Clearly more research is warranted.    
63 
 
There are only about 69 peer reviewed randomized controlled medical studies 
involving the actual use of marijuana and investigating the effects, benefits and 
dangers. This could be put into perspective in many ways. This warrants further reviews 
of the benefits dangers and social effects of marijuana. 
More than 90% of the studies that purport to investigate marijuana are actually 
studies investigating purified pharmaceuticals such as Nabilone (Schedule II Synthetic 
THC), Dronabinol (Schedule II Synthetic THC isomer), and Levonantradol (Schedule I 
Synthetic Analog NOT used in clinical applications but widely used in medical research; 
the isomer is some 30 times more powerful than pure THC). Several excellent and 
detailed bibliographies referencing marijuana studies are available online. The most 
comprehensive is some 60 pages long and categorizes all the human cannabis 
research ever done with links to the full study (Clinical Studies 2011). The categories 
include:  (1) The medical condition studied (i.e. nausea and vomiting- cancer 
chemotherapy, nausea and vomiting- radiotherapy etc.); (2) the modality of the study 
(i.e. controlled, uncontrolled, case reports and surveys); and (3) the substance studied 
(i.e. Nabilone, Dronabinol, Levenantradol, sublingual tinctures, and Smoked marijuana) 
(Id). Further study is warranted on actual cultivated marijuana in actual human subjects. 
Another reason to study marijuana as it is actually used in situ is the fact that 
health care, mental health, drug policy concerns, and criminal law issues can be 
informed by better understanding the perspective and demographic characteristics of 
the medical marijuana population. Better understanding will also guide important social 
and government policies. The conflict between pro-medical marijuana activists and anti-
medical marijuana regulators is one of the most polarized debates in our society 
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touching on major public policy decisions.. While pro-medical marijuana activists claim 
that medical marijuana patients are desperately sick and desperately in need of their 
“medicine,” anti-medical marijuana regulators claim that marijuana patients are 
malingerers, drug addicts and frauds who just want to get high. The former has an 
incentive to prevaricate and even fabricate in order to gain access to their favored 
intoxicant while the latter is motivated to expand their power, scope, and influence as is 
characteristic of most bureaucracies according to many observers who have variously 
described them as “imperialistic” or “expansive” (Weber 1922).  The question of whether 
the individual should have the freedom to endanger one’s life or health by taking an 
intoxicant or medication is a legitimate social concern; and at least as much so are the 
antisocial consequences of government action. There is an argument that the tendency 
for expanding bureaucratic influence is arguably counterproductive to the civil society. 
Current anti-drug policies and laws provide government workers with an expanding 
client base via increasing prison, parole, and drug treatment populations (Peters 2010). 
In short, deciding whether marijuana is a legitimate medication or if the patient 
population is composed of malingerers and frauds aids the decision making process on 
several much larger questions such as projections and staffing for prison, health care, 
and rehabilitation populations. 
Research on the population will also inform pending and future legal disputes. 
Medical marijuana has already generated significant and important case law on the 
Commerce Clause and State’s Rights issues.3  Some fundamental constitutional and 
                                                 
3
 The two most prominent cases so far are U.S. vs. Oakland Cannabis Buyers Cooperative 542 U.S. 483 
(2001) which rejected the common law necessity defense for a medical marijuana buy clubs and Gonzales 
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federal principles have not yet fully been decided by the Courts such as the scope of 
States rights and the 10th Amendment, along with related and wholly unresolved conflict 
of laws issues between the State and federal government. California’s Proposition 215, 
Michigan’s Ballot initiative and all the other State laws that have legalized and regulated 
medical marijuana stand in opposition to federal law which specifically categorizes 
marijuana as a Schedule  I drug with no legitimate medical use and a high propensity 
for abuse (21 USC 811). A better understanding of the perspective of the medical 
marijuana population may aid the legislative and judicial decision-making process in 
these matters by assessing the dangerousness, criminal history and propensity for law 
breaking in the population. 
Conclusion of Literature Review:   
From the time long before humans began settling into villages and towns, to the 
Magna Carta and to the 80,000 pounds of hemp on the Nina, Pinta, and the Santa 
Maria, hemp has played a pivotal role in world history.  From the time of the U.S. 
Constitution, to Washington and Jefferson, all the way to the present day, hemp (which 
was renamed “marijuana” in the 1930’s) has continued to be of critical importance to the 
nation.  In the late 1920’s, southwestern States began outlawing marijuana as an attack 
on Mexican immigration and “negro” jazz singers. Meanwhile, the claims makers in the 
media, law enforcement, and in Hollywood began making the case against marijuana in 
earnest and by 1937, culminating with passage of the Marijuana Stamp Act.  By the 
1960’s more and more people began using marijuana again as a counter-culture protest 
which was answered first by the Controlled Substances Act of 1970 and then by Nixon’s 
                                                                                                                                                             
v. Raich 545 U.S. 1 (2005) which upheld the commerce clause power of the federal government to regulate 
intra-State distribution of medical marijuana despite contrary State laws. 
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1972 declaration of a “war on drugs.”  The “war” continues even today and despite 
federal obstacles to research, and the massive effort expended to show the harms of 
marijuana, there are increasingly compelling claims that marijuana can be used 
medicinally. Medical marijuana laws in Michigan and 16 other states are challenging 
federal jurisdiction and developing a body of case law that will have unpredictable 
interactions for many different people, social groups, and institutions. Further research 
on the population of medical marijuana patients is warranted.  
Since there is little or no ability to study medical marijuana using double blind, 
clinical paradigms used in most pharmaceutical drug studies because the United States 
government has limited medical studies on the efficacy of marijuana as medicine using 
a variety of procedural and regulatory obstacles. This study, therefore, pursues a 
different modality of inquiry. When ethical, moral, practical, or legal concerns prevent 
scientists from employing the entire scientific method, social scientists can still 
investigate matters such as the efficacy of a claimed medical procedure or drug by 
systematically obtaining the perspectives of the patient’s themselves (Westfall, 2004). 
In August, 2013, Dr. Sonjay Gupta, CNN’s Chief Medical Correspondent aired a 
special known simply as “Weed.”  Dr. Gupta has long been an opponent of medical 
marijuana, claiming that “the scientific research does not support the use of marijuana 
as medicine.”  He held this view until he took the time to interview some actual patients 
and review the actual medical marijuana research in the United States and around the 
world.  That was when he finally realized why there is so little research supporting 
medical marijuana.  His epiphany was discovering that there is so little research 
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supporting marijuana use as medicine because the U.S. government has deliberately 
created a self-fulfilling prophecy by preventing this research since the 1960’s.   
We have been terribly and systematically misled for nearly 70 years in the 
United States, and I apologize for my own role in that.  I had steadily reviewed 
the scientific literature on medical marijuana from the United States and 
thought it was fairly unimpressive.  Marijuana does not have a high propensity 
for abuse and it does have legitimate medical uses.  In fact, sometimes it is 
the only thing that works. There were in fact hundreds of journal articles, 
mostly documenting the benefits. Most of those papers, however, were 
written between the years 1840 and 1930 (Gupta 2013). 
 
This ‘new’ information caused him to revise his original conclusions and his 
documentary describes in detail the federal obstacles to marijuana research already 
reviewed.  His biggest objection, and the reason he changed his mind about medical 
marijuana, is the fact that NIDA will only approve a drug study on the harmful effects of 
marijuana which does indeed create a ‘fairly unimpressive’ body of research on the 
beneficial effects of marijuana, which is a gap this dissertation attempts to begin to fill. 
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CHAPTER 3:  METHODS 
 
Introduction: 
This study employed in-depth, recorded interviews of medical marijuana patients.  
A total of 31 medical marijuana patients gave recorded interviews with twenty recorded 
participants who were “regular” patients and eleven who were patients and also 
producers or “Caregivers” under Michigan law so that all Caregivers interviewed for this 
study were also card holding patients.  Several dozen shorter, often impromptu 
discussions were also conducted but not recorded for various reasons.  Pursuant to IRB 
protocols, all persons who gave interviews from which data was collected via handwritten 
notes during or afterwards, or who were recorded and transcribed were provided IRB 
approved information sheets.  Often impromptu discussions took place while awaiting the 
scheduled recorded interview or while visiting various marijuana vendors, seminars, and 
political rallies around the State of Michigan. 
Sociology of Medical Marijuana:   
Sociology is a discipline that explores the social interactions between people, 
groups and institutions as the primary unit of study. In almost all scientific disciplines, the 
goal is to reduce the object of study to the most basic components. That is, the goal of 
science is usually to focus the “lens of inquiry” as finely and as detailed as possible and to 
“zoom-in” on what is being studied. However, Sociology “zooms-out” the lens of inquiry 
and attempts to take in the larger picture to include the social forces that affect human 
social behavior. The focus is not only on human behavior but also the larger focus of the 
social influences on that behavior using what C. Wright Mills called the “sociological 
imagination.”  Engaging the sociological imagination teaches us to step back from the 
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most typical unit of study, individual human behavior, and consider the broader social and 
group influences on that behavior. Thus, sociologists study the social interactions of the 
organism, not the organism itself.  In this case, the unit of study was the newly created 
group of Michigan medical marijuana users and informed producers. 
The qualitative sociological methods of in-depth interviews and observation used in 
this study started with anthropological research on primitive and exotic cultures (Neuman 
2006).  Beginning with the Chicago School “Field Work” in the 1920’s and accelerating 
with conflict theorists in the 1960’s, particularly the feminists, qualitative methodologies in 
anthropology began to be applied to the study and understanding of contemporary 
cultures and groups (Creswell 2008). The goal of anthropological research is to “grasp the 
native’s point of view, his relationship to life, to realize his vision of the world” (Malinoski 
1922). Thus, the goal of qualitative research is often expressed as an impressionistic or 
interpretive task of finding individual meaning that empowers “certain agents to create 
representations and thereby to authoritatively pronounce on the shape and structure of 
the world” (Hess-Biber & Levy, 2004). The interpretive researcher is encouraged to view 
the world as the participants view the world and to see what the participants see. In short, 
the fundamental characteristic of qualitative research, whether used to study “primitive” 
cultures or contemporary cultures and groups, is the “commitment to viewing events, 
actions, norms and values from the perspective of the people being studied (Bryman 
1988). 
 Interpretive research is the “systematic analysis of socially meaningful action…in order 
to understand the interpretations of how people create and maintain their social worlds” 
(Hess-Biber & Levy 2004 page 88). Hermeneutics is the dominant interpretive paradigm 
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which advises the researcher to discover the meaning embedded in the text. The text in 
this study came from recorded and transcribed interviews of medical marijuana patients 
and caregivers and from memoranda prepared following some of the unrecorded 
interviews. Objectivity is not completely discarded in interpretive research; however, it is 
often understood that all value points are equally valid and that nobody has a superior 
position, value or point of view that is better than any other (Hess-Biber & Levy 2004 page 
94). 
 Interpretive research is used frequently in research on traditionally oppressed groups 
such as African-Americans and women, especially where such research can be used to 
identify the roots, causes and forms of oppression. Critical theorists and researchers see 
their role as destroying the myths and empowering people to change society. This is 
achieved by bringing forward the ideas and perspectives of the oppressed group and by 
giving them a voice (Rubin & Rubin, 2005). The paradigm used in this research with 
medical marijuana patients is construed as a critical perspective since one primary goal 
was to report on the perspective of a group that has been legally and socially 
discriminated against.  Society has created meaning for them that includes labeling them 
as deviants, drug abusers, and criminals. The users of marijuana for medical reasons 
have been arrested and vilified in print and visual media since before the 1930’s. In fact, 
one would be hard pressed to find another group in the United States who has 
experienced more legal and social discrimination than marijuana users over the last 90 
years. Thus, the research methodologies, the analysis of socially meaningful interactions 
and the goal of providing an understanding of a disenfranchised social group provide a 
better understanding of human behavior and social interaction. 
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Recruitment: 
Recruitment of prospective participants was an ongoing venture and a particularly 
difficult and delicate job for a group like medical marijuana patients.  IRB approved flyers 
were posted at Compassion Clubs and other sites where medical marijuana patients were 
known to congregate. IRB also permitted referrals from medical marijuana producers and 
suppliers including compassion club owners and operators, growers, certifying physicians 
and others who become known to the researcher.  During the course of the research, 
potential referral sources were presented and utilized.  These sources included various 
Compassion Clubs who held monthly public meetings, medical marijuana certification 
physicians, and contacts with various producers.  Making contact with several owners and 
operators of compassion clubs, dispensaries, growers, and caregivers greatly simplified 
participant recruitment and resulted in substantially more referrals for interviews than 
were actually conducted.   
 
Table 1 Interview Recruitment Sources 
Number Interviews Method of Recruitment 
n=7 1-3, 7, 8, 20-21 Flyers (not purposive) 
n=7 6, 11, 16,19, 23, 24, 30, 31 Personal contact with the PI  during the 
research (Purposive) 
n=26 
 
4, 5, 9, 10, 12-15, 17, 18, 22, 
25, 26, 27, 28, 29-31 
Referrals (Purposive) 
 
 A total of seven participants, and the first three participants who provided recorded 
interviews, were obtained by posting flyers at medical marijuana dispensaries, 
compassion clubs and other areas where medical marijuana patients were known to 
gather.  Additional contacts were requested at the conclusion of each interview and the 
remaining 24 participants were recruited using a partially-purposive snowball 
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methodology.  This means that efforts were made to obtain a recorded interview sample 
population that roughly looked like the Michigan medical marijuana population on gender 
and qualifying medical condition.  However, proper caution must be taken in interpreting 
these results since the sample in no way represents a probability sample. 
Table 2: Internal Referrals of Interviewees by other Study Participants 
Referring source Participant by Identifying 
Number 
No. Participants 
Referred 
Non-referenced 
Participant 
4,5 2 
Non-referenced 
Participant 
30, 31 2 
11 9, 10, 12, 13, 14, 15, 17 7 
16 25, 26 2 
24,26 18, 22, 27, 28, 29 5 
 
Interview number 4 and 5 were referred by one of the early respondents who 
functioned as an information source.  Interviews 9, 10, and 12-15 and 17 were referred by 
interview 11, a delivery service operator. Interviews 25 & 26, a couple who operated a 
dispensary, were referred by interview 16, another dispensary owner. Interviews 18, 22, 
27, 28, and 29 were referred by interviews 25 & 26. Interviews 30 and 31 were referred 
after a discussion with one of their work associates at the dispensary operated by 
interviews 25 and 26. 
The initial research protocol to interview five medical marijuana patients and 
caregivers, advertising flyer, and participant information sheet was approved on February 
16, 2011 by the Institutional Review Board at Wayne State University.  Amendments 
expanded the number of participants and added additional prospective interview slots for 
activists and other knowledgeable persons who did not need to be carded patients. 
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The interviews were a convenience sample but “partial purposive sampling” was 
used because the interview sample group quickly diverged from the known population 
parameters, especially along the domains of gender and qualifying condition to use 
medical marijuana.  The percentage of female patients and the occurrence of very serious 
conditions in the patient population are known from government sources in Michigan and 
comprise just 30% of the card holding patients in Michigan and less than 5% of patients 
with stage IV cancer or multiple sclerosis (LAR 2012).  Therefore, the sampling 
methodology is characterized as “partial” purposive. Because although there was not a 
clear defining exclusion principle, there was a strong counter-resistance to the tendency 
of being primarily referred to the sickest patients.  The referral sources and participants 
were repeatedly told we were looking for “the common and regular” medical marijuana 
patient.  Therefore, due to selective exclusions, and with a goal from the beginning on the 
goal of obtaining a somewhat representative sample, the majority of the female 
volunteers and referrals were not interviewed and only two cancer patients and 1 Multiple 
Sclerosis (M.S.) patient were interviewed.  Considerably more female patients 
volunteered or were referred to be interviewed than males even though only 30% of the 
population is female (LAR, 2012).  Therefore 35% of the sample (11 of 31) chosen to be 
interviewed were female even though significantly more females volunteered to be 
interviewed than males.  Similarly, while the actual population of patients is less than 5% 
cancer or multiple sclerosis fully 20% of interview volunteers and over ½ the referrals had 
one of these conditions.  However, slightly less than 10% of the sample chosen to be 
interviewed had cancer or M.S. (3 of 31).   
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In short, considerably more women than men volunteered to be interviewed even 
though women are a minority in this population while a disproportionate number of cancer 
and M.S. patients were referred or volunteered to be interviewed.  The initial goal was to 
determine if medical marijuana was a “ruse” or whether people were actually using 
marijuana as medicine.  As stated previously, this soon changed to a more interpretive 
structure with a goal of finding the views and perspective of the “regular” medical 
marijuana patient not just to provide evidence for the efficacy and utility of medical 
marijuana by interviewing a population that was unbalanced on gender and qualifying 
condition.  Therefore after the first couple of interviews and a larger number of volunteers 
and referrals began to come forward, the rejection criteria became more selective and 
there was a deliberate effort to over-sample certain categories such as qualifying 
conditions like chronic pain which is over 70% of the population (LARA 2012) and under-
sample other categories such as females which is just 30% of the population, so that the 
final sample was more qualitatively similar to the known population parameters.  
This was not always a simple task because there was a very strong tendency for 
medical marijuana patients, particularly activists with a financial incentive in the medical 
marijuana industry, to refer the most serious patient cases.  However, while the sample is 
not a random sample, it was not a pure convenience sample either with gender, severity 
of medical condition, and type of medical condition all roughly balanced in proportion to 
the known population parameters.  Interviewee characteristics are shown in Table 3. 
Table 3: Interviewees by qualifying medical condition 
Medical Condition Interviewees Percentage 
Severe Pain/Post-Surgical Trauma 8 (25%) 
Cancer 2 (6%) 
Multiple Sclerosis 1 (3%) 
Minor Back, Neck or Muscle Pain 2 (6%) 
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Arthritis 7 (23%) 
Minor Headaches 1 (3%) 
Severe Headaches (Cluster/Migraine) 2 (6%) 
Minor Knee pain 3 (10%) 
Severe Knee or Hip Pain 3 (10%) 
Other 2 (6%) 
 
Consenting Procedure: 
Participants who volunteered for interviews initiated contact and were then 
provided information about the study.  Those who agree to a taped interview and provided 
contact information were provided the information sheet before any data was actually 
collected or recorded.  Consent to participate in the study was obtained verbally once the 
participant read the information sheet and any questions or concerns were addressed.   
Unsigned Information Sheets were used because the main risk of the study was a breach 
of confidentiality and the use of an Information Sheet protected the anonymity and 
confidentiality of the respondents.  Participants were given the opportunity to review the 
transcript of the interview and explain or supplement the answers although only one 
participant took advantage of this opportunity. 
Creating the Questions, Gathering Information: 
During the course of two years of research, dozens of patients, caregivers, 
dispensary principles, growers, lawyers, professors, reporters, public organizers, 
lobbyists, and physicians shared opinions and feelings on the use of medical marijuana 
and the implementation of the Michigan Medical Marijuana Act.  In most of these 
impromptu discussions actual data was not collected, but, the information was often used 
to formulate the themes for the recorded interviews.  When notes were not taken during 
or after an informal interview an Information Sheet was not always provided.  When the 
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Information Sheet was not provided to individuals and notes were not taken during or 
immediately after the interview, the information gained was not used in the final report of 
findings since this data was insufficiently systematic to warrant reporting as “Findings.”  
Further, the prospective participants were insufficiently informed of their role as research 
participants to justify using this as primary data.  However, the transcripts of the recorded 
interviews are filled with prefaced questions such as:  “I had heard that…”  Thus, this data 
from the discussion where an Information Sheet was not provided was formative in 
refining the Interview Guide and the topics to be discussed with the recorded participants. 
There were also several dozen unrecorded discussions where notes were taken 
during, or memoranda were drafted or dictated after, the discussion.  These individuals 
were considered interview participants and were given an information sheet, and freely 
gave consent for their information to be used as data in the study.  Some of these were 
short conferences, perhaps while in the waiting room at a dispensary or before the start of 
a conference or political rally while other information was gathered over multiple 
conferences and some even lasted several hours.  Over 100 pages of handwritten and 
dictated notes and memorandum were accumulated during the information gathering 
process and reviewed during the writing and hypothesis formulation process for this 
paper.  However, the primary use of this information was to help develop the formal codes 
for the transcribed, recorded interviews and not as a separate, systematically collected 
set of data points. 
Study Procedure: 
Interviews took place at a location of the patient’s choosing.  Approximately a 
quarter of the interviews were in a public location such as the library (n=2) or a restaurant 
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(n=4).  The majority of the interviews took place in the participants home (n=18) while the 
rest (n=7) took place at a medical marijuana center.  Six of the interviews were tandem or 
dual interviews with two married couples and a long-time intimate couple.  In these 
interviews, both members of the dyad were medical marijuana patients and both were 
interviewed concurrently. 
Interview Guide 
The interviews were conducted using an eight page Interview Guide as a template 
(Appendix 1). However, these interviews were not heavily structured. Instead. they were 
guided by the Interview Guide and developed as semi-structured qualitative interviews 
whose purpose was to learn the patient and caregiver perceptions about the effects, use, 
acquisition, and provisioning of marijuana.  Therefore, the format of each interview was 
unique and the topics ranged depending on the participants interests and knowledge.  
Each participant had areas of interest and stronger feelings about certain topics than 
others.  After the first few interviews, when it became manifestly clear that the originating 
question about whether marijuana is actually being used as medicine was going to be 
affirmative, the interview format changed slightly to provide more room for the participants 
to express their individual concerns, perceptions and experiences. The interviews were 
recorded and transcribed.  Most of the patient interviews took approximately an hour 
while most of the caregiver interviews took one to two hours. 
Each recorded interview began with the question:  “What is your qualifying 
condition to use medical marijuana in Michigan?”  This was followed by a detailed medical 
history, and then the participant’s perception about his or her use of medical marijuana, 
including beneficial and harmful effects, method of use and frequency of  medical 
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marijuana use, as well as, an interactive discussion of the certification process, and each 
individual’s visit to the medical marijuana doctor.  The topics of stigma, dealing with the 
children of patients, use of different medical marijuana strains, and initiation into the use 
of marijuana and medical marijuana were added later to the interview guide.  Finally, 
demographic information such as income, class, political affiliation, work and school 
history, and religion were briefly discussed.  
Some topics were not even considered as a research theme or question until 
several transcripts were reviewed.  They showed a clear theme.  For example, almost 
every participant spontaneously provided detailed stories of social isolation, and the loss 
of family, friends and significant others over opposition to the participant being a medical 
marijuana user or patient.  Therefore, the Interview Guide was changed to add the topic 
of stigma.  Similarly, a review of the transcripts revealed a clear tendency of several 
participants to revert to euphemistic expressions about the efficacy of marijuana that took 
a few readings to identify.  Participants extemporaneously described marijuana as an all-
natural remedy, and some talked about marijuana as an almost sacred herb that 
promotes peace and harmony.  Ultimately in a few cases, the participants began extolling 
the benefits of free love and sex that the individual participants felt were fostered by the 
use of marijuana.  This topic was recognized as a similar ideology to that expressed by 
hippie culture.  Thus discussions in this genre were coded under the heading “Hippie 
Talk.”   
Four topics were chosen to present as findings for this paper: reduced opiate 
usage, unequal enforcement and stigma, availability, and quality. Each chosen topic or 
theme (as well as subtopic and themes) is given a separate Chapter in the “Results” 
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section.  Narrative passages from the transcripts provide multiple perspectives that were 
used in a discussion of the interconnected themes (Creswell 2003).   
Data Analysis:   
The interview transcripts were subjected to a first pass of open coding followed by 
more tight and specific codes at the conclusion of data collection (Creswell, 2003).  The 
initial categories were the twelve main topics listed in Table 4 and were covered in the 
interview guide which was constantly revised as more information was discovered: 
Table 4: Initial Categories of Discussion in Interview guide 
1 Perceived adverse effects of marijuana; 
2 Perceived beneficial effects of marijuana; 
3 Certification procedure including fraud in the process and experiences with medical 
marijuana physicians; 
4 Children of medical marijuana patients 
whether they know of patient status, whether this affects them, and how they were 
told; 
5 Patient Demographics; 
6 Initiation into the use of marijuana and medical marijuana; 
7 Patient views on the cannabis dialectic; 
8 Patients qualifying medical condition; 
9 Strain specific effects of marijuana as perceived by the user; 
10 Qualifying medical condition; 
11 Stigma experienced by medical marijuana users; 
12 Use of medical marijuana such as frequency, modality etc. 
 
The process of qualitative data analysis involves making sense out of text data, preparing 
the data for analysis, and interpreting the larger meaning of the data (Creswell 2005).  
The process is iterative and reflective which means that data analysis is circular with new 
information feeding back and causing the researcher to change tone and the questions 
for the next interview. 
Preparation for data analysis begins even before the researcher begins collecting 
data with narrowing of the research topic and a literature review of previous data points 
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that have been collected on the topic. Once data collection begins the process of analysis 
continues and deepens.  As data is collected from qualitative interviews, this new 
information is used to refine the existing themes and questions and even formulate 
entirely new themes and questions through a continual process of data collection and 
reflection.  Data is collected, interviews are conducted and the information is used to 
modify the existing questions and themes.   
The process continues until saturation of the data is achieved.  Some of the 
findings reported in this study were obvious almost immediately and saturation of the data 
occurred relatively quickly.   For example, the first four interviewees spent some time 
talking about the fact that marijuana use let them decrease their opiate use and this 
continued throughout every single one of the thirty one interviews where the patient’s 
complaint was chronic pain.  However, it was not until very late in the interview process 
(specifically interviews 25 and 26) that the structure of dispensaries and alternate 
marijuana delivery organizations came into focus.  Complete saturation of the data on this 
topic did not occur until the final two interviews.  Saturation of the data for different strains 
of medical marijuana did not occur during this study and this report is very preliminary.  
This subject is strongly recommend for further interview studies that focus on comparing 
patients with more serious qualifying conditions to those with less serious conditions. 
Development of Interview Themes:   
In Qualitative Research, the themes are often said to ‘jump out’ of the interview 
transcripts or observation notes (Rubin & Rubin 2004).  In this study, over 1,200 pages of 
interview transcription was completed and typed over the course of 31 interviews.  During 
the course of the interviews, the Interview Guide was further developed via hand-written 
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notations, memoranda and further research. The interviews were then transcribed and the 
relevant portions of the transcript were coded under 19 major themes that had been 
discussed during the interviews.  Four categories in the major themes were later 
collapsed from the 19 categories into a total of 15 thematic categories that are listed and 
described in Table 5 Final Codes below along with the pages of transcript devoted to that 
topic over 31 interviews.   
The quotations, discussions, and questions from the transcripts were included in a 
“Qualitative Data Analysis” directory which was used in the analysis and comprises the 
portions of transcript cited in the results section as shown in Table 5 : 
 
Table 5:  Final Codes and Interview Themes by Volume of Data Collection 
Code Description of Discussion Pages of Transcription 
Adverse 
Consequences 
Negative effects from use of 
marijuana 
30 
Beneficial Effects Positive effects from use of medical 
marijuana 
25 
Cannabis Dialectic Social split between pro and anti-
marijuana groups including discussion 
of larger social issues like legalization 
and the effect government control 
57 
Children Explaining patient status, diversion 
issues, use by children 
40 
Demographics General demographic questions 172 
Doctor’s Visit The Medical Marijuana certification 
process 
41 
Dispensaries Formation, operation and structure of 
medical marijuana centers in 
Michigan 
63 
Fraud Evidence for fraud in the certification 
process and no legitimate medical 
need 
41 
Reverse-Gateway Medical marijuana reducing opiate 
usage 
47 
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Hippie Talk Discussions of free love, peace, 
communal living, open sex practices, 
new age, Eastern religions including 
references to ‘all natural’ or ‘chemical 
free’ life while using. 
28 
Initiation First time using marijuana and 
medical Marijuana 
14 
Michigan Marijuana 
Act 
Implementation, rule changes, case 
law 
12 
Stigma As experienced and perceived by 
users 
6 
Strains Discussions about different types of 
marijuana including modality of use 
such as concentrated oils and 
tinctures 
59 
Use of marijuana A catch-all category including types 
and modalities of the use of 
marijuana 
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Using MS Word, each of these themes was given a separate directory name and 
the transcript excerpts were labeled, and then cut and pasted into the appropriate file.  
Because of the fluidity of the qualitative interview process, this was by necessity a flexible 
process.  For example, the section on the “Certification Process” was collapsed entirely 
into “Doctor’s Visits.”  Similarly, sometimes a transcript excerpt was placed into more than 
one file.  For example, discussions about the “Doctor’s Visit” often segued into “Fraud” 
because the physician’s certification is closely related to the seriousness of the patient’s 
qualifying condition and because some patients claimed the doctor’s visit was itself an 
example of “Fraud.”  
Some categories were not used in the final analysis of the results:  “Adverse 
Consequences” had 30 pages of transcription, but most of it was questions about any 
adverse consequences from marijuana use followed by a denial of any adverse 
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consequences although a few patients complained about coughing and headaches from 
“smoking too much.”    
The topic of “Children” was fascinating and was almost chosen as one of the four 
to present in this dissertation, but space constraints prevented this.  Questions about the 
children of medical marijuana patients were not pursued until later in the interviews, 
beginning with interview 18 and most of the 40 pages of transcript devoted to this topic 
were from just 4 interviews.  This topic is strongly encouraged as a future area of 
research. 
The topic of “Demographics” was not an important topic for a qualitative study 
except insofar as it revealed the participant population which was 99% white (30 of 31) 
and 35% female (12 of 31).  The interview population was also highly educated (see 
Table 9). 
The most significant results were collapsed into four main categories 
corresponding to the four sections in this dissertation on “Findings.” 
Table 6: Findings Reported In this Study 
Final Findings Original Questions Category 
Reduced Opiate Use • Beneficial Effects 
• The Cannabis Dialectic 
• Reverse-Gateway 
• Hippy Talk 
Unequal Law Enforcement and 
Legal Concerns 
 
 
• Cannabis Dialectic 
• Doctor’s Visit 
• Michigan Marijuana Act 
• Stigma 
• Dispensaries 
Medical Marijuana Distribution • Dispensaries 
• Michigan Marijuana Act 
Strains of Medical Marijuana • Use of Medical Marijuana 
• Strains 
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Therefore, the Results section was primarily derived from the data that was copied 
into the 15 Thematic Categories (Table 5) and then interpreted and condensed into the 
final findings (Table 6).  
Patient and Caregiver Interview Characteristics:   
 
There were two categories of interviews:  
 
Table 7 :Interview Types 
Regular patients n=20 
Caregivers n=11 
   
A “regular” patient was an individual with his or her certification card from the State of 
Michigan who had been approved to use medical marijuana by a physician who judged 
he or she had a serious or disabling medical condition, the symptoms of which could be 
helped by the use of marijuana. These interviewees did not have any significant contacts 
with the medical marijuana industry in Michigan except as consumers and their interviews 
took approximately one hour. 
The remaining interviews (n=11) were with patients who were also individuals 
classified as caregivers under Michigan law.  The Caregiver interviewees were all 
producers and activists in the medical marijuana community.  Proposal 1 under Michigan 
law allows each patient designate a caregiver who may grow, purchase, or otherwise 
obtain marijuana for his or her patient and legally receive remuneration from the patient.  
These interviews took approximately two hours, and included the personal observations 
about the categories and types of patients they had observed.   
 
Table 8:  Caregiver Interviewees by medical marijuana experience 
“How many patients have you personally observed or advised about the use of medical 
marijuana?” 
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Number of Caregivers Number of Patients claimed to have advised others about the 
use of medical marijuana 
1 A few dozen 
4 Lots…too many to count 
2 Hundreds 
2 Thousands 
 
The Caregivers interviewed were not representative of the population of medical 
marijuana patients as they were mostly highly educated producers, leaders, and activists 
in the medical marijuana community.  Only three Caregiver interviewees did not have a 
college degree, two of these were young females recently graduated from high school 
who intended to go to college while the 3rd was a middle-aged, self-identified hippie who 
had a tie dyed shirt and rainbow pony tail. Three of the eleven recorded Caregiver 
interviews held a Master’s Degree. 
 
Table 9:  Interviewees by Education 
Interviewee Characteristics: High School College Masters 
Patient Interviews (n=20) 11 (55%) 7 (35%) 2 (10%) 
Caregiver Interviews (n=11) 3 (27%) 5 (46%) 3 (27%) 
 
Interviewees Previous Experience with Marijuana:   
Twenty-eight of the Thirty-one respondents (both Patient interviewees and 
Caregiver interviewees) reported using marijuana before they developed their qualifying 
condition.  Two others were born with their qualifying medical condition and began using 
marijuana before age 15.  This convenience sample is too small to provide a meaningful 
average (mean) age of entry into the use of marijuana and this was certainly not the 
purpose of this study.  However, the median (middle number in the range) and mode 
(most common number in the range) is interesting:   According to the interviewees, both 
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the median and mode of entry into the use of marijuana was age 15.  Four respondents 
reported first using marijuana at age 9, two at age ten, and one at age six.4  All but two 
had been smoking regularly on a daily or weekly basis since their initiation.  Several 
claimed they started smoking marijuana at age 18.  Only one first tried marijuana at age 
25 and one stated she was in her 60’s the first time she used marijuana.  Five patients or 
caregivers were unclear on the age they began or did not wish to divulge this information. 
 
Observations of “Medical Marijuana Dispensaries” as Alternate Medical Care Providers:   
The interview process provided a number of opportunities to physically inspect 
approximately twenty medical marijuana centers across the State of Michigan including 
visiting facilities located in Lansing, Flint, Detroit, Grand Rapids, Ann Arbor, Northeastern 
Michigan, and Northern Michigan.  The results included personal observations, formal 
recorded interviews, and the ability to gather information from lawyers, medical marijuana 
center principles, and employees working within the medical marijuana industry in 
Michigan.  Personal observations backed up by formal recorded and unrecorded 
interviews were used in specific circumstances particularly in order to describe the 
physical operation of medical marijuana centers in Michigan. 
Methods- Conclusion:   
This study employed in-depth interviews with a non-probability sample of Michigan 
medical marijuana patients and caregivers which is a unique and little studied population.  
A total of thirty one medical marijuana patients gave recorded interviews for this study 
including twenty “regular” patients and eleven producers or “Caregivers.”  Several dozen 
                                                 
4 This interviewee grew up in a “hippie commune” and believed her initiation may have been several years earlier 
but listed age 6 because this was her first memory of smoking marijuana. 
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short, information sessions were also conducted and used to modify the interview guide 
and refine the initial codes into the final codes that were used.  The recorded interviews 
were then transcribed and the interview guide codes (Table 5) were developed in a highly 
iterative process into the final codes (Table 6).  Each transcript was then read and the 
relevant excerpts from the transcript were copied into the appropriate final code category 
for data analysis. 
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CHAPTER 4:  USE OF MARIJUANA DECREASED OPIATE USE: 
THE “REVERSE GATEWAY EFFECT”5 
  
The most prominent and earliest theme uncovered was the almost universal 
claim by patients and caregivers that medical marijuana reduced or eliminated use of 
prescription painkillers, in particular orally administered opiate narcotics.  This claim is 
at odds with previous studies on marijuana use and abuse.  In fact, there are 
numerous studies on the Gateway Hypothesis that the use of marijuana leads to use 
of “hard” drugs like heroin and cocaine, but very limited research on the potentially 
beneficial effects of marijuana.  The Gateway Hypothesis is the centerpiece of the 
campaign against marijuana.  The Drug Enforcement Administration (DEA) argues:  
Marijuana is a frequent precursor to the use of more dangerous drugs… 
marijuana users are five times more likely to become drug dependent, eight 
times more likely to use cocaine, and fifteen times more likely to use heroin 
later in life (DEA 2011). 
 
However, proving the Gateway Hypothesis has been problematic.  There is no 
question the use of marijuana is associated with later use of more dangerous drugs  in 
specific cases, but it has not been proved that these individuals were not influenced by 
other factors.  Some studies find support for a general causal model that marijuana use 
leads to use of “hard” drugs (Fergusson 2006) while others dispute the methodology 
and interpretation of these findings (Kandel 2006).  Most reviews acknowledge the 
interesting correlation but reach an inconclusive result.  One of the more convincing 
recent studies used a meta-analysis of longitudinal, animal, epidemiological and twin 
studies to determine causality of the gateway effect claims (Hall 2009).  Hall showed 
                                                 
5 An earlier version of this Chapter was published by the author as “Patients and Caregivers Report Using Medical 
Marijuana to Reduce Prescription Opiate Narcotics” Humbolt Journal of Social Relations Issue 35:29-41 (2013).  
The term “reverse-gateway” was coined by an early physician participant who was not recorded.   
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that pre-existing traits, along with social and peer influences caused by early and/or 
heavy entry into the drug culture are the primary influences in later abuse of other illicit 
drugs.  He concluded that regular cannabis use may have pharmacological effects on 
brain function that increase the likelihood of using other drugs, this “minor” effect is a 
“secondary concern” in human subjects (Hall 2009). 
The claim that marijuana use decreases the use of other drugs was called the 
Reverse-Gateway Hypothesis” in several conferences including all four discussions with 
medical marijuana certifying physicians in Michigan.  All the physicians agreed with the 
Reverse Gateway Hypothesis and claimed that the “overwhelming majority” of their 
patients seek marijuana in order to decrease their prescription use, especially opiate 
narcotics. 
Therefore, since the primary aim of this paper was to present the patient 
perspective and perceptions about the effect of medical marijuana, the effect of 
marijuana use on prescription drug use was the first finding.  All patients and caregivers 
who had experience with opiate narcotics expressed the view that medical marijuana is 
not a Gateway Drug that increases the likelihood of illicit drug use but a Reverse 
Gateway Drug that permits a decrease in concurrent opiate narcotic drug utilization.  
No studies were located on the issue of using marijuana to substitute or 
decrease opiate narcotics or any prescription medicines.  However, there is a growing 
body of research showing marijuana may reduce the negative side effects of various 
symptoms and signs associated with narcotics use and withdrawal, especially nausea 
(Todaro  2012) and headaches (Robbins 2009).   Thus, the additional untested claim 
that marijuana use may also decrease opiate narcotic consumption by acting (like 
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alcohol) as a mutually exclusive agent cannot be ruled out.  A claim that greater 
consumption of marijuana is associated with less consumption of opiates appears to be 
plausible.  This paper is the first to report the medical marijuana patient’s claim that 
marijuana acts as a mutually exclusive agent with opiates and thereby decreases the 
use of opiates with greater use of medical marijuana. 
Finding 1 on Decreased Opiate Use is an example of Applied Medical Sociology:   
Medical sociology is an application of sociological methods and theory to the 
evaluation of the role of social factors in the development of disease and illness.  
“Sociology of medicine” is the study of the organization, structure, relationships, norms, 
values, and beliefs of medical practice as a form of human social behavior (Cockerham 
2010).  Medical sociology is also interested in the causes and consequences of social 
effects on the health of particular groups and the larger society which is often referred to 
as “sociology in medicine” (Cockerham 2010).  Medical sociologists often collaborate 
with physicians to study the social cause and determinates of diseases or conditions 
and tend to be motivated by a medical problem, rather than a direct social consequence 
(Cockerham 2010). This study primarily focuses on Medical sociology, or the sociology 
in medicine. These interviews are examining the social effects on the medical marijuana 
users of Michigan.  
The interview results from this study are reported in two sections as outlined 
above in the “Interview Types” section.  Results from “Patients” are reported in Section 
One while results from “Caregivers” (Producers and activists) are reported in Section 
Two.  Eleven of nineteen patients and eight of nine caregiver interviewees who talked 
about the topic had experience with opiate narcotics.  All patients and caregivers who 
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had experience with prescription opiates made sweeping claims that they personally 
reduced opiate consumption and/or had personally observed patients reducing opiate 
consumption as a result of using medical marijuana.  Many provided personal, specific 
and detailed examples of patients using medical marijuana to substitute for other drugs, 
particularly prescription opiate narcotics.  The only patients who did not claim they 
substituted marijuana for opiate narcotics were patients who were not originally taking 
opiates. 
 
PATIENT RESULTS 
 
A. Patients reported completely eliminating prescription opiate narcotics by 
substituting medical marijuana.  
 
Several patients claimed they had been able to completely eliminate narcotics by 
substituting marijuana.  One participant, a male P8 in his 40’s with dual hip-
replacements and severe arthritis described months of his life in a “complete daze” 
taking Darvon, Oxycodone, and sublingual Codeine.  He mentioned several times that 
he was only able to completely discontinue these drugs because of marijuana:   
I: You mentioned, and I want to just get it out on the record, you have been 
able to decrease or discontinue narcotic medications because of having 
medical marijuana? 
 
P: That’s exactly right. 
 
I: You have been able to completely discontinue? 
 
P:  Yeah.  
 
Many patients were almost unable to contain their glee when they reflected on their 
drug use before and after access to medical marijuana.  One male, in his 50s, a College 
Graduate was suffering lumbar pain post-surgery after he broke his back at work.  The 
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medical history was consistent with low back herniated discs and lower right side 
peripheral neuropathy: 
I: Are there other drugs that you are not on now that you might be if you 
didn't have marijuana? 
 
P:    Yes I no longer take, the… frankly, I want to jump up and dance  
because of that. You know. I took those pain pills and all those other pills 
for so long. But, no more Tramadol [a prescription opiate pill] for me!  I 
don't have to see the doctor at the prescription mill for any pills, so no. 
 
I:   So, no antidepressants, no pain medications, no Tramadol just marijuana. 
 
P:   That is correct   
 
Four of eleven patients who claimed experience taking opiate narcotics agreed they 
were able to completely eliminate the pharmaceutical opiates by using medical 
marijuana. 
B. Patients reported reduced use of prescription opiate narcotics by 
substituting medical marijuana.  
 
Other patients whose condition was more life altering claimed they had been able 
to reduce their use of opiate narcotics by substituting marijuana.  Seven of eleven 
patients reported they were able to reduce the number of pills taken, but did not 
completely eliminate the use of opiates because the pain was still existent. 
In two interviews, the respondents claimed they had significantly reduced opiate 
narcotics use while simultaneously claiming they had recently added a morphine pump 
to their medication regimen.  The morphine pump was described as considerably less 
psychoactive and did not have the side effects associated with opiate pills.6 During the 
interviews it became clear that the participants believed the medical marijuana in 
conjunction with the morphine pump made it possible to decrease opiate usage. 
                                                 
6 An intrathecal pump delivers morphine at about 1/300 the dose used for oral administration. 
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In an interview with P12, a female in her 30s with Multiple Sclerosis it was 
disclosed: 
P: When I was on oral meds I was just not with it.  You could talk to me and 
have a conversation with me and 10 minutes later I wouldn't remember 
what you said, and then I'm on the liquid morphine it's like a whole new 
world to me.   
 
I: Is that because it is a steady supply and not an up-and-down situation? 
what do you attribute that to? 
 
P: They said when you're taking oral meds it has to go through your whole 
entire body…head to toe.  When they put the pump in, it goes to my back. 
I don't have to swallow. It doesn't have to go through my whole entire 
body. I don't feel high all the time like I did when I had to take the orals 
every six hours, every day  
 
She claimed her ability to get off some of “the orals” was directly related to use of 
medical marijuana:  
I: Have you been able to reduce or discontinue any of your medications as a 
result of your use of marijuana? 
 
P: Yes, absolutely. I used to be on probably about 20 different pills, and I am 
down to I think 7 or 8.  
 
I: So by two-thirds? 
 
P: Oh, absolutely yes, yep  
 
A male patient in his 40s, P14, who suffered severe post-surgical lumbar trauma, 
also related a history of taking “handfuls” of narcotic pain medications.  He described 
taking large numbers of narcotic pills every day and claimed a dramatic reduction in his 
pill use due to the availability of medical marijuana: 
I:   Is it your claim you have been able to reduce or discontinue some of your 
narcotics and high schedule medications because of your use of Medical 
Marijuana? 
 
P: I was taking 20 pills a day, almost 20 pills a day and now I am down to 12  
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Patients frequently provided specific and detailed quantitative information 
about their reduction in opiate use based on their perceptions and 
memories. This patient believed his morphine pump was particularly 
effective in conjunction with medical marijuana to reduce oral narcotics 
use. 
 
I:    So, do you think you would have graduated to the morphine pump  
earlier if you had not had access to medical marijuana? 
 
P:    Of course.  The pump and the pot work together a lot better than  
the pills. It takes out the pain, but it doesn’t mess up your mind.   
 
 The combination of morphine and medical marijuana, in the perception of several 
patients allowed a reduction in prescription opiates, allowing them to function more 
clearly. This preference was obvious not just with back pain, but also with other 
maladies, such as Cancer.  
Both Cancer patients interviewed were Stage IV with severe pain and mental 
distress.  They spent some time describing their experiences with prescription narcotics.  
Medical marijuana was literally their last stop, and both talked extensively about the 
importance of being able to reduce their narcotics intake and about the amounts of 
narcotics they were prescribed. First was PP22, a 60s aged female cancer patient. 
I:  Well, let’s talk about that what kind of drugs were you taking? 
 
P: I was taking Vicodin extra-strength three times a day backed up by an 
Ultram which is an anti-inflammatory, and also a Duragesic patch with 50 
micrograms that I change every three days. It gives me a constant flow of 
medicine. 
 
I:    Have you had to take a lot of narcotics? 
 
P: I had to take a tremendous amount of narcotics.  Tremendous, 
tremendous, tremendous amount  
 
Both cancer patients claimed they were able to significantly reduce their narcotics use 
by substituting marijuana. P60s was able to take less of the “tremendous” amounts of 
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narcotics that she had as part of her treatment. This was echoed by P27a female 
cancer patient in her 50s :  
P: When I use the oil and smoke, I find it. I realize – wow. It is two hours past 
the time when I would've normally taken my Fentanyl [a potent opiate and 
general anesthetic].  I have two 100 milligram patches Fentanyl that I use 
at a time.  As well as, 40 or 50 milligram of Oxycodone [a/k/a Oxycontin, a 
potent oral opiate] immediate release on top of that. 
 
I: Were you able to decrease any of your treatments since you started using 
medical marijuana? 
 
P: Well, that I have been able to do, yes, absolutely.  Like I said before, be, 
be less dependent on those pills…which makes me happy.  But as far as 
changing any protocol like at the cancer center, then no.   
 
Results were consistent across several medical conditions.  Of the eleven patient 
interviewed who were prescribed opiates/narcotics for their condition, regardless of 
whether the medical condition was trauma, Cancer, Multiple Sclerosis, Arthritis, or some 
other pain inducing condition, they unilaterally made nearly the same claim. If the 
patient had a history of prescription narcotics utilization, after integrating medical 
marijuana into their treatment they had been able to reduce or eliminate opiate narcotic 
pills by using medical marijuana. 
C. Caregiver Results: Caregivers agreed that medical marijuana is routinely 
substituted for prescription narcotics. 
  
 In addition to 20 patients, eleven caregivers (producers, activists and patients) 
were also interviewed.  They were also asked about their observations on the use of 
marijuana in order to reduce opiate use.   
One of the 11 caregiver interviewees (P19) was a male in his 20s who worked as 
a medical marijuana dispensary operator did not agree that medical marijuana regularly 
decreased opiate use.   
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I: [of the “thousands” of people you have talked with about medical 
marijuana] How many people have you personally witnessed able to 
reduce or discontinue medications, pharmaceuticals, because they started 
using medical marijuana? 
 
P: Personally, about 10. 
 
He thought this was a fairly low percentage of patients because narcotics addiction is so 
powerful.  
His position involved in administrative matters, and he did not routinely talk to patients 
about their  
medical condition. His personal history did not include personal experience with opiate 
narcotics 
P: I would say about sixty percent [of medical marijuana patients] are taking 
pharmaceutical pills still. 
 
I: So well over half you think? 
 
P: Oh, yeah. 
 
I: And, how many of these sixty percent have been able to reduce the 
number of pharmaceuticals they’re taking? 
 
P: Probably not many, I would say probably five percent. The rest are still so 
hooked on it; that it is really hard. 
 
The other 10 other caregiver interviewees reported they had experience talking to 
patients specifically about their medical conditions and also had personal experience 
taking opiate narcotics.  They all claimed that medical marijuana was used to decrease 
opiate narcotics. 
The interview with Participant 1 was indicative of many of the users. She was a 
young white female in her early 20s a High School Graduate, who suffered fibromyalgia 
and Scheuermann's disease (mid-back kyphotic or “hunchback” changes that are often 
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very painful) and worked as a medical marijuana dispensary employee in a medical 
marijuana dispensary in Northeastern Michigan.  She and her parents were both 
caregivers who worked at the medical marijuana facility.  Her specialty was baking THC 
candy and other edible medical marijuana preparations (“medibles”).  She described her 
condition as including extreme and disabling pain that caused her to miss a significant 
amount of high school and develop an extensive medical history.  She talked for some 
time about her medications that included “huge amounts” of Vicodin, and several other 
narcotics, anti-depressants, Flexerol, and non-steroidal anti-inflammatory medications.  
Both her personal experience, and her broader experiences working with the patient 
population supported the hypothesis that marijuana might be useful to “decrease” 
narcotics intake: 
I:   Have you been able to decrease other treatments since you started 
using medical marijuana? 
 
P:    I use nothing but medical marijuana.   
 
I:     You don’t use any narcotics? 
 
P:  Nope.  Nothing.   
 
The young woman’s observations about the patient population matched her personal 
medical history: 
I: I have heard some doctors mention that perhaps marijuana is a reverse-
gateway drug, that is. It doesn’t cause you to try other drugs, but it helps 
you get off some of the drugs you are already on. 
 
P: Oh, yeah.  Especially working, you know at a Compassion Club. I, well, 
have seen that a lot.  People will are coming to us mostly because they 
don’t want to be on any more, or so many. I mean I started [using medical 
marijuana] because I didn’t want to be on those pills.   
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P1’s experience with “Wanting to get off those pills” became one of the most common 
themes  
in the interviews. 
The second caregiver interview (P2) was a female in her late teens that suffered 
from chronic knee pain and worked as a medical marijuana employee had the least 
experience in the medical marijuana industry of all the interviews classified as 
“Caregiver” interviews.  She had only worked in a dispensary for six months, but 
extemporaneously set the tone for later interviews despite critical questions and pointed 
probes: 
I: Have you ever seen anybody use marijuana as a gateway to use harder 
drugs? 
 
P: I have because I feel like that’s what we’ve been told our whole life, and 
so that’s just how it is.  That’s what we’ve been told, but I mean they don’t. 
It is not true. 
 
I: Can you be more specific what did you see? What have you heard? 
 
P: I mean, my whole life going to D.A.R.E. classes for instance? That 
marijuana is a gateway drug, and then I believed that for the longest time 
you know, and then I previously worked at [Medical Marijuana Center 
name withheld] in [City name withheld] and I saw everybody coming in 
there for it, and just like especially the old people. It really touched me 
because they come in complaining mostly about Vicodin, and ‘how they 
put me on this and that, and it was killing me.’  Lots of older people would 
come in and tell me about how medical marijuana saved their life by letting 
them get off that stuff. 
 
Both groups of interviewees,  Patients and Caregivers, used very similar language such 
as “saving their life” or “lets me live my life” or “lets me function in my life” in describing 
how medical marijuana is used to substitute for opiate narcotic pills. 
 Participant 11 was a Master’s level college instructor in his 50s who had back 
pain. He worked as a medical marijuana delivery service provider and a medical office 
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consultant. He reported, when asked about his experience with patients and narcotics 
usage before and after medical marijuana:  
 
P:    I may have personally processed four hundred doctor certifications.  I am  
the one the person talks to the longest...doing their case prep [for the 
doctor’s office] And through these hundreds of patient encounters, I would 
say about ninety percent of them have already been taking doctor 
prescribed narcotic and opiate pharmaceuticals and…the side effects of 
these are so onerous and debilitating themselves they are not able to 
function in their normal capacity, and they are seeking to get off the 
zombie effect of the pharmaceuticals.  That is where medical marijuana 
really works well. 
 
His statement about the “zombie effect” of opiate narcotics is one that many suffers of 
pain find difficult to combat, without narcotics they are in pain, with narcotics they are 
numb. Their reports of medical marijuana making life bearable and still being able to 
function is both interesting and promising for the Reverse Gateway Hypothesis. 
A medical marijuana dispensary owner and operator, P 16, was a male in his 30s 
who was an avid activist and lobbyist for medical marijuana. He personally suffers from 
back pain. In his interview, he continued the assertion of the earlier participants, using 
an even larger sample.  He is a prominent political activist, the president of a statewide 
medical marijuana advocacy group, a caregiver, and a ‘bud tender.’ He owned a large 
medical marijuana center in the State of Michigan.  “Bud tender” is a California term.  
Because of legal ambiguities there is no commonly accepted term for the retail vendor 
in Michigan who actually hands the cannabis samples to patients and advises them 
about the properties and expected effects of the available types of cannabis.  Many in 
Michigan prefer the title “Cannabis Counselor.”  All of the caregiver interviewees were 
“Bud tenders” except the first interviewee quoted in this section who did not agree that 
marijuana commonly substitutes for opiates.  P16 had considerable direct access to the 
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patient population that included “several thousand” sit-down interviews and discussions 
with patients specifically about their medical condition: 
I: How do we compare cannabis to other drugs that are available?  We start 
off with Tylenol and Motrin, and most people tell me oh no it (medical 
marijuana) is better (at killing pain) than Tylenol and Motrin.  And then we 
get into Tylenol with codeine, and they tell me they don’t want to take it.  
And then we get onto Vicodin, and then Percodan, and a Morphine drip. 
 
P: We will help everybody but sometimes they need to supplement and cut 
down on a bunch of the pills that they are taking and use cannabis 
instead, but then still have to take those from time to time because the 
combination, or at certain times of pain, it’s just, you have to go there 
when it gets too bad. And that’s fine, everybody is different.  Sometimes 
people eliminate them all together which is better.  And sometimes— 
 
I: You mean the pharmaceutical? 
 
P: Right. And then sometimes people eliminate one or two pills a day, and 
that’s it. But over a period of time the amount of stuff you are putting in 
your body, and the amount of cost, health costs, [of]  those things is 
realized, even if it is just a couple of pills a day, you know.  So there’s, 
there’s a combination of everything.  Just reduce it a little bit, reducing it a 
lot, and eliminating it.  But either way, if you interject marijuana in there, it 
makes things a little bit better  
 
Like Interview 1, his personal experiences were similar to his broader observations: 
 
I: And you know what a gateway drug is of course? 
 
P: Yeah, and I know cannabis is not.  Cannabis is an exit drug, it helped me 
quit taking opiates, and all that crap.  I’m also on over 6 years of not 
drinking. 
 
Interview P16’s personal and professional experience is interesting in light of the social 
stigma that is currently on the use of marijuana and medical marijuana because of its 
affiliation with crime and other harder drugs. In P16’s experience, he credited cannabis 
with getting many people away from pharmaceutical narcotics, and for his departure 
from drinking. He states quite clearly that it is an “exit drug.” And, he was not the only 
interview with strong feelings on this subject. 
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A tandem dual interview (P25 & P26) with a manager and girlfriend of a West 
Michigan medical marijuana center yielded even more sweeping claims.  They were in 
their 30s-40s both college graduates and suffered from chronic radiating pain and 
headaches. They owned and operated a medical marijuana dispensary. Both 
Participants had already discussed the issue before the interview with the researcher.7  
Each had talked with and advised “hundreds” to “thousands” of patients and were so 
eager to tell their story the interviewer could barely complete the questions: 
I: Have either of you ever heard mentioned in your presence that maybe 
somebody was able to reduce pain killers and narcotic drugs… 
 
Female: (interrupting) all the time… 
 
I:  as a result of their marijuana use? 
 
Female: All the time. 
 
Male:  Yes, all the time. 
 
...Crosstalk…. 
 
Female: Yes, yes, more people than I could list.   We have people come in here, 
well, all the time, every day, and talk about that. Yes, of course. 
 
I: Do you think that the majority of people who come in here and you talk 
with you claim they are able to reduce the meds, the narcotics they're 
taking….. 
 
Male:   Yes 
 
I: because it is probably really only a few people who…. 
 
Male:  No! 
 
Female: No! 
 
….Crosstalk…. 
 
                                                 
7
 The center was also participating in an investigation with the author comparing patient perceptions of blinded 
strains of medical marijuana with the chromatographically revealed components and concentrations. 
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Female: So many people. So many people, you know, text us. They thank us, this 
is something we hear all the time.  It is not a small thing. I mean, people 
want to wash our car, or babysit our kids for free. Their so thankful, and it 
really is all the time. It's every day. 
 
Male:   Every day, and several times a day 
 
…Crosstalk… 
 
I:   go ahead. 
 
Male: I see, I mean. Yeah, I see people myself, firsthand, come in, and more 
times than not, they're not happy when they come in. And every single one 
of them will tell you ‘hey, I went from taking 10 pills a day to taking  2 pills 
a day.’ With fewer pills, it's still a better quality life because of the medical 
marijuana  
 
P25 and P26’s enthusiasm and excitement about the help they were able to offer their 
clients was touching. The two believed that the work they were doing was helpful, even 
essential in the quality of life for those they were serving. Every single Caregiver 
interview transcript includes consistent and numerous claims that at least some patients 
were using marijuana to decrease prescription opiates.   
Every Caregiver who was interviewed gave specific examples and articulated 
personal observations about patients using medical marijuana to decrease prescription 
drugs use, particularly opiate narcotics.  Even the single Caregiver who did not have 
any personal experience with opiate narcotics reported that he personally observed 
about 10 patients who reduced their narcotics use by using medical marijuana. Every 
Patient that was interviewed (including the 11 Caregiver interviewees) with experience 
taking narcotics claimed they reduced or eliminated their prescription opiate narcotics 
because they substituted medical marijuana. These findings are important in when 
viewed against the social perception of marijuana mentioned by the second Caregiver 
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interviewed (P6) who felt that it must be a Gateway Drug, because that is what she had 
been taught, in direct contradiction of her personal experience. 
 
PATIENTS PREFERED MARIJUANA TO PRESCRIPTION OPIATE NARCOTICS  
 
   Though pharmaceuticals are currently available for almost every ailment in a 
variety of strengths, participants in this study reported they preferred medical marijuana 
to narcotic opiates. There were several reasons for this preference; the most common 
was that the side effects caused by opiates were pervasive and severe.  There were 
also claims that medical marijuana was more effective at relieving pain than some 
opiates and that marijuana was a natural remedy and not a synthetic pill.  
A. Opiates caused very unpleasant side effects:     
Most patients described unpleasant side effects from taking opiate narcotics. A prime 
example was P9 and P10, another tandem or dual interview with a husband and wife 
team of patients in their 50’s or 60’s: 
Female: He simply can’t take [Vicodin] without getting sick. 
 
I: Now when you say you get sick, do you throw up? 
 
Male: Yeah, what happens is I get a severe headache, and I start feeling, I don’t 
know, like fuzzy in my head, like there’s cotton all over inside my head, 
and then it starts making me feel like motion sickness, is the best way I 
can describe it, and then I just started getting sick and trying to throw up 
and throw up and throw up (Male and female, 40’s-50’s, married couple, 
college graduates, chronic pain). 
 
Beyond physical effects, such as headaches, nausea and vomiting, another very 
unpleasant side effect that was commonly reported was the claim that high doses of 
opiate narcotics caused the patient to literally become disassociated with reality, or go 
crazy. P27 a female in her 40s stated:   
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P: Marijuana doesn’t put me off in some world where I don’t know where my 
kids are, and I don’t know what’s going on with the world. 
 
I: And oxycodone does? 
 
P: Yeah it does that.  I don’t like [sic] take it.  They gave it to me, and I gave it 
back to them because ‘you take this, I don’t want this.’  I can’t even 
remember having a conversation with my own husband or my own child.  
This is bad stuff, ‘you take this I don’t want it.’  I gave it back to them, 
because I refuse to take it.  Give me a joint, give me a bowl, do whatever, 
because I can smoke a bowl ,and then have a conversation with my 
husband, or my kid, and I can still remember that conversation.  Because 
I’m sorry I would rather do that than to take one of those pills they gave 
me because it just puts you off in a world that you don’t even know that 
you’re in, and that’s scary.  
 
The medications given to her for her torn rotator cuff were so off-putting that she turned 
to medical marijuana. She was not the only one. Several of the patients with experience 
taking high doses of opiate narcotics reported detailed, graphic, and apparently valid 
fears about their mental health if they could not find an alternative to “the pills.” In a 
humorous, but frightening, anecdote P27, a woman with end stage cancer related how 
she came to make her decision to try medical marijuana: 
P:   I was on almost 300 mg of oxycontin a day between the long-acting 
and the short term.  It was a very high dose. I was also given other 
pain relievers Percocet, vicodin, Norco, you name it.  I have a 
drawer full of these pills.  When it came to my final decision when I 
decided to try medical marijuana was when I asked my dog to 
make me lunch one day. 
 
The stark reality of this situation is that she was not aware of her surroundings, and that 
in trying to find relief from pain, she was losing her grasp on her life. 
In addition to the complaints of nausea and insanity, some of the complaints 
were frightening. Patients reported that opiate drug use was putting their children in 
danger because of their lack of ability for function correctly. Opiates also caused 
patients to sleep all the time as well as making them feel they were missing out on life. 
105 
 
The overwhelming responses from patients were that medical marijuana returned them 
to their life in a way that opiate narcotics could not. 
B. Medical marijuana was perceived to be more effective at relieving pain than 
some opiate narcotics but not the more powerful narcotics: 
 
All patients and caregivers who had experience taking narcotics (n= 21of 31) in 
this small sample said medical marijuana was more effective at relieving pain than 
codeine.  This is consistent with earlier work (Campbell 2001).  In addition to being 
more effective, all of the participants interviewed agreed that medical marijuana did not 
have any of the negative side effects associated with codeine or narcotics. And, two 
patients and three caregivers claim that medical marijuana relieved pain better than 
Vicodin, which has not been previously been reported.  All participants with narcotics 
experience agreed that medical marijuana was not as effective at relieving pain as 
stronger narcotics such as morphine or oxycontin.  However, medical marijuana was 
often still preferred over the more effective opiate. 
In discussing with patients and caregivers the comparisons between opiates and 
medical marijuana, there was some difficulty separating out the two issues of the 
adverse side effects of opiates and the pain relieving effects of opiates.  Although it was 
clear that most patients preferred marijuana over Vicodin, it was not always clear 
whether marijuana was preferred because it was more effective at relieving pain than 
Vicodin or whether marijuana was preferred because it was not associated with the 
adverse side effects of Vicodin which can include nausea, blurred vision, confused 
thoughts, headaches, etc. 
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One patient, a college educated Afghanistan Veteran in his 20s, attempted to 
explain the differences including the disadvantages of opiates and the advantages of 
marijuana: 
P: [Smoking marijuana]… makes my life better than when using narcotics.  
Narcotics keep my back from hurting, sure, but the medical marijuana 
helps me forget about the fact that I'm in pain.  Narcotics, you know, I 
don't have the nausea like that, and I physically feel better. 
 
I:  I want to get very specific about what it does for your pain it doesn't work 
as well as Percodan, am I right? 
 
P: Well, yeah, that that is that medication’s job. It is the thing that they do.  Is 
to kill the pain…and mess your head up a little bit, is obviously their main 
purpose of life is essentially to dull pain, and they do a very good job. That 
however is a Catch-22.  You can be pain free, but you'll feel like garbage 
with the nausea and the side effects from the narcotics that come with it. 
 
His experience taking narcotics to help his back pain were echoed by almost all 
participants who complained about “that sick nausea feeling” caused by taking opiate 
narcotics.  
 
C. Several participants refused to take opiate pills because they believed 
marijuana was a “natural” remedy different than synthetic pills 
 
Of the nine patients and one caregiver (out of a total of 31) who had no 
experience taking opiate narcotics, seven claimed they never even started taking 
opiates because they used medical marijuana.  One young woman, a female high 
school graduate had chronic pain and reported she had never started using narcotics. 
She attributed this to medical marijuana:  
I:   What about other treatments, have you been given drugs? 
 
P:  I choose not to take them. I personally, I have personal beliefs. I don’t like 
to take chemicalized pills. You know what I mean?   
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I:    OK, you don’t have a problem taking medical marijuana though? 
 
P:    No. 
 
I:    How is medical marijuana different than the… 
 
P:   Well it is grown, it is an actual plant. So, for me it is just a natural  
way to treat this. 
 
Her belief in the natural approach to medical aid was expressed by others as well. 
Another participant in her 20s was against smoking marijuana, until she suffered from 
knee pain: 
P: I was against smoking marijuana for a long time for recreational use, and 
then the whole medical marijuana thing started to come around, and so I 
gave it a try. And I was like, wow, it really does help.  And now, I have a 
whole other different lifestyle now. I don’t do any chemicals, nothing like 
that, it’s all natural. Everything natural, and I feel a lot better just as a 
person. 
 
I: Can you go into that a little bit more?  What do you mean you live a whole 
different life style? 
 
P: I don’t, I mean, anything unnatural, I don’t do to my body.  I don’t take any 
prescription pills; I don’t drink alcohol any more, I use hash oil actually.  
It’s very, very, very potent and you have to work up tolerance to be able to 
vaporize a lot of it, but I mean once I’m at that level I don’t even want to 
drink.  I used to drink heavily and stopped when I started smoking hash 
oil.  I haven’t drank in two years now.  
 
Most of the patients who had never started taking opiates, explained this by using some 
version of the ‘natural remedy’ claim.  
 It is interesting that the natural medical marijuana was favored so highly, even 
with the stigma of marijuana in the United States. The legal form of THC, Marinol was 
also reviewed with four participants who had experienced both.  Three of the four 
participants were ‘informal interviews’ and were not recorded while the other was 
recorded but the discussion about Marinol was off the record.   Marinol, a 
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pharmaceutical product that is synthesized THC has been promoted by the drug 
companies as a substitute for medical marijuana. All medical marijuana patients who 
have taken Marinol characterized it as negative. These comments place it closer to 
opiate narcotics in the opinions of the medical marijuana users, than to grown 
marijuana. The agreement and condemnation of the four participants dealt with both the 
side effects and potency. They offered comments such as:  “scary stuff”, “makes you 
hallucinate”, “makes you jittery and paranoid”, “doesn’t help at all” and “you can’t 
regulate how it makes you feel.”   
The main complaint for opiates were the “sick feeling”, fear of putting their loved 
ones in danger due to opiate intoxication, and fear of going crazy. Medical marijuana 
patients and caregivers who volunteered to be interviewed for this study were more 
positive toward medical marijuana’s effectiveness and side effects as a whole than the 
effectiveness and side effects of opiate narcotics.  Consistent with previous work 
(Campbell 2001) medical marijuana was thought by patients to be more effective than 
codeine elixirs, but less effective than hard narcotics like oxycodone or morphine.  
Some patients reported they preferred medical marijuana over Vicodin  either due to the 
lack of side effects from medical marijuana or from superior analgesia.  Medical 
marijuana patients who did not have experience taking opiates often actively avoided 
taking them even when prescribed because they preferred the “all natural” remedy of 
medical marijuana. 
These results should be viewed with caution given the unusual cohort that was 
interviewed.  Many participants had started using marijuana many years before they 
developed their qualifying medical condition; so it is not clear from these results that 
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novice marijuana smokers who did not begin until they developed their qualifying 
condition would have the same experience of superior analgesia, lack of side-effects, or 
the almost belief in marijuana as an ‘all natural’ remedy.  Many of the people who turned 
to medical marijuana without previous marijuana experience found they needed to 
overcome the legal stigma that surrounds marijuana before being willing to try it. The 
legal issues of medical marijuana in the state of Michigan are complex and frightening, 
and though these participants unilaterally agree that medical marijuana helps their 
condition, almost all of them expressed serious concerns about where they stand in the 
legal system. 
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Chapter 5:  PARTICIPANTS COMPLAINED ABOUT SEVERAL LEGAL CONCERNS 
IN PARTICULAR THAT ENFORCEMENT OF THE MEDICAL MARIJUANA ACT WAS 
UNCLEAR, AMBIGUOUS, AND UNEVEN 
 
Introduction:   
Medical Marijuana users in Michigan have many concerns, and not just about the 
legality of the medicine they have chosen. Several reoccurring legal concerns were 
expressed by the participants during the course of the interviews specific to the 
enforcement of the Michigan Medical Marijuana Act.  In terms of duplicating these 
results with future samples, it is first important to mention that this researcher practiced 
law for more than a decade as a licensed attorney in the State of Michigan so it was 
probably inevitable that the interviews often covered legal aspects. There were six 
primary legal issues and concerns that were addressed and expressed by the patients 
and caregivers about the enforcement of the Michigan Medical Marijuana Act and the 
effect of various interpretations of the act on medical marijuana patients. 
Legal Issue 1:  Long Delays for State Issued Card:  The first and most commonly 
expressed concern was about the delay in issuance of certification cards by the State to 
patients.  In order to obtain a medical marijuana card, first the patient would see a 
physician and obtain a statement that verified the patient had a legitimate qualifying 
condition.  Then after issuance of the application materials to the State, the State was 
supposed to issue the card within 25 days (20 days to review and reject or deny the 
application and 5 days to issue the card, see MCLA 333.26426).  However, at the time 
the interviews were progressing, patients often had to wait up to 6-months for the State 
to issue the certification card and this created problems with access, particularly their 
ability to procure marijuana from dispensaries.  
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Legal Issue 2:  Access to medical marijuana and Dispensary Operations:  Since 
many dispensaries would not serve patients who did not have the ‘hard card’ from the 
State, the often 6-month wait caused a loss of access to marijuana.  This was 
expressed as a strong concern over and over again by the patients and was a primary 
issue for every single caregiver that was interviewed. 
Other Caregivers had other often very specific legal concerns.  For example, 
each of the Caregiver interviewees asked to go off the record and solicited the 
Research Interviewers legal opinion on the issue of whether they could serve individuals 
with just their paperwork rather than the hard card from the State of Michigan, and it 
was clearly of primary importance for almost all of them during the course of the 
interviews when providers and patients were attempting to comply with an ambiguous 
law and everyone was waiting for the courts to decide. 
Legal Issue 3:  Protective Measures Taken by Dispensary Operators:  The 
discussion about dispensary operations very frequently included specific measures that 
were taken by the operators to work with or even avoid the law.  Fortunately there is a 
fair amount of transcript devoted to this topic as the tape was often turned back on as 
we discussed the specific steps various dispensary operators took to comply with the 
law and to win allies in the community and in local government.  Even though most 
providers and caregivers strongly claimed they were “true believers” willing to go to 
prison for their beliefs, they also inevitably adopted several protective mechanisms to 
help avoid that outcome.  
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The final two concerns were primarily medical in nature: 
Legal Issue 4:  Inclusion of other medical conditions:  Just under one-half the 
interview participants (14/31) mentioned the dilatory practices of the State government 
in refusing to consider inclusion of additional medical conditions or convening a panel to 
consider adding other medical conditions to the list of medical qualifying conditions to 
use marijuana.   
Legal Issue 5:  Scope of a valid Medical Marijuana doctor-patient relationship.    
Every single care caregiver and patient who discussed the issue of the medical 
marijuana certification provided by the medical marijuana doctor thought the scope of 
the doctor-patient relationship needed clarification especially about what constitutes a 
legitimate physician patient relationship.   
 
Findings on Legal Concerns of Patients and Caregivers are Sociology of the Law and a 
Study in Law and Society:   
 
Just as there is a division between “Sociology of Medicine” and “Sociology in 
Medicine” there is also a division between research focusing on “Sociology of Law” and 
the study of “Law and Society.”  Sociology of law, like sociology in medicine is the study 
of the legal system and the actors in the legal system or a segment of the legal system 
that includes an analysis of social institutions or societal segments as a self-contained 
entity or in relation to society as a whole (Sutton 2001).  In contrast, studies of law and 
society or sociology of law tend to focus on human social behavior in the context of the 
legal system and regulatory structures and the impact on society. 
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 This research is an example of both sociology of the law and law and society.  
One of the primary purposes of this work from the beginning was to better understand 
the interaction between the legal and medical systems and to investigate a rarely 
studied population that occupies a unique subset of both systems.  The issues of 
marijuana regulation, use and abuse have been treated as legal concerns and matters 
for the court and prison systems since the 1930’s while the issues of medical marijuana 
are, obviously, medical issues.  The goal from the beginning was to obtain the 
perspective of the patients and caregivers who are most affected by the legal, 
adjudicative, penal, and medical systems.  The legal concerns of patients and 
caregivers reflect a myriad of issues about the legal and medical system. These issues 
reveal truths about the sociology of medical marijuana law.  At the same time, this was 
obviously a study that focused on human social behavior in the context of the medical 
and legal systems along with the regulatory structures and as such it attempts to assess 
the impact of medical marijuana on society and the impact of society on the medical 
marijuana user. 
 
Legal Concern Finding 1:  State Delay in Issuing Registry Identification Cards:   
The first concern was the long delay between submission of the certification 
materials to the State and approval being granted by the State.  Every single participant 
who was interviewed expressed concerns about ambiguities in the Michigan Medical 
Marijuana Act which resulted in at least a temporary loss of access to medical 
marijuana.  At the time the interviews were ongoing, the State of Michigan routinely 
delayed the delivery and distribution of certification cards.  Most participants complained 
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about waiting for up to 6-months for their medical marijuana certification cards to arrive 
in the mail from the State of Michigan.  The drafters of the medical marijuana 
referendum, having experience with 90 years of government tactics such as the 
marijuana stamp act (where marijuana cultivation was made illegal without a stamp 
which the government then refused to print or distribute) wrote into the statute an 
automatic certification trigger of 20 days so that:  “If the department fails to issue a valid 
registry identification card in response to a valid application or renewal submitted 
pursuant to this act within 20 days of its submission, the registry identification card shall 
be deemed granted, and a copy of the registry identification application or renewal shall 
be deemed a valid registry identification card” (MCL 333.26429). 
However, while this anticipated and attempted to thwart internal opposition to the 
act, the problem became inextricably linked to the issue of dispensaries.  At the same 
time one government agency was delaying the delivery of medical marijuana cards to 
qualified applicants, other government agencies were engaging in selective 
prosecutions of various medical marijuana centers that had sprung up in the 
unregulated environment.  As a result of legal pressure, many dispensaries refused to 
serve patients who were waiting for their “hard card” from the State.  Many patients who 
only had their “registry identification application” (consisting of a 1-page application and 
a 1-page physician’s certification statement) were denied service at dispensaries.  Thus 
a patient might not have easy access to their medication for half the year while they 
waited for the “hard card.”  Nearly half the interview participants (14/31) complained, 
often bitterly, about this application of the law and expressed concern they had been 
denied service (or in the case of Caregivers that they were unable to provide service) at 
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a medical marijuana center or dispensary, and that their access to marijuana was 
limited because of the delay in getting their certification cards from the State.  
Whether the primary concern was about legal liability or wasted resources was 
not always clear; but, the concern of the participants was both genuine and warranted. 
In one interview, P8 was able to identify how much money the State of Michigan had 
made, and was bitter that little of the money was being used to facilitate the legality and 
legitimacy of Michigan  Medical Marijuana Act. 
We have given them $38 Million already and they don’t have anybody working 
at Community Health8 like [sic] four employees.  $38 Million in money and they 
hire four employees while we have to wait six months (P 8). 
 
The obvious distress of the participant at the wait compared to the influx of funds the 
state had received due to medical marijuana appeared in many interviews. 
Several patients, and every single caregiver who was growing marijuana, 
expressed concerns they were exposed to legal liability in the event of police action. 
I don’t understand what they expect us to do.  We have pot growing in our 
basement and the drug laws all say that is illegal.  Then we have the Medical 
Marijuana Act that says it is OK if you have a card, but they won’t issue the 
cards, you know, they delay.  This is the marijuana stamp act all over again. (P 
6). 
 
After the conclusion of the interviews, the public message boards at 
Michiganmedicalmarijuaan.com began reporting that the wait for hard cards had been 
dramatically reduced from 6-months to less than 2 months. 
 
 
 
                                                 
8 The Michigan Medical Marijuana Program was transferred from the Michigan Department of Community Health 
to the Bureau of Licensing and Regulatory Affairs effective April 22, 2011. 
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Legal Concern Finding 2:  Access and Dispensary Operations:   
The long wait for cards was connected to the overarching concern over a loss of 
access to marijuana.  Nearly one-half of the patients interviewed were concerned that 
the 6-months wait to get their certification card issued by the State prevented them from 
getting marijuana at some dispensaries. These dispensaries would not serve patients 
until they were in possession of the hard card from the State. A Dispensary Operator 
stated:  
A lot of patients get upset because of our policies.  Our lawyers told us we 
need the hard cards if there is any problem with the paperwork.  We turned 
away a guy yesterday because the doctor did not check both boxes on the 
certification form so it creates problems (P 11). 
 
The interviews that were conducted were not a completely random sample, and it is not 
clear what the scope of this problem was before McQueen.  During the interviews the 
law was changing and after McQueen there are no legal dispensaries left, so this may 
no longer be an important problem for medical marijuana users, except insofar as it 
illustrates the reliance on and importance of dispensaries for the distribution of 
marijuana to patients in Michigan.  
Some caregiver participants were less concerned because they were not 
involved in the distribution chain.  The level of concern on the part of the eleven 
Caregivers (dispensary owners and operators, activists, and growers) who were 
interviewed apparently depended on their responsibility in the distribution chain and 
their role in the medical marijuana center.  Caregivers who were responsible for dried 
marijuana weight quantities at the medical marijuana center or who provided direction to 
patients about the products available for acquisition were particularly concerned about 
getting legal direction for their activities. 
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In most of the caregiver interviews, a substantial portion of the interview was 
done without the tape rolling and involved this discussion and an analysis of the 
effective legal interaction between Section 4 and Section 8 of the Marijuana Act.  My 
interpretation was always prefaced by the rather cynical (and prescient) warning that 
courts tend to do whatever they want to do and interpret statutes however they choose 
without regard for the clear and plain meaning of the law.  I consistently offered my legal 
opinion when asked (which is to say in the majority of the patient interviews and 10 of 
the 11 Caregiver interviews) that the dispensaries were protected under Section 8 but 
possibly not Section 4 (as was later held in McQueen) and that they could still be 
arrested and held before they could even assert the “affirmative defense.”  Further, 
under Section 4 it did not matter whether the patient had a hard card. The only 
determining factor was whether the medical condition was valid, and the marijuana was 
being acquired for that legitimate medical condition.  Each dispensary owner who asked 
was also counseled there was a good chance of prevailing at trial under Section 4.  I 
also offered specific legal guidelines when asked, for example, suggesting to several 
dispensary owners that they would be better protected by obtaining a notarized affidavit 
of each patient each time they obtain marijuana swearing under oath that they needed 
to acquire marijuana at the dispensary in order to insure uninterrupted access (from the 
language of the Medical Marijuana Act section 4). 
 
Legal Concern Finding 3:  Protective Measures Taken by Dispensaries 
Although most providers and caregivers strongly believe that what they are doing 
is the right thing, and claim they would go to prison if necessary to continue helping 
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those who need medical marijuana, they wisely adopted several protective 
mechanisms.  
Local Organizing:  The first layer of protection included forming local 
organizations for support.  For example, all of the 11 dispensary owners and operators 
who were recorded had engaged in extensive organizing with sympathetic local 
government and regulatory officials.  All claimed they had received local approval to 
open their dispensary or alternative medical marijuana provider, and they were 
confident that they were not under immediate threat of arrest because they would be 
informed before any arrest warrant could be issued.   
During one Caregiver interview the participant initially claimed his club had done 
no local organizing, but he later admitted the reason his club did not organize was that 
he had relatives well placed in the local government office who were “providing 
protection.”  The owner of this Compassion Club stated:  “If they think they are going to 
go after our place, I will know about it way before they can get a warrant.  We will be 
there in court ready to argue our case” (P9).  Most providers and caregivers were not so 
lucky as to have family who were watching out for them.  Some medical marijuana 
centers worked directly with the local city council, some worked with the prosecutor’s 
office, and some worked with the mayor’s office.  All of the owners and operators of 
medical marijuana centers who agreed to recorded interviews had some branch of local 
government in support of their activities.  
As of the time these results were written up in summer, 2013, after the decision 
in McQueen effectively barred medical marijuana dispensaries in Michigan, none of the 
“caregiver” research participants who owned or operated a dispensary had been 
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arrested.  In fact, as predicted by the participants, each was notified by their allies in the 
local government that it was time to close down any operations associated with the 
transfer or sale of marijuana even before they received the official correspondence.  
Only one of the dispensaries where recorded interviews took place remained open as of 
summer, 2013 in defiance of the ruling 
Compiling a Legal War Chest:  There was one singular common theme in all the 
medical marijuana centers, owners, and operators who were formally and informally 
interviewed, and that was that each had a roster of retained lawyers ready to spring into 
action.  Every single dispensary owner who was interviewed had already retained an 
attorney and had set aside money to pay for extended legal action in the event this 
became necessary. When asked if they thought it was important the response was:  “Oh 
sure, you absolutely have to have an attorney lined up if you do this kind of work” (P19). 
Another aspect of constant readiness to defend themselves came from the business 
model that many chose to employ. Instead of making dispensaries a profit making 
business, the dispensaries found it most beneficial to work as non-profit organizations, 
to shelter under the laws that might protect non-profit organizations. 
The “Donations” Model:  The most popular model way in which the non-profit 
model was operated was the so-called “Donations” model.  The premise is that non-
profit ventures are somehow protected more than for-profit ventures.  Thus any use of 
the word “Sale” or “Buy” is prohibited during the entire transaction even as money is 
exchanged and “recommended donations” of $15.00 to $20.00 per gram are being 
quoted while precise weights are being calculated on digital scales.  There is some 
support for the Donations Model as the law developed in Michigan in that courts have 
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consistently ruled that transfers of marijuana between patients for money are not 
allowed (People vs. McQueen, L.C.) while several courts have ruled that transfers of 
marijuana between patients where no money is exchanged are allowed (People vs. 
Green, 2013 Court of Appeals). 
The idea behind the Donations Model was that patients paid money to join a 
private club.  Ostensibly the patients are then able to go to the club to obtain marijuana 
“for free.”  In reality, they must pay the “suggested donation” each time, or they will be 
kicked out of the club.  The legality of the donations model was supported by the idea 
that many medical marijuana centers often give away large amounts of marijuana and 
marijuana-laced products to the sickest, unemployed patients while supporting their 
operations by voluntary donations from members who are in better health.  This model 
was unequivocally invalidated by the Supreme Court case of People vs. McQueen in 
2013. When McQueen clarified the Caregiver system as the only legal distribution 
system in Michigan, the Donations Model became immediately obsolete.  
Community and Charitable Outreach:  While the Donations Model was one way 
of trying to protect the distributors from legal ramifications, most medical marijuana 
centers that were observed during this study were heavily involved in community 
outreach and charitable work.  Toys-For-Tots was one of the most common programs 
supported by medical marijuana centers and almost all of them worked with local food 
banks and competed very favorably with local bars and bowling alleys in providing large 
amounts of charitable and needy contributions.  For example, the researcher gave an 
invited talk at a dispensary and followed a representative of the charitable group 
“Loaves and Fishes” who was there to thank the dispensary for making the largest 
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donation of any organization (except for a large multinational pharmaceutical company) 
in the entire State of Michigan.  Every single compassion club I visited had a donations 
box for food and other non-perishables in the front door.  The connection between the 
caregiver and distribution network and the community was very strong before McQueen 
but it is not clear whether this connection remains after McQueen. 
Conclusions:   
Before McQueen, dispensaries, alternate provider organizations, and advocacy 
groups were formed to provide access to the newly legalized marijuana.  However, the 
legality of the dispensary organizations remained in question until the Supreme Court 
opinion in People vs. McQueen in February, 2013 when most transfers of marijuana 
were made illegal under the court’s unique interpretation of the Michigan Medical 
Marijuana Act.  Therefore, this is possibly the only study that investigates and attempts 
to explain the social behavior of patients and caregivers during the time they were 
responding to the ambiguous, but developing, case law.  Those responses included the 
formation of several types of organizational structures that functioned as quasi-legal 
entities in order to deliver marijuana to patients.  These newly formed dispensaries, and 
patients at large, spontaneously formed together into several statewide organizations to 
defend the right, and ability, to access medical marijuana.  In response to the legal 
pressure, the various dispensary organizations and provider groups increased their 
reliance on “legal fictions” such as the “donations model.”  They also increased their 
engagement with the community and charitable organizations, while at the same time 
put money aside for what they believed was the coming legal battles.  Again, since this 
research ended a the precise time when dispensaries were made illegal, it is not clear 
122 
 
how patients and caregivers are reacting to the changes, and whether there are supply 
interruptions with patients unable to obtain their medicine.  Further research is 
warranted on these questions.   
 
Legal Concern Finding 4:  Inclusion of other Medical Conditions 
Over half the knowledgeable patients (who possessed at least a college degree) 
and were carefully following the legal developments and all but three of the eleven 
Caregivers, were concerned about the refusal of government agencies to follow the act 
and consider scores of petitions asking for the inclusion of: 
additional medical conditions and treatments.  In considering such petitions, the 
department shall include public notice of, and an opportunity to comment in a 
public hearing upon, such petitions. The department shall, after hearing, approve 
or deny such petitions within 180 days of the submission of the petition” (MCL 
333.26425). 
   
The statute requires: 
Not later than 6 months after the effective date of the amendatory act that added 
this subsection, the department shall appoint a panel to review petitions to 
approve medical conditions or treatments for addition to the list of debilitating 
medical conditions under the administrative rules. The panel shall meet at least 
twice each year MCLA 333.26432(k). 
 
In short, the State has absolutely refused to set up the required panel despite the fact 
the 6-month time period for doing so expired in August, 2009.  The practice of the State 
government refusing to consider adding additional qualifying medical conditions, was a 
concern for most of the participants.  According to the attorney handling the case, 
Michigan NORML (National Organization for the Reformation of Marijuana Laws) had a 
lawsuit filed in the Court of Claims (a Michigan court with original jurisdiction over claims 
against government units) alleging the department has “willfully failed to reply to multiple 
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petitions for including several medical conditions such as ADD, ADHD, depression, and 
GERD on the list of qualifying medical conditions to use marijuana.”  The case of 
Chilcutt v. Hilfiger was dismissed on Summary Disposition motion by the State of 
Michigan later that year, and the lawyers are attempting to fund another attempt at 
forcing the State to comply with the law (Informal interview, ongoing conversations, and 
email exchanges with lead counsel for Michigan NORML). 
Most patients and caregivers who discussed the issue thought certain psychiatric 
conditions needed to be added to the list of qualifying medical conditions.  For example, 
the first interviewee stated: 
P:  I do think the medical marijuana act should be expanded to include mental  
      conditions. 
 
D:  OK, and what types of mental conditions would you include? 
 
P:  Anxiety.  I mean it is amazing for anxiety.  (laughs).  Umm, depression.  
Definitely.  I mean very effective, I mean.  You hear about the effect, you know 
when you get high, it makes the world good, you know (P1). 
 
This became fairly common with several participants claiming that their main qualifying 
was some type of anxiety disorder even though anxiety disorders are not qualifying 
conditions under Michigan law: 
D: You mentioned panic attacks, is it your opinion that panic attacks should 
be added (to the list of qualifying medical conditions)? 
 
F: Absolutely, I mean unequivocally, absolutely it works that well and there 
are so many horrifying and dangerous side effects from the 
pharmaceuticals that are able to be completely avoided. 
 
D: There’s a wide choice of pharmaceuticals. 
 
F: [overlapping] 
 
D: And have you tried every one of them? 
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F: I’ve tried probably a dozen over the years.  I’ve had the panic disorder for 
decades, and it gets worse as the years go by, but now that I’m able to 
legally get medication that I can use, I don’t have a need for those things, 
and my quality of life is much better. 
 
Later in the interviews, the conditions of Depression, bipolar disorder, Gulf War 
Syndrome and Post Traumatic Stress Syndrome were all mentioned as potential 
psychiatric issues that might be treated by the use of marijuana. 
By the 11th interview, we were able to tie down the issue of what is covered 
under the Act.  The delivery service operator who acted as a medical doctor’s office 
manager stated: 
So the (marijuana) Act requires (a medical condition to be) chronic AND 
debilitating. Now chronic could be a bad lower back but she copes and 
exercises and keeps good posture but it does not debilitate her.  The other 
key word- you’re a lawyer so you know words matter- what is the definition 
of debilitating?  Now there is a moving target.  Debilitating is subjective 
and is usually defined as something you have to do something about, to 
treat it or it will get worse or at least not get any better.  Go to a doctor.  
Get it looked at.  Take action to deal with the fact.  Show objectively that it 
is there.  That's debilitating.  a soft spectrum.  Debilitating, for an athlete 
who is otherwise in strong That's body but a grandmother with the same 
condition might make her not be able to drive to the store to get 
groceries…so debilitating is a soft definition but what is solid, clear bright 
line definition is the term chronic.  Under the Michigan Public Health Code 
“chronic” is a condition that has existed for at least 90 days. 
 
In other words, a hangnail, or even a sprained ankle that lasts for 89 days is not a 
qualifying medical condition under the marijuana act because it is not “chronic.”  Even a 
broken bone that heals without further treatment is not “chronic” although it last for more 
than 90 days and the patient could conceivably get a marijuana card for the time the 
bone was casted and during the healing process.  However, “debilitating” is 
considerably more subjective since what might be “debilitating” to one person might not 
be debilitating to another.  For example, a pro-athlete might ‘play through the pain’ and 
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not find himself “debilitated” until years after retirement from the league.  Similarly, pain 
is subjective and there are few reliable ways to measure pain.  In general, at a 
minimum, evidence of a “chronic” condition, including pain, requires a recognizable 
condition and a minimum of three physician’s visits over a 90 day period.  In our broken 
bone example, this would require at least three physicians visits after the bone had 
healed, complaining about ongoing pain in the bone. 
 No patients or caregivers mentioned diabetes, lupus, or rheumatoid arthritis as 
possible conditions, but several medical marijuana physicians during informal 
conversations mentioned these conditions as possible candidates for inclusion in the list 
of qualifying medical conditions to use medical marijuana in Michigan. 
 
Legal Concern Finding 5:  Scope of a valid Medical Marijuana doctor-patient 
relationship needs clarity:   
 
The Michigan Medical Marijuana Act only requires patients to get a physician 
certification, or signature on the State approved certification form, and does not specify 
the level of medical supervision required.  This has become a particularly important 
issue because of the interpretation of Section 4 and Section 8 in the Michigan Medical 
Marijuana Act.   If the patient and caregiver are connected through the caregiver registry 
system and are below the weight and plant counts permitted under Section 4, then they 
are completely immune from arrest or prosecution.  As we have seen, the Marijuana Act 
permits a caregiver to register up to 5 patients with the State, permitting them to grow 
up to 12 marijuana plants and possess up to 2.5 ounces per patient (MCLA 333.26424).  
However, to register a patient, the patient must designate a specific caregiver to provide 
marijuana for that specific patient and a caregiver may only register up to 5 patients.  
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Therefore, in a dispensary, for example, it would be rare for a caregiver to see the 
specific patient registered to be served by the specific caregiver that he or she had 
designated with the State.  Rather, in a dispensary it would be much more common for 
“a” caregiver to assist “a” patient in procuring marijuana without regard to whether the 
patient and caregiver had registered that relationship with the State.     
The problem is if this transaction takes place outside the caregiver registry 
system, for example if the patient acquires medication from a medical marijuana 
dispensary operated by a caregiver, or caregivers, to whom they are unconnected 
through the caregiver registry system, then any transactions between them are not 
immune from arrest or prosecution under Section 4 of the Act but may only be defended 
after arrest and prosecution and at trial by way of an “Affirmative Defense” under 
section 8 of the Act.  A caregiver is “connected to a patient” through the caregiver 
registry system when he or she registers them with the State using a “Caregiver 
Attestation Form.”  As previously noted, a Caregiver may resister up to 5 patients with 
the “Caregiver Registry System.”  However, while the broad Section 4 immunity requires 
registering with the State, the Section 8 Affirmative Defenses may still provide a 
defense if the “marijuana was not more than was reasonably necessary to ensure the 
uninterrupted availability of marijuana for the purpose of treating or alleviating the 
patient’s serious or debilitating medical condition.”   
The problem then becomes that Section 8 requires a “bona-fide doctor-patient 
relationship.”  Therefore, the issue of what constitutes a “bona-fide relationship” has 
been the deciding issue in several dispensary cases (c.f. People vs. Redden, id; People 
vs. Feezel et al).  In brief, to determine the legality of a particular medical marijuana 
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transaction, some Courts go back to the legality of the original certification and whether 
legitimate medical need existed in the first place.  This, in turn, depends on the 
existence of a bona-fide doctor-patient relationship between the certifying physician and 
his or her patient.  Therefore, the requirements to establish a bona-fide relationship with 
the certifying medical marijuana doctor may be crucial to some cases, particularly cases 
involving medical marijuana centers that distribute outside the caregiver registry 
protections provided by Section 4 and rely on the affirmative defenses of Section 8.   
The same question was asked by more than ½ of the participants and all but 2 of 
the Caregiver interviews:   
I just want to know what type of medical records they need.  I mean, you know, 
what is valid?  How are we supposed to know if the doctor is legitimate and 
who the hell are they to say that somebody is not really in pain when they say 
so?  (P7). 
 
Every single care caregiver and patient who discussed the issue of the medical 
marijuana certification provided by the medical marijuana doctor thought the scope of 
the doctor-patient relationship needed clarification.   
The questions about how the courts might view the adequacy of the registered 
patient’s medical examinations were hardly spurious.  Only a total of two patients and 
caregivers were even given a hands-on examination by the certifying medical marijuana 
physician and two others were certified via their family physician or specialist rather 
than the medical marijuana physician.  Even the most serious patient cases, including 
both Stage IV cancer patients were not certified by their oncologists or their family 
physicians.  Instead, one was given a note by her oncologist and referred to a medical 
marijuana physician while the other was given her typewritten medical records and 
referred by her family doctor to a medical marijuana physician.  Among the most serious 
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patient cases, only the single M.S. patient interview was certified by her treating medical 
specialist.  According to the patients even the treating physicians of dying patients 
would not certify them due to concerns with DEA or because the agreements granting 
them hospital privileges prevented them from formally recommending the use of 
marijuana.  This issue clearly needs further research as this finding suggests it could be 
an important barrier to adequate medical treatment. 
The scope of the doctor-patient relationship and what the doctor needs to do to 
establish this relationship was clarified in House Bill 4851 in 2012 which defines a “bona 
fide physician-patient relationship…[requires]…review and maintenance medical 
records…[and]… reasonable expectation of follow up care” (MCLA 333.26423 and 
333.26428 as amended).  However, it is not clear whether this legislation solved the 
ambiguities expressed by the interviewees in this study since the bill was passed within 
a couple of weeks after the interviews in this study were completed.  Again, further 
research on this particular topic, including the barriers to access and the fears of 
recommending a substance banned by the same agency that issues the physician’s 
controlled substances license permitting them to prescribe pain killers and other drugs 
regulated by the Controlled Substances Act.  
All but the four caregivers and patients mentioned above who discussed the 
issue of the medical marijuana certification provided by the medical marijuana doctor 
thought the scope of the doctor-patient relationship was a problem.  One called the 
certification system “A joke” (P 6).  Four called the system “inadequate” and over one-
half did not believe they even had a legitimate doctor-patient relationship with their 
medical marijuana certifying doctor.  The lack of a legitimate doctor’s visit for their 
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medical marijuana certification was primarily prefaced on the fact that no hands-on 
examination was done.  Again, only two interview participants reported that they had 
what they considered a “hands-on” or “normal” or “traditional” medical examination.  Of 
the other 29 interviewees, none even had their blood pressure checked, only 6 of 31 
believed they had an adequate medical examination. 
One Caregiver interview participant was a doctor’s manager who had handled “at 
least 400” interviews of prospective patients.  Part of his job was to “pre-screen” 
patients before bringing the patient to the doctor for his or her medical marijuana 
certification.  He expressed considerable concerns about the viability of most doctor 
certifications under the Michigan Medical Marijuana Act stating:   
The law does not provide physicians any guidelines.  We have had one guy 
telling people to slip $100.00 under a door along with the filled out form.  He 
would take the money, sign the form, and slip it back under the door.  That is 
not a legitimate doctor-patient relationship (Participant 11). 
   
All of the patients interviewed would agree with the Michigan prosecutors and the 
medical ethics board that a legitimate patient doctor relationship should be part of 
medical marijuana treatment and that the law needed to be clarified in this regard. 
Several discussions with professionals and activists prominently featured 
concerns about the Section 8 defense and the scope of the requirement of a “bona-fide 
doctor-patient relationship.”  One physician informally interviewed argued that, at a 
minimum, an actual doctor-patient relationship required a “level 1 medical examination.”  
However, there is disagreement on whether an actual physical examination is required 
or whether a records review and a consultation type of appointment met the criteria of a 
bona-fide doctor-patient relationship.   
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Patient 11, the office manager and conference organizer, argued that a “bona-
fide” relationship does not require a physical exam but merely a consultation since “a 
bona-fide relationship does not require the doctor to take on the person as a patient.”  
For example,  
Nobody would contest that a radiologist who views a CT Scan and 
diagnoses a patient without ever having seen the patient has, in fact, 
established a bona-fide doctor-patient relationship by virtue of interpreting 
his medical tests for the treating doctor (P11). 
 
Similarly, the manager argued, a medical marijuana certification doctor should be able 
to make a recommendation based on adequate medical records without even seeing 
the patient.  More than half of the participants, and all of the doctors, and lawyers, 
informally interviewed agreed that any diagnosis based on medical records and not an 
actual physical examination of the patient would, at a minimum require medical records 
showing three separate doctor’s visits, treatments, and/or diagnosis of a condition for 
which marijuana may provide actual or palliative relief. 
Another issue in the certification process was the viability of “Skype” and remote 
or internet certifications.  There was broad agreement during all formal interviews and 
information gathering discussions (except one physician who gave his opinion during a 
discussion) that Skype or internet certifications were not valid.  This lone physician 
holdout argued, like the office manager, that the situation was similar to a radiologist, 
perhaps in India, making a remote diagnosis.  However, all other respondents did not 
agree, claiming that medical marijuana certification doctors, unlike radiologists, were not 
diagnosing or interpreting detailed imaging data.  Several participants did agree that 
renewals of certifications could potentially be done by Skype provided the patient’s 
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condition was relatively stable and updated records were provided and reviewed by the 
doctor’s office.   
“Internet Certifications” where the patient never even sees the certifying 
physician, were considered substandard medical care by everybody who was 
interviewed who discussed the issue.  However, there was disagreement on whether a 
substandard level of medical care removed the protections of a medical marijuana 
certification based on a bona-fide doctor-patient relationship as the Redden court had 
held.  As of summer, 2013, this issue has still not been resolved by the Michigan 
Supreme Court. 
Obtaining opinions on this issue was not always easy.  Very few patients and 
caregivers were interested in the precise details of the requirements for a medical 
examination to receive protections under Section 8.   Patients, and caregivers, were 
much more concerned with obtaining clear instructions that could be followed than in 
precisely what the doctor was supposed to do to at their medical examination.  Many 
seemed to take the attitude exemplified by one patient:  “If they will just tell us what to 
do and stop playing games, I will be glad to do it” (P 9). This frustration with the law was 
universal in the interviews. The illegality of marijuana and its reputation in the popular 
media make it important to medical marijuana users to make sure they stay within the 
laws. However, with the laws amorphous and unclear, this is not always either easy or 
even possible. 
Conclusion of Findings on Legal Concerns:  Several legal issues and 
concerns were expressed by the participants during the course of the interviews 
especially about uneven and ambiguous enforcement of the Michigan Medical 
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Marijuana Act.  These included the problem of receiving certification cards from the 
State of Michigan which in turn created a problem of access which was a concern of 
nearly one half of the patients interviewed.   The legality of dispensary operations was 
also a major concern, particularly for the dispensary owners and operators and a 
number of measures were taken by these operators to insulate them from criminal 
liability. The dilatory practices of the State government in refusing to consider inclusion 
of additional medical conditions as required by the Act was another concern along with 
the lack of direction on the proper scope of the doctor-patient relationship. 
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Chapter 6:  DISPENSARIES AND MEDICAL MARIJANA PROVIDER 
ORGANIZATIONS UNDER THE MICHIGAN MEDICAL MARIJANA ACT BEFORE 
MCQUEEN 
   
Introduction:  The writers of the Michigan Medical Marijuana Referendum 
removed all the dispensary language at the last minute because dispensaries were not 
polling well with Michigan voters (MPP 2013).  Although the Michigan Medical Marijuana 
Act legalized the use and possession of marijuana, it was left deliberately unclear on the 
scope and structure of the distribution system.  As a result, a number of organizations 
arose to provide access to the newly legalized marijuana.  However, the legality of such 
organizations remained in question until the Supreme Court opinion in People vs. 
McQueen in February, 2013.  The issue was the legality of transactions outside the 
“Caregiver Registry System” between Caregivers and Patients who were not registered 
with the Caregiver with whom they were conducting a transaction.  With McQueen, such 
transactions were effectively made illegal under the Michigan Medical Marijuana Act.   
The organizational structures that preceded this ruling are the subject of these 
findings and this section.  The organizational structures included the “Traditional 
Compassion Club” where phone numbers and contact information rather than marijuana 
were exchanged, “Farmer’s Markets” where marijuana was freely exchanged, and 
several other structures to be covered in more detail in this section. 
More than one third (11/31) of the interviews were with owners and operators of 
these entities.  Therefore, since these structures have now been made clearly and 
unambiguously illegal under the Michigan medical marijuana act, this is the first and 
probably only study that will investigate patients and caregivers as they responded to 
the ambiguous developing case law that culminated in the definitive McQueen case 
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which declared that any transfers of marijuana between any patient and any caregiver 
are not protected by Section 4 immunity unless that patient and caregiver are registered 
together in the State system.  The interviews for this study took place when most of the 
case law was being actively argued and decided.  Dispensary owners and operators 
and other caregivers attempting to comply with these cases and an unclear law amidst 
a variety of ambiguities is the main story of this finding. 
Findings on Dispensaries: A Functionalist Report:  Until the end of the 1960’s the 
discipline of sociology was dominated by the functionalist perspective.  Functionalists 
claim that sociology should be concerned primarily with describing, explaining, 
improving, and predicting the structure and function of social institutions, traditions and 
norms, and their place in the larger society.  The findings on alternative medical care 
providers and the description provided by the participants is undisputedly derivative of 
this rich tradition in sociology research. It examines the traditions and beliefs of the 
dispensary operators, the institutions of the dispensaries and their function in the 
medical marijuana community of Michigan as well as their place in the ambiguous laws 
of today’s society. The confusing state of the law on medical marijuana has become 
both the norm and tradition of the political atmosphere when dealing with marijuana. In 
explaining the function of the dispensaries, and the ideas of the dispensary operators, 
the functional approach makes the most sense. 
The structure of alternate medical care providers or medical marijuana centers 
and the delivery of marijuana to Michigan patients after the Medical Marijuana Act 
before McQueen is important for several reasons.  First, it is a great example of the 
nebulous world in which medical marijuana users and providers find themselves 
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functioning.  Second, there is active legislation pending in Michigan and in other states 
to regulate dispensaries, and this report demonstrates what type of structures are 
available, how patients and caregivers interact within them, and how organizations 
deliver marijuana to patients in an unregulated environment.  These results suggest 
organizational structures that work for patients and caregivers, and structures that do 
not work for them.  Most important, this provides considerable direction for future 
regulation and legislation of marijuana distribution centers.   
Results on the formation, operation, and structure of medical marijuana providers 
are derived from three distinct sources:  First, Results from “Patients” are from recorded 
and transcribed Interviews; Second, Results from Caregivers are also from recorded 
and transcribed interviews. Third, descriptions of the operation of alternate health care 
provider networks and facilities in Michigan are from personal observations and 
inspections as well as from formal recorded interviews and informal discussions with 
Patients and Caregivers (Producers and Activists).  Consent for all discussions was 
obtained verbally in the same manner as with formal interviews, and each participant 
was given a copy of the HIC approved Information Sheet if notes were taken after or 
during the interaction.   
 
 Dispensary Models Before McQueen:  The data permits us to describe the types 
of medical marijuana centers and dispensaries in the State of Michigan before the 
Supreme Court case of McQueen effectively outlawed all transfers of marijuana except 
between patients and caregivers connected through the registry system.  Observations, 
recorded interviews with patients and caregivers, and dozens of informal conversations 
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with dispensary owners and operators suggest there were five main dispensary models 
in Michigan before McQueen.   
The first medical marijuana dispensary model to arise was the Traditional 
Compassion Club.  These organizations function less like medical marijuana 
dispensaries or delivery organizations than as advocacy groups and information 
clearing houses.  A person who contacts a Traditional Compassion Club will be 
screened and interviewed. The patient is then provided with a list of available caregivers 
and growers with whom they can register through the State and obtain their marijuana.  
The often thinly veiled cover for most of these groups was that they were not directly 
involved in the transfer, sale, or delivery of marijuana and so they are perfectly legal 
under the law.  However, many Traditional Compassion Clubs also held “Private 
Events” that function more like “Farmer’s Markets” (see below) where transfers of 
marijuana do occur.  So long as no transfers of marijuana occur, this is the only 
organizational structure that is still legal in Michigan after McQueen. 
The Farmer’s Market was the model endorsed by the Michigan Medical 
Marijuana Association, the main medical marijuana patient advocacy organization.  
Before McQueen, they conducted several weekly “Farmer’s Markets” throughout the 
State with the consent of local governmental authorities.  Several other “Farmer’s 
Markets” not organized by the MMMA were also held, some of them almost every day of 
the week.  A medical marijuana Farmer’s Market functions in the same way as a more 
traditional themed Farmer’s Market except, instead of a choice of corn, soybeans, and 
wheat the patient is given a choice of different strains of marijuana.  As at a traditional 
Farmer’s Market, a Caregiver or grower at a medical marijuana Farmer’s Market 
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typically rents a table for a nominal fee, displays the product of their own hands and 
skill, and these are then acquired for value from a public eager for fresh produce, and 
the ability to talk directly to the farmer.  
The experience of walking into a bustling medical marijuana Farmer’s Market is 
interesting and informative.  The patients are much different than the hippie stereotype, 
and almost always are dressed in work casual clothing with only a scattering of tie-dyed 
shirts and only rarely does one see the stereotypical John Lennon sunglasses.  The 
tables are arranged similar to any large farmer’s market except the farmers in these 
facilities display their wares in large glass containers arranged on the tables in front of 
them.  Patients circulate through the room speaking to various growers about their 
product, often sampling it, and then negotiating the price with the individual farmer.   
There are several advantages to the Farmer’s Market.  First it appears to fall 
within the intent of the Michigan law, which limits a grower/caregiver to 12 plants per 
patients (maximum 5 patients or 60 plants) and thereby takes away power from large 
agribusiness.  If there are large 1,000 plant grows in Michigan they were certainly not 
approved by voters under the Michigan medical marijuana act.  Second, many patients 
appreciate the bustling market with a wide variety of choices and a friendly, often 
decidedly smoky atmosphere.  Related to this is the third advantage which is that 
patients and growers often are able to speak directly to one another about the product, 
and in many farmers markets patients would even have the opportunity to sample the 
product before purchase.  Finally, and perhaps most important, the farmers market 
model cuts out the large scale distributor and the prices for patients is often dramatically 
lower than at medical marijuana dispensaries. 
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However, farmers markets were not without problems.  Almost one half of 
participants complained about insects, pesticides, stems, and leaves, and poor quality 
marijuana they had purchased from farmer’s markets.  The complaints from this plurality 
were primarily about poor quality control and inaccurate information from caregivers and 
growers about the quality and expected effects of the marijuana they were acquiring.  
There were also concerns about the lack of legally enforceable remedies against a 
grower or a vendor’s false statements.  
Yah man, what are you gonna do, call the cops when they cut you a bag of 
dope that is full of chemicals and gives you a headache?  Now don’t get me 
wrong, I am not saying the health department needs to inspect but they gotta 
control that (medical marijuana).  We need testing for all marijuana that is 
sold and standards.  With dispensaries, like in Colorado, it is a free market 
with competition.  You can just stop going there if they don’t have good sh*t 
but all kinds of people sell at the farmers markets (P7).     
 
No Farmer’s Market organizer consented to a formal interview and no interviews were 
recorded at Farmer’s Markets.  However, in attending more than fifteen to twenty 
different Farmer’s Markets throughout the State of Michigan, there was the opportunity 
to circulate and gather formative information from dozens of vendors at these events, 
including the original organizer and Michigan Medical Marijuana Association President.  
In addition, several of the Caregivers who were formally recorded and interviewed 
stated they routinely rented tables at these events: 
I:  So you get rid of your overages at Farmer’s Markets also? 
 
P:  I do like the Farmer’s Market format better because, you know, some 
dispensaries will just take bull crap and try to pawn it off.  You know, seeds, 
stems, fertilizer, insecticide, the whole 9 yards.  With the Farmer’s Market you 
can often get a better price when you sell, I mean, provide the marijuana to them 
and you can talk directly to the patient (P24). 
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After the Farmer’s Markets, there is also the Provider Network Dispensary.  
This model is a reaction to the law and an attempt to comply with the ambiguities.  
Specifically, they attempted to limit the interaction between patients seeking to acquire 
marijuana and the retail vendors.  On the surface, these organizations functioned like a 
Traditional Compassion Club.  However, in this type of club, several caregivers “hang 
out” and wait to be paged as patients arrive.  Each caregiver is responsible for his/her 
own supply of marijuana, and hours are coordinated through the club so that a core 
group of growers and caregivers is available at the club during business hours.  This 
insures variety and choices for any patients who “drop by” the club.  Transactions are 
between the individual patient and the individual caregiver or grower who is in 
possession of the type of product the patient wishes to acquire.  For example, the 
Interview P1 was with a young female who specialized in baking THC laced 
confectionaries.  During the one hour interview, we were interrupted no less than five 
times as her name was paged on the club intercom.  She disappeared behind a private 
screen for several minutes each time and confirmed, off the record, that she was in 
charge of “medibles” for the club that day.  Medibles are marijuana laced food products, 
often delivered as candy or the stereotypical brownies and other confectionaries.  Other 
provider’s names were frequently called over the intercom during this interview 
indicating there were other caregivers at the club ready to provide the varieties and 
types of marijuana demanded by patients.  The details of how these organizations 
functioned such as percentages paid to the club by the various caregivers, if any, and 
the specific financial arrangements were not a subject of these interviews as any 
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reporting on this information was considered to be potentially harmful to the subject 
population. 
The California Style Dispensary is a well-known structure that was first seen in 
California and involves a dedicated facility where marijuana is exchanged between 
growers, caregivers, and patients.  In Michigan, this model manifested in a few different 
ways before McQueen. 
The California Storefront Model Dispensary typically has a large display case 
with several different kinds of marijuana visible in jars behind a retail counter.  Several 
Caregivers on duty share the weight limits, or the Caregiver on duty behind the counter 
simply disregards the weight limits.  Again, the scope of this practice was considered 
potentially harmful to the research participants and was not pursued during the recorded 
interviews but the subject was discussed in unrecorded interviews.  In Michigan, a 
Caregiver may possess a maximum of 15 ounces if the Caregiver behind the counter is 
a patient and has five additional patients registered to him under the Caregiver Registry 
System.  In order to comply with the weight limits, a few of these dispensaries function 
like Amsterdam dispensaries and attempt to keep below the applicable weight limits via 
deliveries conducted several times a day by other Caregivers.  More often than not, 
however, these dispensaries were small businesses that featured one or two proprietors 
on duty at the same time who were obviously in possession of well over the 15 (or 30 
with two caregivers) ounces allotted to them under the Act.  These proprietors offered a 
variety of justifications for exceeding the allowable weight limits under Section 4 of the 
Act.  Most relied on Section 8 which permits excess amounts beyond the maximum 15 
ounces that any one individual caregiver can possess so long as it is necessary “to 
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insure an uninterrupted supply of marijuana to treat their qualifying medical condition 
(MCLA 333.2724).” 
The Private Club Model blends the Provider Network Dispensary and the 
California Storefront Model.  In a Private Club Model with one caregiver on duty, there 
are no display cases in front.  Members sign in as if at a doctor’s office, and wait to be 
called to the back.  In a private room, a display of marijuana and the single caregiver 
who is wholly responsible for and in possession of a maximum of 15 ounces of 
marijuana permitted under Section 4 works with the patient.  Interview P16 was a 
Private Club Model dispensary operator and a Lansing lobbyist who also runs the 
second largest medical marijuana advocacy group in Michigan. He explained: 
Our model is better (than a California style storefront dispensary) because all 
of our caregivers are in possession of only the amounts they are allowed to 
possess and no more.  We don’t always have the variety some of the other 
stores have but we are trying to be legal…at least the weight limits are clear 
in the law. 
 
The Private Club Mixed Model features mixed caregivers who share the 
allowable weights and commingle the marijuana for display and may also rely on 
deliveries to keep below the total allowable amounts. This is useful for a medical 
marijuana user who wants to be able to choose from many different types of marijuana. 
Dispensaries argue they are the same basic model as Farmer’s Markets, in that 
they are relying on Section 4 to protect a transaction outside the caregiver registry 
system since it allows transfers between a Caregiver and a patient.  They argue that all 
models of distribution are perfectly valid under the law even though a number of 
dispensaries have been closed down in Lansing and throughout the State of Michigan 
and several dispensary owners and operators are currently facing State prosecutions. 
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Finally, the Delivery Service operates like a Private Club dispensary, 
occasionally in conjunction with such a dispensary, delivers the product directly to the 
patient’s living room.  Interview P 11 was a Delivery Service operator who traveled the 
State of Michigan with a briefcase he called his “pot-in-a-box.” This method is especially 
useful for those medical marijuana users who are unable to travel, or are bedridden due 
to their condition.  
Each of these models involve patient-to-patient or caregiver-to-patient distribution 
of marijuana functioning mostly outside the caregiver registry system.  The Supreme 
Court of Michigan held in People vs. McQueen that the Michigan Medical Marijuana Act 
does not provide for any distribution of marijuana outside the caregiver registry system.  
However, these models, even though they have been invalidated by the court, are still 
important because some are still functioning and the legislature is considering laws to 
modify the distribution system in Michigan, and these are the only models in Michigan.  
Most interviews felt the model of distribution they used was valid under the 
marijuana act and many defended their preferred model whether it included 
dispensaries, home delivery, or Farmer’s Markets.  However, most patients were not 
aware of the variety of models that were available.  If a patient was aware of a 
dispensary, for example, it was very uncommon for them to also be aware of how 
farmer’s markets operated.  The large majority of medical marijuana users, regardless 
of the system they used to obtain their marijuana were interested in changing something 
about the system. Only eight participants favored the State of California model of 
completely unregulated dispensaries. However, almost all participants discussed the 
problem with access and in particular access to marijuana distribution centers whatever 
143 
 
form they took.  They wanted better regulated marijuana distribution and more open 
access.  They talked about the involvement of the criminal element without legal 
distribution centers, and universally wanted safe, public, legal access, and the provision 
of regulated locations to acquire marijuana rather than in the black market. The primary 
issue was access to varieties and different strains of medical marijuana and most 
participants’ primary concerns centered on practical issues such as quality control, 
availability, and access rather than legal issues such as the specific defects in the law. 
This concern for quality control in medical marijuana was supported by twenty 
three of the participants. These patients and caregivers, wanted specific, clear 
guidelines for dispensaries, and substantially increased government control and 
regulation over marijuana cultivation and delivery, quality control, testing, and inspection 
of medical marijuana and production/growing facilities.    Approximately one-third of the 
recorded interviews expressed the desire to see the entire process of marijuana 
cultivation and medical use regulated from the original grow operation to the sale and 
distribution with most of this group citing the State of Colorado as a model. 
The bottom line for patients and caregivers alike was the desire to have a safe, 
regulated, legal place to obtain different varieties of high quality, potent, medical 
marijuana.  Most were not concerned with the precise structure of these facilities and 
most individuals, even the dispensary owners and operators, were only aware of one or 
two distribution models in the State.  Most interviewees were not even aware of 
Farmer’s Markets if they usually purchased their marijuana at a dispensary and most 
that frequented Farmer’s Markets were not aware that dispensaries were still open.    
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The ability to find a variety of quality medical marijuana was a concern when 
multiple sources were available for medical marijuana users. Now, with the decision in 
McQueen and the current system allowing only a primary caregiver allowed per patient 
those concerns are likely to be greatly increased.  Supply interruptions, quality issues, 
and a lack of variety in the medical marijuana following McQueen are likely to be the 
major issues in the medical marijuana community today and further research on this 
topic is warranted. 
Before McQueen, Patients wanted the ability to speak with the grower or a 
knowledgeable seller about the expected properties of the marijuana being acquired 
and, most important, to have a variety of choices. These options were available in the 
dispensaries models, but not in the current caregiver system.  
Chemical Testing of Marijuana:  One particularly desirable feature of some 
medical marijuana centers was the availability of chemical testing for the samples of 
marijuana.  This was benefit of dispensaries was cited by patients and caregivers.  
I: Can you talk about that what strains work for you best? 
 
P: I like the strains that have high cannabinoids.   
 
I:  We are here at the (dispensary name withheld) so we have these testing 
sheets with all the percentages of chemicals in the testing results and… 
  
P:  Yes I like to look at the numbers I like them because they say it is the 
cannabinoids that attack the cancer cells. They either repair or destroy so you 
know, I always go for the highest cannabinoids, especially CBD (P28).  
 
The ability to know the chemical composition of the medical marijuana, which was only 
available at larger dispensaries, was mentioned as benefit to the patient in order to have 
a better understanding of what works best for their condition.  
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State and Federal Provider Advocacy Organizations   
Several organizations in the state of Michigan and at the Federal level have 
developed to help Caregiver and medical marijuana users. These organizations vary 
from groups that offer support to those that actively advocate for the users of medical 
marijuana. 
Michigan NORML (National Organization for the Reformation of Marijuana Laws), 
MPP (Marijuana Policy Project) and the MMMA (Michigan Medical Marijuana 
Association) were all organizations known before this dissertation research began.  
However, the MACC (Michigan Association of Compassion Clubs) was not formed until 
just before the interviews for this dissertation began.  Most of the information that 
follows comes from discussions with various “Compassion Club” (dispensary) owners 
and operators, and was confirmed using public sources to the extent possible.  The 
patient and caregiver perceptions about the precise operational structure, goals, and 
membership activities of the organizations were actively sought from the participants 
throughout the interviews. 
The largest medical marijuana advocacy organization in Michigan is the MMMA:  
The “Michigan Medical Marijuana Association” is devoted to preserving and protecting 
patient rights under the Michigan Medical Marijuana Act.  The purpose of the MMMA 
was articulated in an informal interview with a high ranking official in MMMA.  He is a 
fiery individual who served in the armed services and who brings his passion for gritty 
city and jungle battles to the fight for medical marijuana and gave a long and detailed 
informal, unrecorded interview for this paper:  
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We are a grass roots organization of patients, and our main goal is to protect the 
marijuana act, and make sure patients have access which is our right under the 
law no matter what the Attorney General says (MMMA Official). 
 
The large group boasts thousands of members, and the official stated several times the 
primary goal of the MMMA was to protect patients and the caregiver registry system.  
The interview took place at a Western Michigan Farmer’s Market sponsored by the 
MMMA.  A major topic of discussion was the Farmer’s Market model and why it is the 
preferred distribution advocated by the MMMA because “it empowers the small grower 
and preserves the caregiver registry system.  The relationship between the MMMA and 
other provider organizations was also discussed.  The MMMA maintains an exceptional 
web site (www.Michiganmedicalmarijuana.com) which is devoted to legal and practical 
discussions about the medical marijuana act.  Besides State-wide information and 
organizing, the MMMA is concerned with local, grassroots efforts such as turning out 
patients to appear in the court rooms and to protest during important court cases and 
during legislative sessions where the Act is being debated. 
By 2009, several medical marijuana centers and dispensaries in Michigan joined 
together to form a competing organization, the MACC (Michigan Association of 
Compassion Clubs).  A prominent member of the MACC was recorded interview P 16.  
Unlike the MMMA, this is not a grass-roots organization, but an organization of 
professional centers who banded together in order to engage in lobbying activities. The 
MACC arose from one of the first medical marijuana centers in Michigan, and at the 
time of the interviews, had several dozen dues paying centers, and two full time 
lobbyists in Lansing at the State legislature.  Several pieces of legislation are and 
continue to be advocated by this organization, including a bill allowing local control of 
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medical marijuana centers, and bills to better define the scope and requirements of the 
medical marijuana law such as better defining “bona-fide doctor-patient relationship” 
and the meaning of “locked enclosed facility” which has been the subject of unresolved 
litigation and several criminal prosecutions. 
 P16 discussed MACC’s relationship with the MMMA: 
I:    What about the MMMA? 
 
P:   We do a lot of the same type stuff, but we are different at the point where 
we are pooling money to go do this type of lobbying, the capital and stuff. 
Where they would be the masses and show up at the rallies. And their 
leadership of course is pretty cool, and they have similar philosophies.   
 
Despite the show of unity, the relationship between the MMMA and the MACC has 
been, at times, quite acrimonious, tending to divide the medical marijuana community 
between patients represented by the MMMA and dispensary organizations represented 
by the MACC. In fact, relations between the MMMA and the MACC could even have 
been called openly hostile.  For a time there was a split in the medical marijuana 
community between patient advocates in the MMMA and the “big money lobbyists” in 
the MACC.   
However, this split was largely patched together after the Michigan Attorney 
General Bill Shuette began raiding and prosecuting patients, caregivers, and 
dispensaries:   
Sure, we are at odds, as it happens in a few of these emerging things. You 
know, the details of how we distribute this new legal product, but we had this 
rally September 7th where about 3,000 people showed up in Lansing. That 
was a community effort, and what we did (is) work together, and as I say, 
look, and obviously, I will tell you what else made it easier for us to get along 
was Bill Schuette who made himself known as the real enemy.  What he was 
bringing to us was so much bigger than our inner community squabbles that 
we just said, ‘Okay, this is obviously kind of stupid right now when we just 
kind of have this serious threat hanging out here.’  So, we said ‘Let’s identify 
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three, four things here that we absolutely iron clad agree on, and this will be 
the basis of our unity efforts’ (P16). 
 
There was an obvious attempt to “smooth over” differences between the 
organizations and present a united front.  Both the MMMA leader (who was interviewed 
informally and not recorded) and P16 denied any current friction between the two 
organizations, and both strongly emphasized how their different goals and objectives 
were complementary.  In fact, both used almost the same words to describe their 
relationship and both talked about collaboration efforts: 
I have no problem with [MACC].  They are doing their thing which is organizing 
and lobbying and protecting their business model, and we are all about grass 
roots organization and making sure the will of the people is heard.  There is no 
conflict at all between us, no problem at all (Informal Interview Notes). 
 
Similarly, in his recorded interview P16 stated: 
 
Well [the MMMA leader] is quite an advocate, and we certainly don’t have any 
conflict with the MMMA at all. They are doing their community organizing thing, 
and we are focused on the business and access side.  There is no conflict 
between our groups at all.  We are in total agreement about the overall goals and 
objectives (P16). 
 
The interviews confirm a well-known result from the sociology and social psychology 
literature that a clearly definable common enemy increases inter-group coherence by 
providing a singular direction (Fisk 2012).   
A third advocacy organization is the Michigan chapter of NORML: The National 
Organization for the Reformation of Marijuana Laws, which predated the medical 
marijuana law and advocates for the complete legalization of marijuana.  NORML's 
mission is to “move public opinion sufficiently to legalize the responsible use of 
marijuana by adults, and to serve as an advocate for consumers to assure they have 
access to high quality marijuana that is safe, convenient and affordable” (NORML 
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2013).  The Michigan Chapter of NORML (www.MINORML.org) has a lead attorney who 
is an old friend of this dissertation author. This researcher worked for him in his first job 
as an attorney between1992 - 1994 and has maintained some contact. This contact was 
renewed after he had become lead counsel for MI-NORML and learned about my 
dissertation topic.  He was corresponded with several times for this paper about 
ongoing cases, the developing case law, the likely interpretations, and various legal 
issues that arose during the pendency of this dissertation. 
A fourth organization which also predated the Act is the MPP (The Marijuana 
Policy Project).  This group actually wrote the referendum that was placed on the Ballot 
and passed by the people which became the Michigan Medical Marijuana Act.9  It is a 
national advocacy organization with offices in Lansing, Detroit, and Washington D.C. 
and around the country.  The organization has been instrumental in getting medical 
marijuana legislation passed in 17 States and the District of Columbia, and legalized 
completely in two States.  However, this organization was heavily criticized by several 
participants in the interviews because of ambiguities in the legislation and for their 
failure to include dispensaries in the original referendum because they “were not polling 
well” (Interview 11, 16, et al).   
The MMMA leader stated: 
We are trying to clean up the mess these people [MPP] left with even 
though the intent of the law is clear. 
 
P16, the MACC leader had similar thoughts: 
 
P: Well these people [NORML and MPP] don’t agree with us. They think 
specifically that anything of medical marijuana is useless because they 
keep on fucking with it and finding new ways to subdue it.  So you got to 
                                                 
9 Full disclosure necessitates revealing that the author has been a dues paying member of the MPP since 2008. 
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go straight to decriminalization [of marijuana].  Some people think that is 
the problem with the referendum [written by MPP].  If they wanted to 
screw it up so bad the only alternative was full legalization and…well 
they…. 
 
I:  They would have written the same legislation? 
 
P:   Yeah, basically (P16). 
 
Other participants were less diplomatic: 
Those fuckers ruined my life. Why did they have to put all this ambiguous 
shit in there when it could have been clear and still passed?  We had two 
thirds of the people vote for this thing (defendant in a prominent Michigan 
medical marijuana case informally interviewed). 
 
Nobody from the MPP was interviewed for this dissertation, and the leadership has 
moved their activities to other States, passing medical marijuana laws in Arizona (2010), 
New Jersey (2010), Washington D.C. (2010), Delaware (2011), Massachusetts (2012), 
Connecticut (2012) and full legalization in the States of Washington and Colorado (Pro-
Con, 2013). 
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CHAPTER 7:  STRAINS: THE PERCIEVED EFFECTS OF DIFFERENT VARIETIES 
OF MARIJUANA 
 
Introduction:  Marijuana has over 100 components that act together within the 
human body and brain.  Growers, patients, seed banks, and others have long claimed 
that different marijuana strains and cultivation techniques produce strains that have 
different psychoactive and medicinal properties (Rosenthal 2004).  However, the claim 
is unsupported by clinical research due to the restrictions and obstacles to research that 
were previously discussed.   
Therefore, explaining the effect of these different substances in the human body 
has been missing from the literature.  The most well characterized and best known 
chemical component in marijuana is delta-9 Tetrahydrocannibinol (THC) which has well 
known psychoactive properties through its activation of CB1 and CB2 receptors in the 
nervous system.  This effect in isolation is fairly well characterized given the fairly 
substantive body of research on orally delivered synthetic THC such as Marinol, 
Nabilone and Cesamet (Armentono, 2011).  The second best characterized component 
in marijuana is Cannabidiol (CBD) which is increasingly known for its anti-inflammatory 
and other potentially medicinal qualities (Project CBD 2013).  However, as we have 
seen, federally approved research employs marijuana with an average potency of 1-3% 
THC ,but marijuana available to a medical marijuana patient (at least before McQueen) 
was often more than eight to twenty-five times as potent at over 25% THC (Canalytics 
2012).  Almost no government approved or funded research has ever measured CBD 
levels, but commonly available medical marijuana has a wide range of CBD from 0% all 
the way up to 15% in some samples (Rosenthal 2004).  The effect of these chemicals 
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present in the remarkable array of strains available to the medical marijuana consumer 
has been problematic for those on the anti-marihuana side of the argument and 
government organizations such as NIDA have worked hard to prevent any systematic 
research into those effects. 
Findings on Strains of Medical Marijuana is Intepretevist and Critical:   
In order to investigate this huge gap in the literature about the effects of different 
strains of marijuana, without the ability to conduct double blind, randomized clinical 
studies, sociological methods commonly employed to study hidden or other difficult to 
study populations were employed.  Patients and growers were interviewed and several 
“Farmer’s Markets” and dispensaries were visited.  In discussions with dozens of high 
volume growers, all experienced growers acknowledged a difference in varieties, and 
only three of the dozens of growers and vendors interviewed were not able to clearly 
articulate those differences.  The remainder were in almost total agreement and spoke 
about “up” vs. “down” or “daytime” vs. “night-time” or most commonly “Indica” vs. 
“Sativa.”  The basic claim from patients agreed with the growers and producers, and the 
literature on growing marijuana (Rosenthal 2002) that a product with a higher THC 
content has a more euphoric effect.  Conversely, there was broad agreement that a 
product with a higher CBD content has sedative effect, known on the street as “couch-
lock” which (in the highest dose) imparts the classic “stoner” effect of sitting on the 
couch practically unable to move, staring off into space.   
The astounding variety of strains in medical marijuana currently available is an 
entirely new area of research that does not have very many predicates in modern social 
research, or medical research because of marijuana’s unique social history.  The 
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closest analogy would be the strictly medical question of pharmaceutical choice.  For 
example a medical sociologist would probably not choose to design a study to 
determine whether morphine or oxycontin provided better pain relief since this does not 
concern the social causes of disease and is not related to the study of the medical or 
legal systems.  There is usually no direct nexus that can be studied between the 
sociological and biological causes of disease and medication preference.  However, in 
the case of medical marijuana there is a direct nexus between the sociology and biology 
of strain preference.  This nexus is the methodological approaches that sociology offers 
which can circumvent the legal and social barriers to research on marijuana.  As a 
scientific discipline, Sociology is both methodological and theoretical and, given the 
barriers to research, indirect qualitative methodologies aimed at hypothesis generation 
are the only way to study issues like the proposition that different types of marijuana 
may have different effects and therefore different medicinal properties.  When social, 
ethical or legal barriers impede research, another way to engage in the search for 
scientific truth is to query the experts on the issue in question (Westfall 2004). 
As this research evolved from the question of whether “medical” marijuana is 
actually being used as medicine to a more advocacy oriented critical perspective, the 
goals increasingly sought to provide a voice to this disenfranchised population. This 
social group is marginalized and by bringing them to the light it is hoped it might 
empower them to destroy myths about the dangers of marijuana and especially about 
the self-fulfilling anti-marijuana argument regarding proof of medical benefits in different 
types of marijuana.  The population of medical marijuana users has been the subject of 
intense legal and social discrimination.  Marijuana patients are lampooned as lazy, 
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antisocial, hippie pot smokers in the popular media.  Yet the types and strains of 
medical marijuana, as well as the use of these strains indicates considerable rational 
thought, and provides objective evidence of medical need on the part of the medical 
marijuana users. The preferences that were consistently indicated by patients about the 
effects of certain types of medical marijuana for specific illnesses suggests that this 
group is not only using marijuana as medicine, but the group is in fact using different 
types of marijuana for different types of medicinal effects.  By investigating these 
different types of marijuana and the perceptions that their use evokes, the hope is to 
discover the rationale behind the use of medical marijuana in this group and to provide 
evidence for the existence of different medicinal effects in different types of marijuana.  
In turn this enlightens, in part, why so many would subject themselves to possible legal 
action and produces testable hypotheses for future medical, clinical, and sociological 
work. 
The “Orchestra Effect”:  
Marijuana contains more than 100 ingredients in different concentrations 
depending on the strain and the harvest techniques (Rosenthal, 2002).  According to 
one unrecorded participant who was a tireless advocate for the cause of marijuana 
activism and a prominent blogger and public speaker for the Michigan Medical 
Marijuana Association, the heterogeneity of psychoactive components creates the 
“Orchestra Effect.”  He claims that all or almost all strains contain the same essential 
components, but different strains contain different quantities and concentrations of 
those components.  Therefore, by analogy one strain might have a stronger “trumpet” 
section while another might have a stronger “percussion” section “and this unique 
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mixture in each strain produces that beautiful music we all love so much.”  Even though 
both strains (Indica and Sativa) contain basically the same components, albeit in 
differing concentrations, the effect of the overall “composition” (i.e. the effect 
experienced by the user) can be very different.  The extended musical analogy is an 
interesting way to conceptualize the different strains as different varieties of music 
where different genres produce very different music even while using basically the same 
instruments.  Continuing, this participant provided the example of a Rock band and a 
Blues band which both use a guitar, a bass, and drums but the music that is produced is 
markedly different and unique to each genre.  Like an orchestra, or a particular type of 
music, different marijuana strains and cultivation techniques use the same building 
blocks to produce strains that have different perceived psychoactive properties 
(Rosenthal, 2002). 
Medical Marijuana is different and much more potent than the illegal Marijuana 
used before the change in the law:  
Besides different medicinal effects, potency differences were also a prominent claim.  
Most patients reported that “medical” marijuana available at dispensaries and other 
vending locations was much different than the marijuana that was available before the 
Michigan Medical Marijuana Act passed.  The most prominent claim identifying this 
difference was about the potency of the marijuana which most (except for two interview 
participants who came originally from California) claimed was much higher with medical 
marijuana than the marijuana previously purchased on the street. 
I:   When did you start using medical marijuana instead of Vicodin most of the 
time?  
 
P:   I would say this happened when it got better, you know, when we passed 
the law. 
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I:    What got better? 
 
P:   The pot got better 
 
I:    What do you mean the pot got better? 
 
P:   Stronger, more variety, much, much stronger than most of the ditch weed 
you could get before. That did not help me like the stuff we have now.  
(P5). 
 
Caregivers agreed that “medical” marijuana was much more potent than most of the 
marijuana available before the law passed. 
P:   We test all of our medical marijuana here and, you know, the government 
reports that most of the weed seized on the streets is 7% or 8% THC.  
Just about the weakest stuff we carry is 12% THC, but that has a lot of the 
Terpenes and CBDs that make it more medicinal.  A lot more!  
 
I:  So, your inventory, the weakest strain in your inventory is half again as 
strong as the average strain on the street? 
 
P:   No. Our weakest is probably two three or four times stronger than the 
average ditch weed you get on the street.  You have to consider more 
than just the THC because the other chemicals control how much is 
absorbed, how fast it is absorbed, how long the body takes to break it 
down. 
 
I:    And if it takes the body longer to break down then… 
 
P:   [interrupting] Right, you feel it is, you know, a lot more potent.  Our best 
strain is almost 30% THC and one hit of that is like smoking an entire joint.  
There is no comparison. 
 
Far from the characterizations of the dangers of potent marijuana (NIDA, 2013) the  
more potent marijuana was viewed by patients and caregivers as more effective 
medicine which, paradoxically, also let patients decrease their overall use of marijuana.  
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Medical Marijuana patients titrated their dosages of marijuana depending on  
the potency:    
 
Along with the claim of greatly varying subjective potency, patients and 
caregivers consistently reported that they titrated the dosage depending on the potency 
in order to achieve the desired effect.  That is, when the marijuana was strong then the 
patients smoked less to achieve the same “high” while when the marijuana was not as 
strong they smoked more to achieve the same “high.”   
I:   Has your use of marijuana increased or decreased since you became a 
legal certified patient?   
 
P:   Yes, I am able to find much better product, so I don't have to use as much. 
 
I:    You are suggesting that potency means less use? 
 
P:    That is exactly what I am saying, yes (P3). 
 
Patients consistently reported that it was desirable to use less marijuana and therefore 
inhale less smoke in order to achieve the same psychoactive or medicinal effect. 
 
Different Strains of Marijuna Were Associated with Different Perceived Effects:   
Most patients, and all of the recorded caregiver interviewees were aware of the 
“Indica/Sativa distinction,” and most claimed agreement with the known literature that 
Indicas provided a sedating effect while Sativas provided a more uplifting effect.  In an 
interview with a Caregiver, the differences were briefly outlined: 
I:    Could you give us a primer on Indicas and Sativas, and medical use? 
 
P:   OK, cannabis comes in two primary strains, one is Indica.  Which comes 
from South East Asia, the Indus river valley, and Sativa comes from more 
equatorial Central America and South America.  So, the nature of the 
plant, Sativa has a greater impact on the person’s mental health in terms 
of THC in Sativa particularly helps elevate mood, uplifts mood, creates a 
mental relaxation state and is calming.   
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I:    So the calming version is more of an equatorial plant? 
 
P:   Yes, now in contrast, Indica as a plant comes from Northern Pakistan, 
Southern Afghanistan, Indus River valley, same part of the world.  And uh, 
this the border region of Pakistan and India.  The Indica plant naturally 
produces a higher level of CBD which is Cannabidiol (P11). 
 
Overall patients agreed that Indicas were preferred at night for the more “sedating” 
qualities while  
 
Sativas were preferred during the day for the more “uplifting” qualities.  
 
 
There was Disagreement between the Limited Available Literature and Two of the Most 
Serious Patient Cases Who Claimed Indicas Gave them More Energy While Sativas 
Were Not As “Uplifting”:   
One very interesting result, which should be viewed as very preliminary, but 
which certainly deserves future attention was that while almost all patients and 
caregivers consistently reported that even though different strains of medical marijuana 
were associated with different perceived effects, and that they actively sought out the 
preferred effects by choosing specific types of marijuana, there was NOT universal 
agreement about how those effects were perceived.  It is possible saturation could be 
achieved on this topic given enough targeted interviews, but it is certain that saturation 
was not achieved on this topic during the course of this study.   
Some of the growers thought that Indica/Sativa hybridization and controlled 
breeding had essentially erased the categories of “Indica” and “Sativa.” 
No…it is not that simple…you can make an Indica with real high THC that 
makes you wired, not couch-locked; and you can make a Sativa put out more 
CBD and things like CBN just by waiting to harvest for a few days.  Every 
strain is different, sure, but every harvest is different, every grower is different.  
We are all different.  Everybody is different (P3). 
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Several dispensary owners and growers agreed with this analysis and thought this was 
a primary reason to allow dispensaries, so that patients could have access to different 
strains so they could find “what works for them” (P3, P11, P16, and P25). 
However, some minimal evidence was uncovered suggesting it is also possible 
the factors giving rise to what “works for the patient” could be related to the qualifying 
medical condition.  The two most serious participants, both in considerable pain with life 
threatening diseases did not agree with the common formula of uplifting Sativas and 
sedating Indicas.  In fact they totally disagreed about the uplifting qualities of Sativas 
and the sedating qualities of Indicas.  One was a terminal cancer patient, and the other 
had Multiple Sclerosis, and both were in considerable pain.  They both suggested that 
Indicas were more “uplifting” for them even though the other recorded Interviews either 
speculated that the effect was “individual (P11, P16) or agreed that Indicas were more 
sedating.   
Sure I know what they say [about Sativas] but Indicas give me energy, I 
don’t know why.  Isn’t that weird? (P27). 
 
I prefer Indicas because they make me feel better.  I can just do more 
activities when I smoke an Indica (P14). 
   
Based on the limited data collected in this study on this topic, a reasonable hypothesis 
can be offered which requires further elucidation:  Medical marijuana patients with 
terminal cancer or M.S. might perceive the effects of marijuana differently than medical 
marijuana patients with less serious conditions.  Even more significant, patients in 
significant pain appeared to prefer high CBD while those with mental or emotional 
trauma preferred high THC.  As a preliminary matter, this suggests that CBD may be 
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associated with decreased pain sensation which, if true, significantly undercuts the 
argument that medical marijuana is a mere “ruse.” 
Conclusion of Strains:   
The ultimate goal of medical marijuana is to be able to develop strains specific 
for specific conditions.  The heterogeneity of marijuana and the heterogeneity of 
responses to different types of marijuana that is identified in this study also suggest that 
different types of marijuana might be developed for different medical conditions.  These 
results suggest that patients with chronic pain are likely to respond to different strains of 
marijuana differently than patients with anxiety or depression.  Further research is 
clearly needed on whether it might be efficacious to identify medical condition specific 
strains and this requires relaxing federal regulatory obstacles so actual clinical studies 
on actual medical marijuana can be conducted.  The preliminary results from 
interviewing knowledgeable caregivers and patients about their experiences with 
different strains of medical marijuana suggest that a focused scientific program to 
develop specific strains and identify specific psychological and medicinal components in 
marijuana is long overdue.  
In addition to the potential medical benefits, the identification of medicinal 
properties in marijuana is an important piece of evidence in the ongoing Cannabis 
Dialectic.  The amount, degree, and character of the heretofore documented 
governmental resistance to legitimate scientific inquiry and any findings of the potential 
beneficial and medicinal effects of marijuana suggests this evidence may exist, and that 
it may be an important factor in influencing public opinion and claims making on behalf 
of medical marijuana.  As we have seen, this intractable social dispute has been a 
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problem for many decades with two highly polarized sides.  One side claims that 
“medical” marijuana is a “ruse” to legalize all drugs for all purposes while the other 
claims marijuana has significant medicinal properties.  This section presents some 
evidence towards the hypothesis that different types of marijuana have different 
perceived effects.  If confirmed, this could be a highly persuasive argument that 
marijuana does, at least some of the time for at least some types of patients, actually 
have medicinal properties.  Evidence that different patients perceive different types of 
marijuana as more or less medically beneficial depending on both the patient’s medical 
condition and the concentration of various compounds in the marijuana is even more 
persuasive evidence that marijuana is “medical.”  More research on this topic is 
warranted.   
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CHAPTER 7:  LIMITATIONS AND CONCLUSION   
Research Problem and Significance:  
 The War on Drugs, and on marijuana, has remained contentious since even 
before the 1937 Marijuana Stamp Act (P.A. 238, 75th Congress, 50 Stat. 551, Aug. 2, 
1937) with some 700,000 arrests for marijuana possession each year in the United 
States.  This amazing figure has remained fairly constant, year after year, despite the 
fact that marijuana was common and grown throughout the early history of the United 
States as a commodity that provided oil, fiber, food, and medicine.  Recently there have 
been increasing claims about claimed medical uses for marijuana.  By 2013, despite 
federal opposition, medical marijuana was approved in 17 States and the District of 
Columbia while full legalization of marijuana was approved in two States, Washington 
and Colorado.   
The courts, law enforcement, and other government agencies have subjected 
marijuana users to penalties and thereby marginalized them while making research on 
the population of users, and on the banned substance, marijuana itself, extremely 
difficult.  This social split between the pro and anti-marijuana forces which was identified 
as the “cannabis dialectic” is obvious and has been fueled by nearly 80 years of legal, 
social, and media dogma.  The major social actors from government, to the media, to 
the courts, policing, and corrections disproportionately favor the anti-marijuana position, 
often enforced by harsh legal penalties, well-funded research programs, and directed 
media campaigns of social opprobrium.  Until very recently the perspective of marijuana 
users has been almost completely ignored and marginalized by the popular culture, 
including in the media, academia, medicine, and scientific research.   
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In order to address this lack of balance, the research question in this study was 
initially whether marijuana was actually being used as medicine, as claimed by many 
advocates, or whether “medical” marijuana was actually a “ruse” to legalize drugs for all 
purposes as claimed by many opponents.  The advertising flyers used to attract 
participants in this study asked for interviews with medical marijuana patients who were 
willing to talk about their use of marijuana as medicine, and from the earliest interviews, 
it became apparent that the answer was an unequivocal yes.  Beyond doubt, some 
patients were using marijuana medicinally.  Therefore, the major aim of the paper 
became the presentation of the patient and caregiver perspective of the medical 
marijuana issue.  Given the large amount of research expended on drug treatment, and 
the social, psychological, and physiological harms of marijuana, it was believed that the 
perspective of those committed to the use and provision of marijuana as medicine was 
needed, and this was the primary purpose of this study.  If marijuana is actually being 
used as a medicine and not always being “abused” as an intoxicant, then the validity, 
safety and efficacy of marijuana as medicine is the pivotal issues for medical marijuana.  
If marijuana is a safe and legal drug that treats a number of medical conditions, then the 
arguments of the anti-marijuana groups is compromised. 
Methods:   
This study employed in-depth, recorded interviews of medical marijuana patients 
with a total of 31 medical marijuana patients giving recorded interviews.  Twenty 
recorded participants who were “regular” patients and eleven were patients and also 
producers or “Caregivers” under Michigan law.  Several dozen shorter, often impromptu 
discussions were also conducted but not recorded for various reasons.  Pursuant to IRB 
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protocols, all persons who gave interviews from which data was collected via 
handwritten notes during or afterwards, or who were recorded and transcribed, were 
provided IRB approved information sheets.  Often impromptu discussions took place 
while awaiting the scheduled recorded interview or while visiting a medical marijuana 
club or dispensary.  Other discussions were held with medical marijuana physicians, 
and attorneys specializing in medical marijuana law. 
Interpretive Research Methods:   
Qualitative research is often the interpretive task of finding individual meaning 
that empowers “certain agents to create representations and thereby to authoritatively 
pronounce on the shape and structure of the world” (Hess-Biber & Levy, 2004). The 
interpretive researcher views the world as the participants view the world and attempts 
to see and convey what the participants see. In short, the fundamental characteristic of 
qualitative research, whether used to study “primitive” cultures or contemporary cultures 
and groups, is the “commitment to viewing events, actions, norms and values from the 
perspective of the people being studied (Bryman 1988).  This task was simplified by the 
fact that the writer is himself a registered medical marijuana patients and an “insider” 
with this population. 
Recruitment:   
Prospective participants were recruited using IRB approved flyers posted at 
Compassion Clubs and other sites where medical marijuana patients were known to 
congregate and by referrals.  Efforts were made to obtain a recorded interview sample 
population that roughly looked like the Michigan medical marijuana population on the 
categories of gender and qualifying medical condition although proper caution must be 
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taken in interpreting these results since the sample in no way represents a probability 
sample. 
 
Interviews:   
The recorded interviews were transcribed while the unrecorded interviews 
involved either note-taking or subsequent dictation of the findings.  Most of the recorded 
patient interviews took approximately an hour while most of the caregiver interviews 
took one to two hours.  The unrecorded interviews varied from a few minutes to more 
than 1-hour.  Each recorded interview was conducted in a private, safe location of the 
participants choosing and conducted using an eight page Interview Guide as a 
template.  However, they were not heavily structured and the topics drifted depending 
on the interests and concerns of the participant.  The unrecorded interviews were totally 
unstructured.  The main purpose of the interviews was to identify the patient and 
caregiver perceptions about the effects, use, acquisition, and provisioning of marijuana 
in light of their qualifying medical condition.   
Each recorded interview began with the question:  “What is your qualifying 
condition to use medical marijuana in Michigan?”  This was followed by a detailed 
medical history, and then the participant’s perception about his/her use of medical 
marijuana, including beneficial and harmful effects, method of use and how often they 
used medical marijuana, as well as, an interactive discussion of the certification 
process, and each individual’s visit to the medical marijuana doctor.  The topics of 
stigma, dealing with the children of patients, use of different medical marijuana strains, 
and initiation into the use of marijuana and medical marijuana were added later to the 
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interview guide.  Finally, demographic information such as income, class, political 
affiliation, work and school history, and religion were briefly discussed. The Interview 
Guide was changed and adapted as new information became available from 
participants.  Four topics were chosen to present as findings for this paper: reduced 
opiate usage, unequal enforcement and stigma, availability, and quality. Each chosen 
topic or theme (as well as subtopic and themes) is given a separate Chapter in the 
“Results” section.  Narrative passages from the transcripts provide multiple perspectives 
that were used in a discussion of the interconnected themes (Creswell 2003).   
Data Analysis:   
Transcript excerpts were coded and place into one or more of 12 initial 
categories (Table 4).  Qualitative data analysis is iterative and reflective which means 
that data analysis is circular with new information feeding back and causing the 
researcher to change tone and the questions for the next interview.  The process 
continues until saturation of the data is achieved.  Some of the findings reported in this 
study were obvious almost immediately and saturation of the data occurred relatively 
quickly.   For example, the first four interviewees spent some time talking about their 
perception that marijuana use let them decrease their opiate use, and this continued 
throughout every single one of the thirty one interviews where the patient’s complaint 
was chronic pain.  However, it was not until very late in the interview process 
(specifically interviews 25 and 26) that the structure of dispensaries and alternate 
marijuana delivery organizations came into focus.  Saturation of the data on this topic 
did not occur until the final two interviews.  Saturation of the data for different strains of 
medical marijuana did not occur during this study and this report is very preliminary. 
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Results:   
Four major results are reported in this study:  The first finding was that medical 
marijuana patient consistently claim that the use of marijuana by Michigan patients 
reduced or eliminated their need for prescription painkillers.  The second finding 
provides evidence of patient concerns of ambiguity, unfair, and unequal enforcement of 
the Medical Marijuana Act.  The third finding provides a description of the structure and 
functions of medical marijuana centers in Michigan before the McQueen decision 
outlawed transfers of marijuana in February, 2013.  The final finding addressed by this 
research is suggestive that different strains of medical marijuana have different effects 
and are both perceived, and used differently by different patients, possibly depending 
on the patients qualifying medical condition. 
Finding 1: Reduced Opiate Usage was the primary, overwhelming finding in this 
study.  Patients and caregivers agreed that the use of marijuana by Michigan patients 
reduced or eliminated the need for prescription painkillers.  This result was obtained 
from the final codes on “Beneficial Effects,” the “Cannabis Dialectic,” and “Reverse-
Gateway” along with several comments from the category “Hippy Talk.”   
Finding 2 Unequal enforcement and Stigma (Ambiguity and unequal enforcement 
of the Medical Marijuana Act) was the main topic of the interviews.  Many participants 
volunteered to be interviewed so they could speak with a licensed attorney about the 
Michigan Medical Marijuana Act so this topic was front and center in both the recorded 
portions of the interviews and even more so in unrecorded and/or preliminary 
discussions.  The legal concerns were ubiquitous and focused on availability of 
marijuana, and government regulation of distribution in light of the developing case law 
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on the topic in Michigan.  Most of these results were synthesized from the final codes on 
the “Cannabis Dialectic,” “Doctor’s Visit,” “Michigan Marijuana Act,” and “Stigma.”   
Finding 3: Dispensaries, Availability and Access (Medical Marijuana Center 
structures before the McQueen outlawed transfers of marijuana) was another common 
discussion, particularly with dispensary owners and operators and for the same reason 
as finding 2 (i.e. because the interviewer was an attorney in Michigan).  Several 
marijuana distribution strategies were pursued in several different functional 
arrangements with different dispensary structures, delivery services, and farmer’s 
markets.  This topic was chosen as a finding to report because it was considered 
socially important with considerable relevance to how future legislation could be 
structured and because of the unprecedented access to and cooperation from 
dispensary owners in Michigan this author gratefully received.  Paradoxically, this topic 
becomes even more salient with the Michigan legislature, and other State legislatures 
considering dispensary options.  Most of this information was taken from the sections on 
“Dispensaries.”  
Finally, Finding 4: Effectiveness of different strains of medical marijuana was 
taken from the section on “Strains.”  The finding was that different patients pursue 
different strains of marijuana for the different perceived effects and that this perceived 
difference may be related to the patient’s qualifying medical condition.  This was a very 
difficult topic to pursue and, in fact, it is a topic that has never been explored in any 
systematic way, and certainly not in any clinical way.  The new medical marijuana 
strains are extremely potent and have a variety of effects but most are just a few years 
old and cannot be studied in the United States due to NIDA restrictions.  The results 
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from this topic should be viewed as very preliminary and further research is urgently 
needed. 
Limitations:  This study presents a very unique set of data:  The actual words, 
beliefs, and thoughts of a sample of medical marijuana patients and caregivers in the 
State of Michigan.  However, this was not a probabilistic sample of patients and 
participants were obviously over-represented by volunteers with strong, often very 
articulate beliefs in the efficacy of medical marijuana.  All but four of the participant 
patients had (at least) a small personal grow as permitted under Michigan law as did all 
of the caregiver participants.  No African Americans and only one Hispanic were 
interviewed.  Four African American interviews were scheduled but unfortunately none 
were completed.  The medical marijuana law was strongly opposed by the State 
Attorney General and several local prosecutors and a number of prominent patient 
prosecutions occurred during the time this research was ongoing.  Therefore it is not 
surprising that the rate of last-minute cancellations was very high in this sample with 
approximately 80 interviews scheduled over a 2 year period and only 31 completed and 
recorded.  After the first few interviews there were so many volunteers that cancellations 
were generally not followed up.  This sample does approximate both the gender ratios 
found in the medical marijuana population and the types of qualifying conditions in the 
population, but there is no representation that it is probabilistic.  Appropriate caution 
should be exercised in interpreting these results and generalizing them to the population 
of medical marijuana patients and caregivers in Michigan. 
Based on the tone of the interviews, and conditions reported by the State of 
Michigan (LAR, 2012) it is believed that the sample in this study included those with 
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more defensible medical conditions than the general population of patients.  In other 
words, it is reasonable to assume that if patients had a question about whether their 
medical condition rose to the level of “serious or debilitating” (MCLA 333.26424) 
required under Michigan law it is likely they did not volunteer to be interviewed for this 
convenience sample about their “use of marijuana as medicine.”  Certainly no 
“questionable” cases were referred by any of the Caregiver referral sources.  These 
results are qualitative and should certainly not be interpreted to suggest anything about 
the degree of seriousness that would be found in a probabilistic sample of medical 
marijuana patients.  The results from the caregiver interviews contain excerpts from 
highly educated professionals and individuals with considerable specialized knowledge 
of the patient population.  However, they also had a pecuniary interest in the medical 
marijuana industry.  Obviously they were not an unbiased group and were in a position 
where they would be more likely to support the idea of beneficial effects from the use of 
marijuana.  Therefore, their results deserve particular and skeptical scrutiny.  Many 
were tireless advocates for the cause of medical marijuana and could only be described 
as true believers. 
Qualitative Hypotheses and Future Research Directions:   
In depth, qualitative interviews of 20 medical marijuana patients and 11 
“Caregivers” (producers, growers, vendors, and activists) were conducted resulting in a 
wide range of findings.  Shorter, informal interviews were held with approximately 100 
participants including 9 medical marijuana attorneys, 4 medical marijuana certifying 
physicians and (in addition to the 11 recorded interviews of caregivers) 16 growers, or 
dispensary owners and operators who were not recorded.   The most important and 
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most obvious and clear finding was that medical marijuana patients report substituting 
marijuana for prescription drugs, particularly opiates.  A variety of concerns about 
access, legal issues, and enforcement of the Medical Marijuana Act were also 
discussed during the interview process along with the structure of medical marijuana 
centers and the bewildering varieties of medical marijuana strains that are available. 
This is the first reported study on the medical marijuana population in Michigan.  
Qualitative results allow the formation of testable hypotheses.  Based on the data 
provided by this research, the following hypotheses are offered as potential subjects for 
further research: 
1. Some medical marijuana users may be using marijuana as a substitute or 
replacement for opiate narcotics.  In particular this data suggests an avenue for clinical 
research using medical marijuana for adjunctive pain treatment, especially in those 
patients with persistent opiate addiction, or with those individuals resistant to more 
standard forms of analgesic treatment. 
2. Medical marijuana may be more effective than some types of narcotics by 
providing analgesia without the side effects associated with opiates.  Randomized and 
blinded clinical trials need to be permitted by the government and performed by 
researchers to provide evidence or falsification of this hypothesis. 
3. Patients and caregivers agree that law enforcement and courts hostile to 
the medical marijuana act have used the statutory ambiguities to engage in uneven 
enforcement activities contrary to the will of the people as manifested in the referendum 
that created the Michigan Medical Marijuana Act.  
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4.   Most medical marijuana patients were concerned about access to 
marijuana before People vs. McQueen outlawed dispensaries in Michigan.  Without 
dispensaries, it is not clear how patients are obtaining their medical marijuana.  The 
legal caregiver registry system that is still in place may be the vehicle for marijuana 
distribution or patients may have returned to the black market practices common before 
the Marijuana Act.  Further research on this topic is warranted. 
5.   Before McQueen groups formed to distribute marijuana in a variety of 
structures from Farmer’s Markets, to Compassion Clubs, to dispensaries, in order to 
provide access to marijuana.  These structures can no longer be easily studied because 
they are illegal in the State of Michigan but there spontaneous organization and the 
structures that formed and operated before McQueen provides a path for other States to 
follow and for the Michigan legislature as it considers a legal distribution system for 
medical marijuana patients. 
6. Patients and providers formed a variety of advocacy groups and have 
taken other measures to advocate for medical marijuana, protect themselves from law 
enforcement, and help insure access to marijuana.  Private relationships with local 
government officials protected and authorized local distribution networks while 
marijuana advocacy organizations such as the Michigan Medical Marijuana Association, 
the Michigan Association of Compassion Clubs, the Marijuana Policy Project, and the 
National Organization for the Reformation of Marijuana Laws advocate for patients, 
caregivers, dispensaries, and other medical marijuana providers. 
7.   The literature from grow manuals and seed bank publications claim that 
indica strains of marijuana have a different effect than sativas and that indicas are 
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associated with sedation while sativas are associated with a more uplifting effect.  
Patients and caregivers generally agreed about the expected and perceived effects of 
these different strains of marijuana.  However, a few caregivers denied the arbitrary split 
between indicas and sativas and claimed the effects are “individual” to each specific 
patient or there are too many factors involved to identify the categories. 
8. Two of the most serious patient cases gave different answers than the rest 
of the patients and claimed that indicas gave them more energy while sativas did not 
which suggest there may be something medicinal (like CBD) in the indicas which are 
making them feel better and providing more energy.  Interviews focusing on the most 
serious cancer and M.S. patients should be conducted. 
The results in this dissertation do not provide evidence or proof of these 
hypotheses but they do raise the questions, offer solid hypotheses for future research, 
and provide ample justification for that further research.  Research is needed on the 
possibility that medical marijuana might aid the treatment of persistent opiate addiction 
and that marijuana can act as an adjunct or even a replacement to opiate use.  Clinical 
trials comparing opiates with medical marijuana are needed and long overdue.  Future 
work could also survey or interview larger patient samples, or focus on medical 
marijuana patients who are current or former opiate addicts.  There is a need for 
research into the issues of medical marijuana efficacy and patient characteristics.   
Despite regulatory barriers to medical marijuana research, qualitative interviews 
of patients provides a viable alternative to understanding the population, untangling the 
cannabis dialectic, describing the alternative provider distribution network, and providing 
evidence for the medical use and efficacy of marijuana.  However, since all the 
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interviews in this study were before People vs. McQueen outlawed dispensaries in 
Michigan, further work is needed to determine if the legal concerns of patients and 
caregivers and in particular the concerns about access to medical marijuana have 
increased since dispensaries were legally closed by the Michigan courts.  Further work 
could also investigate the scope of dispensaries that remain open in opposition to the 
court ruling and the impact and reaction to the ruling by the State-wide advocacy 
organizations.  Finally, considerably more work is needed on the different strains of 
medical marijuana.  The findings in this dissertation suggest that more serious patient 
cases might prefer high indicas which are higher in CBD which has been shown in cell 
lines and animal studies to have anti-inflammatory, analgesic, and anti-pyretic effects 
which could be important clue to finding the “medical” in medical marijuana. 
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APPENDIX 1:  INTERVIEW GUIDE 
Introduction:  
This is the interview Transcript of Participant _________ who has kindly given his/her (hereafter 
generic male pronoun) permission to record his statement is that correct?  
Your identity will remain confidential and you are free to skip or refuse to answer any 
question(s) for any reason. You may stop the interview at any point, and refuse to answer any 
more questions. Do you have any questions for me before we begin?  
OK, this is for a PhD program in medical sociology so I am primarily interested in the reasons 
why people are using medical marijuana, what is the range of patients and medical conditions 
that are treated and what are some of the problems people experience with this new treatment. So 
I am interested in your medical condition, your qualifying condition, what went into your 
decision to become certified to use medical marijuana, and your personal thoughts, ideas, and 
beliefs about how marijuana works for you.  
So I would like to ask you some questions about your medical history.  
Medical History/Qualifying Condition  
• What is your qualifying condition?  
• How long/When diagnosed  
• Who diagnosed (physician specialty- PCP, specialist or medical marijuana clinic doctor?  
• Could you just give me a narrative of your condition, and the treatment you have 
received? 
• History of medical providers seen for condition  
• How does this condition affect you?  
• Describe daily routine  
• Any impairments, symptoms, signs, etc.  
What type of treatment have you had for this condition?  
• Any major surgeries?  
• other drugs  
• invasive treatments  
• non-invasive treatments  
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Other medical conditions besides your qualifying condition?  
• get into detail  
Use of medical marijuana  
How does marijuana help your qualifying condition?  
• Describe in detail: Specifically WHAT does marijuana do for this condition?  
Does using marijuana help any of your other conditions besides the qualifying condition?  
Have you been able to decrease other treatments since you started using medical marijuana?  
• narcotics decreased?  
• Gateway or Reverse-gateway drug?  
* Reverse Gateway is a new term derivative of several conversations with physicians 
specializing in medical marijuana certifications. There is a large body of well-funded 
psychological research suggesting that marijuana is a “gateway” to “harder” drugs such as 
heroin and cocaine. Some certifying physicians criticize this methodology and characterize 
medical marijuana as a “reverse-gateway drug.” In other words, far from serving as an 
initiation and introduction to “hard” drugs the experience suggests the precise opposite. The 
physicians claim that medical marijuana patients are able to use marijuana to stop using or at 
least reduce the need for harder drugs such as oxycontin, vicodin and opiate pain relievers.  
Have you been able to reduce or discontinue any medications as a result of having medical 
marijuana available to you?  
• frequency of doctor visits and treatment  
How would you rate your ability to function in everyday life before you started using medical 
marijuana and after you became a patient?  
• improved or not?  
• able to work now but could not before?  
• comfort level?  
• Are you able to do any activities now (or more frequently) than you could before as a 
result of medical marijuana?  
• driving  
• work  
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• physical or mental activities?  
• MM vs. other medical tx.  
Has your use of marijuana decreased, increased, or stayed about the same since you became a 
legal certified patient?  
Adverse Effects of M and MM  
Some research suggests that marijuana causes memory impairment and a-motivational syndrome 
or laziness, and that marijuana smoke has a much higher level of cancer causing chemicals than 
cigarette smoke. Have you noticed any physical, cognitive, or mental problems from your use of 
marijuana?  
"How important is medical marijuana for your health?"  
"What are your feelings about the legalization of medical marijuana?"  
Drug History, Past and Current use patterns, before & after registered MMM status  
Now I would like to ask you some questions about your Drug History, Past and current use 
patterns, before & after registered MMM status  
Do you drink alcohol?  
• approximately how much per week?  
• have you ever felt or feared that you might have a drinking problem?  
Have you used other illegal drugs in the past?  
• Cocaine (crack, powder, mainline)  
• Heroin  
• Hallucinogens  
• Meth  
• Nicotine/Cigarettes  
• others  
• Prescription drugs (depending on qualifying condition)  
As you know marijuana is still considered a Schedule 1 drug by the federal government with no 
legitimate medical use and a high abuse potential:  
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What are your thoughts about that?  
How would you personally compare marijuana to these other drugs given your personal 
experiences?  
• dangers  
• abuse potential  
• medicinal value of any other drug (including alcohol and prescription drugs)  
• benefits  
Did you have experience with marijuana before you developed your qualifying condition?  
• when  
• how often  
• how used  
• for how long  
Without being specific or providing any identifying information, how do you get your medical 
marijuana?  
• Grow your own  
• You have a Registered Caregiver  
• Purchase on the street  
• Friend  
• Dispensary  
• Co-op/club or farmer’s market  
• Other source- please be specific without providing any specific identifying information.  
How do you use marijuana?  
• medibles  
• vaporize  
• smoke  
• regular pipe  
• joint  
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• water pipe  
In what type of social setting do you consume marijuana?  
• are you usually with other people/friend/family?  
• are you usually alone?  
How often:  
• Several times a day  
• Every day  
• Every night 4. About every other day  
• A few times a week  
• A few times a month  
What kind?  
Why did you go through the trouble of getting certified to use medical marijuana?  
Was going through the certification process worth it?  
Will you get recertified next year?  
Stigma:  
Ask: what do you think means before reading definition:  
(1) a mark of shame or discredit, disgrace or infamy; a stain or reproach, as on one's reputation.  
(2)Medicine/Medical. a mental or physical mark that is characteristic of a defect or disease: the 
stigmata of leprosy.  
• Family, Parents  
• Social  
• Medical Professionals (see also ‘certification’)  
Dealing with Children  
Strain Preferences Indica/Sativa etc.  
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Initiation- M and MM  
Demographics: Age, Gender, Family, Size, members, status,  
Now I would like to ask you some general demographic family, and employment history 
questions. In your answers please do not be specific enough so that a person reading this 
transcript would be able to identify you personally.  
You are a (male/female) in you (20’s, 30's)  
Did you grow up in a small town, the country, or the city?  
Are you married?  
• Any kids; how many; also other marriages/marital history  
How would you rate your economic status?  
• less than $20,000.00 for a family of 4  
• 25-35K for a family of 4  
• 35-55K  
• 60-150  
• over 150K per year  
How have you been employed?  
• disabled (due to qual. condition?)  
• management  
• temporarily unemployed (for how long) – 
• Professional (doctor/lawyer/executive)  
• office worker  
• sales  
• retail – 
• small business owner  
• construction  
• other  
• manufacturing  
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How are you currently employed?  
If unemployed where were you employed?  
Please tell me about your employment history?  
• go through in detail depending on time  
What is/was your income during your best year? When was that?  
What did your family (parents/spouse/kids) think about you becoming a medical marijuana 
patient?  
• do your kids know about your patient status?  
• approximate ages  
• how did you tell them  
• any barriers or obstacles from family such as parents or spouses opposing?  
• do you feel you have ever been stigmatized or discriminated against, or treated differently 
because you are a medical marijuana patient?  
Politics, Religion:  
Finally, I would like some general information on your political and religious orientation.  
Are you a member of an organized religion?  
On a scale of 1-10 with 10 being the most religious person you have ever met, how would you 
rate yourself in terms of your dedication to your religion?  
• Do you go to church (etc.) regularly?  
• pray?  
o Every day?  
o Every week?  
o About what?  
Is there a conflict between your religious beliefs and your use of marijuana?  
Do you consider yourself a liberal, or a conservative?  
• abortion  
• GWOT  
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• Same sex marriage  
Republican or Democrat?  
Based on your status as a patient, what do you think about the full legalization of cannabis? Have 
your attitudes changed since becoming a patient?  
Are you satisfied with MMM Law? How would you change?  
I am going to read to you a statement from Appellate court Judge O’Connell. Are you aware of 
his concurring opinion?  
--he basically said the law is unclear and that anybody in Michigan who uses medical marijuana 
for any reason can expect the DEA to come knocking at their door.  
I would like to get your reaction to a quote from his opinion:  
“I do not direct my critical comments toward those qualifying patients who do in fact have a 
serious debilitating condition and seek some solace in medical marijuana. This act was intended 
to help those individuals. My comments are directed at those who are currently abusing the 
written certification process, i.e., the majority of the persons who are becoming certified at this 
time… medical marijuana users “who proceed without due caution” could “lose both their 
property and their liberty.”  
Based on your observations, do you think the vast majority of medical marijuana patients are 
abusing the certification process and do not have a legitimate medical need?  
Conclusion  
Is there anything else you would like to tell me that I did not cover?  
Do you have any questions for me? 
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APPENDIX 2:  ADVERTISING FLYER 
 
RESEARCH PARTICIPANTS WANTED FOR 
 
MEDICAL MARIJUANA STUDY 
 
Do you have your medical marijuana card in Michigan?  Are you willing to 
help with some important research sponsored by the Sociology Department 
and the School of Medicine at Wayne State University? 
 
We are looking for patient and caregiver VOLUNTEERS to sit down and 
interview about your personal views, and experiences with marijuana as 
medicine. 
 
We will follow standard research procedures for interviews.  They will be 
recorded and transcribed but identifying information is masked or deleted 
to protect patient confidentiality.  The tape will be deleted after 
transcription.  You have the option of receiving a copy of the transcript and 
providing your additional comments. 
 
You may terminate the interview at any time and refuse to answer any 
question.  There is no funding to compensate participants and participation 
is voluntary.  Interviews will take approximately 1-hour. 
 
Contact Dave:  dpeters@med.wayne.edu or leave message at  
734-765-6212.   Thank you so much for your help! 
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 REDUCED OPIATE USE, DISPENSARY OPERATIONS,  
LEGAL CONCERNS, AND MARIJUANA STRAINS 
 
by 
 
DAVID C. PETERS II 
 
December 2013 
 
Advisor:  Mary C. Sengstock, PhD 
 
Major:     Sociology (Medical) 
 
Degree:   Doctor of Philosophy 
 
After hundreds of years of use the medical properties of Marijuana have been 
marginalized in our society. Qualitative interview data was collected from medical 
marijuana patients and knowledgeable producers and activists in Michigan about their 
perceptions and observations on the medical use of marijuana.  Patients consistently 
reported using marijuana to substitute or wean off prescription drugs.  All patients and 
producers who were taking opiate narcotics claimed they reduced overall drug use, 
especially opiates, by using medical marijuana.  Patients and caregivers also claimed 
medical marijuana was preferred over opiates, eased withdrawal from opiates, and in 
some cases was perceived as more effective at relieving pain.  Other issues explored 
included the operation of the Michigan Medical Marijuana Act, the formation and 
operation of medical marijuana centers in the face of countervailing State and federal, 
opposition, and the varieties and effects of different strains of medical marijuana. 
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